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Abstract 
 
Microorganisms produce a large number of medically relevant small molecules through unique 
biosynthetic mechanisms. These small molecules have been widely used to develop drugs to treat a 
range of infectious diseases, cancers and other pathologies. In their natural environment 
microorganisms use these small molecules for signalling or defence. As microorganisms have 
adapted to different environments, they have greatly expanded their chemical profile and thus the 
investigation of microorganisms from new environments has often led to the discovery of novel 
chemistry. 
 
Microbes often exist in association with higher eukaryotic hosts and are therefore exposed to unique 
environments and thus produce unique chemistry. The host organism can benefit by utilising 
microbial metabolites for their own defence against infections, predators, and for chemical 
signalling. Interestingly, some venomous animals such as puffer fish and the blue ringed octopus 
utilise toxins produced by associated microbes to defend against predators. However this chemistry 
remains largely unexplored for the vast majority of venomous animals. In this study, we 
investigated metabolites from microbes associated with venomous animals including spiders, 
centipedes, cone snails, scorpions and wasps. 
 
We cultivated microbes from 15 venomous animals to produce a library of ~360 strains. The 
microbe library was cultured under a range of conditions and the resultant solvent extracts were 
subjected to chemical, biological and genomic studies. This PhD thesis focuses on metabolites 
produced by three wasp-associated fungi, Aspergillus sp. (CMB-W031), Talaromyces sp. (CMB-
W045) and Quambalaria sp. (CMB-W001) and two cone snail-derived bacteria, Streptomyces sp. 
(CMB-CS038 and CMB-CS150) and Bacillus sp. (CMB-CS100). 
 
Chapter 1 Reviews the current status of drug discovery and symbiotic microbial strains involved in 
producing bioactive metabolites 
Chapter 2 Describes our approach to venomous animal microbial cultivation and microbe library 
biological and chemical profiling  
Chapter 3 Describes the identification and structure elucidation of a new nitrated diketopiperazine, 
waspergillamide A from a wasp-derived fungi Aspergillus sp. (CMB-W031) 
Chapter 4 Describes the identification and structure elucidation of new siderophores and 
azaphilones from a wasp-derived fungi Talaromyces sp. (CMB-W045) 
 iii 
Chapter 5 Describes the chemical investigation of several cone snail-derived Streptomyces sp. 
(CMB-CS038, CMB-CS150, CMB-CS138, CMB-CS143 and CMB-CS145) and their common 
biosynthetic capacity. 
Chapter 6 Describes the identification and characterization of a pheromone from the wasp-derived 
fungi Quambalaria sp. (CMB-W001) 
Chapter 7 Describes the identification of a novel biosynthetic gene cluster in the cone snail-derived 
Bacillus sp. (CMB-CS100), through in silico approaches 
Chapter 8 Conclusions and outlook 
 
Our studies showed that venomous animals are a rich source of fungi and bacteria with the capacity 
to produce diverse metabolites. Chemical and biological screening on microbes demonstrated their 
ability to synthesise bioactive components. The isolation of new metabolites from wasp-derived 
fungi reveals the unexplored potential of venomous animal associated microbes as a source of new 
chemistry. The discovery of an insect pheromone from a wasp-associated fungi and antifungal 
compounds from cone snail bacteria hints at their use as signalling molecules and as anti-infective 
agents respectively by their host organisms. To explore otherwise silent biosynthetic pathways, we 
sequenced and analysed the genome of a cone snail bacterium and identified a novel lantipeptide 
gene cluster whose expression in traditional culture conditions was validated by proteomics. Our 
results indicate this approach can also be applied to other isolates in combination with chemical 
approaches to discover and characterise new metabolites. In summary, this thesis highlights the 
potential of venomous animal-associated microbes as sources of new bioactive metabolites. 
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1 Introduction to Natural Products, microbial specialised metabolites and 
associated microbes as sources of bioactive molecules 
 
Natural products are defined as molecules of natural origin (plant, animal or microorganism) and 
are also referred as secondary metabolites or small molecules.1 A vast amount of human therapeutic 
agents are natural products, or are derived from natural products from plants, eukaryotes and 
prokaryotes. Microbes (bacteria and fungi) in particular have an exceptional ability to synthesise 
bioactive chemistry with a high structural diversity and activity against a range of biological 
targets.2  
 
Microbes have yielded a wealth of specialised metabolites found to be extremely useful in medicine 
and agriculture. However, in recent decades the overuse of antibiotics and pesticides has caused an 
increase in drug resistance, necessitating the search for new bioactive chemistry to deliver new 
antibiotics and pesticides with novel modes of action.3 Recent microbial genome sequencing has re-
invigorated the search for drugs from microbial sources revealing unprecedented biosynthetic 
potential showing there is yet new bioactive chemistry to discover.4 This PhD research focuses on 
the exploration of a unique micro-environment in venomous animals with a view to accessing 
bioactive metabolites of great biosynthetic diversity and ecological/pharmaceutical/agricultural 
value. This chapter will introduce general concepts of microbes as sources of bioactive metabolites 
and the biosynthetic pathways for their production. We also include reported examples of microbes 
associated with higher eukaryotic organisms that produce bioactive chemistry proven to be 
beneficial to its host. Each result chapter includes a specific introduction related to the chemistry 
discussed within it. 
 
1.1 History of microbial specialised metabolites  
 
Microbial metabolites have been used for thousands of years for therapeutic purposes, for example 
molds were used by ancient cultures to treat infectious diseases. In 1928, Alexander Fleming 
identified an antibacterial substance produced by Penicillium sp. which inhibited growth of a 
pathogenic Staphylococcus strain, leading to the isolation of penicillin by Howard Florey and 
Ernest Chain.5,6 With penicillin being in high demand, and the original Penicillium strain delivering 
poor yields, the search was on to discover a high producing penicillin strain.  Eventually, a new 
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penicillin producing strain was discovered by Mary Hunt in a fungal-infected cantaloupe.7,8 The 
discovery and scale-up production of penicillin marked the beginning of the "Golden Age of 
antibiotics”, which yielded numerous antibacterial substances and lasted ~50 years.9 During this 
period, microbes delivered many bioactive metabolites from almost all structural groups of 
antibiotics such as tetracyclines, cephalosporins and aminoglycosides, which eventually turned into 
effective drugs that are still used in the clinic today. However, the re-isolation of known chemistry 
and obstacles in purification methods drove big Pharma companies to shift investment from natural 
products to synthetics. Despite the reduced investment, the technological advances in recent years 
have greatly enhanced discovery of novel bioactive metabolites.10 These technological advances 
include modern chromatography (HPLC-DAD) and spectroscopy (NMR, MS), which allow 
structure elucidation on even smaller quantities of material (< 1 mg).11,12  
 
1.2 Microbial specialised metabolites: sources of therapeutic agents 
 
A 2011 review reported that 27% of all new commercially approved drugs over the period of 1981-
2010 were natural products or derivatives,13 emphasising their ongoing importance and value.14 
Within these statistics, microbial natural products were a determinant source of inspiration,2,13 with 
Actinobacteria and fungi accounting for >50% of microbe-derived drugs taken to the market. 
Several examples of marketed microbe derived antibiotics are shown in Table 1.1.15,16  
 
Table 1.1 Marketed microbial derived drugs. Table from Pelaez17 
Metabolite name 
 
Commercial name Producing organism 
penicillin (1.1) Penicillin G, V, Ampicillin, Methicillin, 
Amoxicillin, Carbenicillin  
Penicillium spp., Aspergillus spp.  
erythromycin (1.2) Erythrocin, Zithromax  Saccharopolyspora erythraea 
vancomycin (1.3) Vancocin Streptomyces orientalis  
fosfomycin (1.4) Monuril Streptomyces fradiae  
mupirocin  (1.5) Bactroban Pseudomonas fluorescens 
fusidic acid (1.6) Fusidin Fusidium grisseum 
streptogramin (1.7) Synercid Streptomyces pristinaerpiralis  
daptomycin (1.8) Cubicin Streptomyces roseoporus 
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Structures 1.1 − 1.8 exemplify the structural diversity of microbial metabolites derived from a 
diverse and abundant biosynthetic genes that encode specialised enzymatic assembly lines in 
microbial genomes. 
1.3 Microbial specialised metabolite biosynthetic pathways  
 
Microbial specialised biosynthetic enzyme assembly lines include polyketide synthases (PKS) and 
non-ribosomal peptide synthases (NRPS).18 Sequencing of microbial genomes has expanded our 
knowledge on the diversity and mechanisms involved in these PKS and NRPS assembly lines. 
 
There are three types of PKS enzymes, type I, II and III, these all involve serial decarboxylative 
condensation of coenzyme A substrates (e.g. malonyl Co-A and acyl-CoA).19 PKS I is a large 
enzyme with different active sites called modules that are subdivided into catalytic domains namely 
ketosynthase (KS), acyltransferase (AT), acyl carrier protein (ACP), kedoreductase (KR), 
dehydratase (DH). PKS II is a group of enzymes that also include include KS, AT, ACP and a 
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Chain Length Factor (CLF).20 PKS III has one single active site (KS) and lacks the acyl carrier 
protein (ACP) (Figure 1.1). Non-ribosomal peptide synthases (NRPS) are large enzymes composed 
of modules, which incorporate single amino acids into the neosynthesised peptide product. There 
are four basic domains in each module: adenylation (A), peptidyl carrier protein (PCP), 
condensation domain (C) and termination domain (TE) (Figure 1.1). NRPS substrates include 
proteogenic amino acids, non-proteogenic amino acids, fatty acids and α-hydroxy acids. Hybrid 
PKS/NRPS biosynthetic pathways exist and the assembly of the natural product is carried out by the 
cooperation of both PKS and NRPS assembly lines.21-23,24 
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Figure 1.1 Schematic representation of Polyketide Synthase (PKS) and Non Ribosomal Peptide Synthase (NRPS) 
pathways   
 
Examples of antibiotics produced by the aforementioned enzymatic assembly lines include 
erythromycin (1.2) and tetracycline (1.9) that are synthesised by PKS I and II, penicillin G (1.1) and 
vancomycin (1.3) that are made by NRPS, and FK506 (1.10) epothilone B (1.11) and rapamycin 
(1.12) which are generated by PKS-NRPS hybrid pathways.18  
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Besides biosynthesis through PKS and NPRS pathways, some microbial metabolites are synthesised 
by traditional ribosomal pathways. Such microbial metabolites are gene encoded and constitute a 
separate large class referred as ribosomally synthesised and post-translationally modified peptides 
(RiPPs). In recent years, the number of gene-encoded RiPPs has increased considerably due to the 
identification of biosynthetic RiPPs gene clusters through genomic approaches.25 Several RiPPs 
have been found to be active against multi-drug resistant and clinically relevant strains making 
them attractive candidates for drug development.26-30 The biosynthetis of RiPPS through traditional 
ribosomal pathways represents an important advantage, since in principle the genes are easier to 
dissect and express in an heterologous host.31,32 Biosynthetic RiPPs pathways use the canonical 20 
amino acids as substrates and their high diversity is due to their abundant post-translational 
modifications. RiPPs biosynthesis initiates with a precursor peptide that undergoes sequential post-
translational modifications guided by a leader peptide (Figure 1.2).33 There are many subclasses of 
RiPPs, some examples include lantibiotics, microcins, linaridins, proteusins, thiopeptides, 
cyclotides, glycocins, conopeptides and amatoxins.33  
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Signal Leader peptide Core peptide Recognition sequence 
Signal Leader peptide Modified core Recognition sequence 
•  Precursor peptide  
RiPP 
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-1 +1 
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•  Modified precursor 
Proteolisis and export 
 
Figure 1.2 General biosynthetic pathway for RiPPs. Figure from Arnison et al.33 
 
With the increase in genome sequencing a number of microbial biosynthetic pathways have been 
studied and characterised. At present, there are over 3,000 microbial sequenced genomes, which in 
many cases exhibit biosynthetic genes detected as either silent or underexpressed under standard 
cultivation methods.  The analysis, dissection and expression of biosynthetic genes using genomic 
methods gave rise to a new discipline called genome mining. 
 
1.4 Genome mining 
 
In 2000, Challis et al., discovered the biosynthetic gene cluster for coelichelin (1.13), a new tris-
hydroxamate tetrapeptide in Streptomyces coelicolor genome.34 In 2005 Lauru et al. identified the 
catalytic sites leading to the prediction of amino acid substrates used to produce 1.13.35 These 
events marked the beginning of the new discipline in drug discovery called genome mining.36 The 
genome sequencing of Streptomyces coelicolor in 2002 also revealed an unprecedented number of 
biosynthetic gene clusters undetected under standard culture conditions or with the analytical 
methods at hand,37 thus the “silent” or “cryptic” biosynthetic pathways and/or genes was 
introduced.  
 
New biosynthetic potential has been accessed through genome mining using different strategies. For 
example, the biosynthetic pathway of the new macrolactone stambomycin (1.14) was detected in 
the genome of Streptomyces ambofaciens ATCC 23877 and overexpressed via activation of a 
regulator gene.38 Another example is the identification of orfamide A (1.15) using a genome mining 
strategy termed genomisotropic approach involving the genome analysis of Pseudomonas 
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fluorescens and isotope-guided fractionation.39 The genome analysis of Aspergillus nidulans 
identified a hybrid PKS-NRPS biosynthetic pathways and the heterologous expression of the 
biosynthetic cluster with an inducible promoter led to the production of aspyridone (1.16).40 
Epigenetic regulation of Aspergillus nidulans yielded the activation of a secondary metabolite 
biosynthetic cluster for F-9775A (1.17).41 
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Genome mining has been greatly facilitated by the study of the genetic organisation of microbial 
biosynthetic gene clusters of polyketide synthases (PKS), non ribosomal peptides synthases (NRPS) 
and RiPPs.18 At present, there are over 3000 sequenced bacterial genomes deposited in the 
GenBank database, which constitute a useful toolbox to sustain many genomic studies. With the 
increase in genome sequencing an increased development of genome mining bioinformatics tools 
and platforms such as antiSMASH,42 Bactibase,43 BAGEL3,44 NaPDoS have emerged.45 Genomic 
sequencing has expanded our understanding of PKS and NRPS biosynthetic genes, useful in 
studying culturable and unculturable microbes. For example in the identification novel biosynthetic 
genes from environmental samples46 and in identifying the biosynthetic origins of associated 
microbe-derived molecules previously believed to be produced by a higher eukaryotic host.47  
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1.5 Bioactive chemistry from associated microbes 
 
Microbes are often found in symbiosis with higher eukaryotic organisms.48,49 Symbiosis (“life 
together”) generally refers to a partnership in which two organisms benefit from each other. A 
typical example of microbial symbiosis is found in human gut and skin, in which symbiotic 
microbes induce intestinal development, immunity and growth inhibition of pathogenic bacteria.50,51 
Herein we will refer to these microbial partners/symbionts as associated microbes, since the 
evidence we discuss does not allow us to confirm a true symbiosis. The type of chemical exchange 
between associated microbes has been shown to be unique and involve bioactive chemistry. The 
investigation of this chemical exchange has led to the identification of new molecules with 
important ecological significance.52  
 
The discovery of associated microbes with the ability to produce potent bioactive chemistry has 
made them the subject of drug discovery investigations.53 Perhaps, the most widely known 
examples are patellamide C (1.18), taxol (1.19) and bryostatin (1.20). Patellamide C (1.18) is a 
cytotoxic peptide first isolated from ascidian Lissoclinum patella,54 yet its biosynthetic genes were 
identified in the symbiotic cyanobacteria Trichodesmium erythraeum IMS101.47 Taxol (1.19) is a 
mitosis inhibitor used in breast, ovarian and lung cancer treatment,55-57 it was first identified in the 
bark of the pacific yew tree 58 but later confirmed as a product of the endophytic fungi Taxomyces 
andreanae.59 Bryostatin (1.20) was isolated in the 1960’s from a bryozoan and in the early 1980’s 
Petit et al. proposed a microbial biosynthetic origin.60 Indeed, further studies confirmed it as a 
product of the symbiont Endobugula sertula.61 
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Microbial association in insects is extremely common and in most reported cases the host benefits 
from the microbial chemistry. For example, the Beewolf digger wasp Philantus spp. harbours the 
actinobacteria Candidatus Streptomyces philanthi, which produces an antibacterial cocktail of 
streptochlorin (1.21), piericidin A (1.22) and glucopiericidin A (1.23), conferring protection to the 
larval cocoon.62 
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Yet another example of microbial-insect association is the southern pine beetle Dendroctonus 
frontalis, and associated microbe Streptomyces, which produces the metabolite mycangimycin 
(1.24) that provides the host with an antifungal against growth of the pathogenic fungi Ophiostoma 
minus, the inhibition of which favours the growth of a beneficial symbiotic fungi Entomocorticium 
sp., useful as nourishment for their larvae.63  
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In addition to the common antibacterial protection, microbes associated with higher eukaryotic 
organisms have shown to carry out necessary biotransformation reactions using the native host 
chemistry as substrates. For example, in the beetle Agabus affinis, gut associated Bacillus spp. 
oxidise the precursors of pregnenolone (1.25) and androst-4-en-3,17-dione (1.26), reaction 
necessary for their secretion.64  
O
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Another example of biotransformation carried out by an associated microbe involves the production 
of volicitin (1.27), a defence molecule used by plants against herbivore attack that is found in the 
regurgitate of the caterpillar Spodoptera exigua. Studies have shown that the linoleic acid (1.28) 
portion of 1.27 derives from plant and the glutamine (1.29) from the caterpillar generating a 
volicitin precursor (1.30).65 Microbes from caterpillar’s gut were investigated and demonstrated the 
ability to yield 1.30 using 1.28 and 1.29 as substrates (Figure 1.3).66 
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Figure 1.3. Schematic diagram of biosynthesis of volicitin precursor (1.30) from plant-derived linoleic acid (1.28) and 
glutamine (1.29) catalysed in Spodoptera exigua gut  
 
The necessary chemistry and biotransformation reactions in which microbes associated with higher 
eukaryotic associated microorganisms are involved highlight their important ecological roles. In 
addition to these aforementioned examples, some associated microbes have evolved the ability to 
produce toxins vital for host survival. 
 
1.6 Microbial symbiont toxins  
 
Toxins are defined as substances with harmful effects produced by an organism, which they often 
use for defence. Microbial symbionts can synthesise toxins that the higher eukaryotic host uses for 
defence. For example, the paralytic shellfish toxin (PST), saxitoxin (1.31) found in dinoflagellates 
from the genera Alexandrium and is produced by the symbiotic Gram-negative bacteria Anabaena 
circinalis.67 Yet another example is the neurotoxin tetradotoxin (1.32), a sodium channel blocker 
with a wide inter-species distribution, which raised questions towards its biosynthetic origin. After 
many years of controversy, the bacterial strains Vibrio harveyi and Arothron hispidus isolated from 
puffer fish were found to produce 1.32.68 
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Okadaic acid (1.33) is another interesting toxin that is known to cause diarrheic shellfish poisoning 
(DSP), and has been isolated from the Halichondria spp. sponges69 and dinoflagellates.70 It is 
highly common for 1.33 to accumulate in edible shellfish such as mussels, oysters and clams, which 
represents a human health threat. Interestingly, 1.33 also targets specific proteins relevant in 
neurodegeneration, making it a useful tool for understanding molecular mechanisms behind 
Alzheimer’s and other related dementia pathologies. The biosynthetic origin of 1.33 remains 
unknwon, efforts on the isolation from several microbial strains presumably producing toxic 
components so far lacks compelling evidence to prove its microbial origin.71  
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1.7 Conclusion  
 
Microbes are an essential source of therapeutic agents. Many microbes associated with higher 
eukaryotic organisms play essential roles by producing bioactive chemistry used by the host mainly 
for defence. Sequencing of microbial genomes has revealed a biosynthetic potential greater than 
previously imagined and has shed light into the diversity and organisation of biosynthetic pathways. 
Hence, the ongoing technological advances improve our ability to access the often unexplored 
microbial biosynthetic potential. 
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The exploration of venomous animals as sources of microbial diversity for drug discovery so far is 
not extensive and represents an interesting environment to search for new microbial and chemical 
diversity. This study focused on the chemical investigation of microbes associated with several 
Australian venomous animals to explore unprecedented chemistry and/or biological significance 
using chemical, biological and genomic analysis.  
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2 Australian venomous animal-derived microbes: dissection, microbial 
cultivation, profiling and prioritisation 
2.1 Introduction 
 
Australia is among the top 17 ‘megadiverse’ countries in the world, ranking first in endemic 
biodiversity.72 This remarkable biodiversity includes highly venomous animals, which have evolved 
venoms for predation and/or defence. Many of these venoms are disulfide bridge rich peptides 
known to target mammalian ion channels.73 Interestingly, disulfide rich peptide venoms can have 
therapeutic potential due to their specificity and potency, and have delivered six FDA approved 
drugs.73,74 Within these venomous animals there is a diversity of associated microbes. 
 
Microbes produce a vast amount of bioactive molecules.  Microbes found in association with higher 
eukaryotic organism produce bioactive molecules and provide benefits to their host, thus we 
hypothesised that microbes associated with Australian venomous animals may impart an ecological 
survival benefit in the form of new or enhanced bioactive molecules. In this study, we isolated 
microbes from a selection of venomous animals and went on to investigate their chemistry. We 
acquired several Australian venomous animals (centipedes, spiders, scorpions and cone snails) from 
collaborator laboratories, and recovered microbes from their tissues. The venomous animal 
specimens were collected at different dates and locations between September 2011 and September 
2012 (Table 2.1). After each collection, specimens were transferred immediately to the laboratory 
for microbial cultivation. 
 
Table 2.1 Venomous animal specimens collected and microbiologically investigated  
Specimen Species Date of collection 
Centipede Ethmostigmus rubripes 
Thereuopoda sp. 
November 2011 
December 2011 
Scorpion Liocheles weigensis November 2011 
Spider Hadronyche infensa October 2011 
Cone Snail  Conus miles 
Conus flavidus 
Conus emaciatus 
Conus ebraeus 
Conus coronatus 
November 2011 
February 2012 
September 2012 
September 2012 
September 2012 
Mud dauber wasp Sceliphron sp. February 2012 
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We recovered microbes from the different venomous animal specimens as illustrated in Figure 2.1. 
The methodology included dissection and homogenization of tissue preparations, followed by serial 
dilutions and inoculation of plates loaded with different agar media. All preparations and 
dissections were performed under a laminar flow biosafety hood to avoid contamination. Proper 
media and reagent controls were placed to assure the absence of environmental contamination. This 
chapter describes the microbial cultivation from venomous animal tissue and the chemical and 
biological profiling screenings applied to the microbial library of prioritised isolates. 
Outer surface microbes (swab) 
Surface sterilisation 
Agar media dispersion  
Homogenate ten-fold dilutions 
Dissection 
 
Hepatopancreas, stomach,  
venom duct, foot 
 
Cone snail 
Cone snail 
Wasp, centipede,  
Scorpion or spider 
 
Figure 2.1 Schematic diagram showing the general steps followed for the dissection and microbial cultivation of 
venomous animal specimens (scorpions, spider, wasp, centipede and cone snail)  
2.2 Venomous animal microbial cultivation  
2.2.1  Cone snail microbial cultivation 
 
Cone snail specimens were collected from Lady Musgrave Island at the Great Barrier Reef between 
September 2011 and September 2012. The cone snail was removed from its shell and rinsed clear of 
debris with sterile seawater. The venom duct, hepatopancreas and stomach were carefully dissected 
from the body using a sterile scalpel and forceps. Individual tissue sections were transferred into a 
sterile eppendorf tube (1.5 mL) and washed with sterile seawater. Each tissue was carefully 
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homogenised using mortar and pestle in sterile seawater (2 mL) and transferred to a clean sterile 
tube. Four tenfold serial dilutions were prepared from this homogenate, with aliquots (50 µL) 
dispersed onto plates loaded with different agar culture media (marine agar, TSA, M1 with sea salt, 
ISP-2, ISP-4, R2A, chitin media) without or with antibiotic supplements of cycloheximide and 
nalidixic acid (10 µg/mL). Inoculated agar plates were incubated at 26.5 °C for 3-4 weeks after 
which individual colonies where observed. A total of 151 microbial isolates were recovered and 
each microbe was cryopreserved in marine broth  (20% glycerol) and cryo-archived at -80 °C. All 
isolates were assigned a code beginning with the letters CMB followed by a dash and the letters CS 
for Cone Snail, and a three digit consecutive number, for example CMB-CS001, CMB-CS002, etc,.  
 
2.2.2  Centipede, spider, scorpion and wasp microbial cultivation 
 
The recovery of microbial isolates from centipede, scorpion, spider and wasp focused on microbes 
associated with both outer and inner surfaces.  Outer surface microbes were recovered by rinsing 
the specimen thoroughly with sterile water followed by a rigorous swabbing with a sterile swab 
moistened by sterile 0.9% NaClaq, after which swabs were re-soaked in a tube containing sterile 
saline (5.0 mL). Aliquots (50 µL) of the saline wash were dispersed onto agar plates loaded with a 
range of culture media (see above) and incubated at 26.5 °C for up to four weeks or until 
pronounced microbial growth was observed. After the outer surface microbe sample recovery, the 
residual specimen was surface sterilised by submerging the specimen for 60 seconds in 80% 
EtOH(aq.) The specimen was then rinsed with sterile saline (10 mL), transferred to a mortar, 
homogenised with a pestle and the recovered homogenate resuspended in saline solution  (5 mL). 
Four tenfold serial dilution were prepared from the homogenate and an aliquot (50 µL) dispensed 
on agar plates loaded with a range of culture media (ISP-2, ISP-4, TSA, NA, chitin) with or without 
the antibiotic supplements of cycloheximide and nalidixic acid (10 µg/mL). Inoculated agar plates 
were incubated at 26.5 °C for up to four weeks or until pronounced microbial growth was observed. 
Microbial colonies recovered after the incubation period were sequentially subcultured to obtain 
pure isolates which were cryopreserved in TSB (20% glycerol) and cryo-archived at -80 °C. All 
isolates were assigned a code beginning with the letters CMB following a dash and the specimen 
identifying letter code (SP=spider, CE=centipede, SC=scorpion, and W=wasp) and a three digit 
consecutive number, for example CMB-SP001, CMB-SP002 etc. 
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2.3 Venomous animal associated microbe library 
 
The microbial cultivation of all the aforementioned venomous animals resulted in the isolation of 
363 microbes, which constitute the CMB venomous animal microbial isolate library (Figure 2.2). 
 
Figure 2.2 Graphical representation of the venomous animal microbial isolates. Total number of microbial isolates 
recovered from each venomous specimen is specified in parenthesis. The number microorganism category is indicated 
with *F for Fungi, A for Actinobacteria and U for Unicellular 
 
Based on the microscopic morphology of their cultures on agar, microbes were identified in three 
categories: fungi (hyphae), actinobacteria (sporulating bacterial colonies) and unicellular bacteria 
(all other non-sporulating bacteria) (Figure 2.3). The unicellular bacteria were the most abundant 
microbes recovered from all the venomous specimens dissected, followed by actinobacteria, which 
were more abundant in centipedes and cone snails, and lastly fungal isolates were found in high 
numbers in wasps. Actinobacteria and fungi are widely recognised as prolific producers of bioactive 
specialised secondary metabolites and special priority was given to their chemical and biological 
analysis.  
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Figure 2.3 Number of microbes recovered from each of the macroscopic categories from the different venomous 
animal. Actinobacteria (red), fungi (blue), unicellular bacteria (green) 
 
2.4 Venomous animal microbial library biological and chemical screening 
 
Extracts prepared from venomous animal derived microbes were subjected to biological and 
chemical profiling. To obtain crude organic extracts, each strain was cultivated on an agar plate 
with media without antibiotic supplement. A total of 300 microbial isolates grew after thawing from 
the cryo-archived vials. After 5-15 days of cultivation at 26.5 °C, the diced agar (1 cm3 cubes) was 
extracted for 1 h with EtOAc:MeOH (3:1) (30 mL) at room temperature. The resulting extract was 
decanted, dried in vacuo, resuspended in MeOH (3 mL), transferred to a vial and dried under N2 at 
40 °C and weighed. It was resuspended in MeOH and divided into two vials for biological and 
chemical profiling, and dried again under N2 at 40 °C to obtain replicates for each extract. Extracts 
were resuspended in a suitable solution for biological (PBS 1X, 5% DMSO) and chemical  (MeOH) 
probing. Figure 2.4 shows a general schematic representation of the steps followed to prioritise 
isolates based on biological and chemical profiling.  
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Figure 2.4 General schematic diagram showing steps followed for biological (purple) and chemical (blue) screenings 
applied to the obtained crude organic extracts of microbes (red) 
2.4.1 Chemical profiling 
 
The microbial extracts obtained from the aforementioned 300 isolates were resuspended in MeOH 
(1 mg/mL) and analysed by HPLC-DAD-MS using a C18 column with a gradient eluting from 90% 
H2O/MeCN (0.01% formic acid) to MeCN (0.01% formic acid) over 15 min. The HPLC-DAD-MS 
chromatograms for each isolate were compared to an extract of the un-inoculated media to 
distinguish the chemistry produced by the microorganism. HPLC-DAD-MS permitted a chemical 
insight of each strain showing UV-vis absorbance and m/z ions for each peak. This preliminary 
chemical profiling permitted prioritisation of the wasp-derived fungal strain extracts, which were 
rich in chemical diversity as indicated by the number of chromatogram peaks with each having a 
unique UV-vis signature (eg. Figures 2.5 and 2.6). By contrast, HPLC-DAD-MS chromatograms of 
the spider, scorpion and centipede microbial extracts typically contained fewer metabolites (eg. 
Figures 2.7 - 2.9). The cone snail-derived actinobacteria were also less prolific at producing MeOH 
soluble metabolites (eg. Figure 2.10). Similarly, the HPLC-DAD-MS chromatograms for 
unicellular bacteria indicated a lower production of metabolites compared to fungal and 
Actinobacteria extracts.  
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Figure 2.5 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-W038 (black chromatogram line) [Zorbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset. 
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Figure 2.6 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-W013 (black chromatogram line) [Zorbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset 
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Figure 2.7 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-SP032 (black chromatogram line) [Zprbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset. 
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Figure 2.8 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-CE026 (black chromatogram line) [Zorbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset 
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Figure 2.9 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-SC019 (black chromatogram line) [Zorbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset 
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Figure 2.10 HPLC-DAD-MS (210 nm) chromatogram of EtOAc:MeOH (3:1) extract obtained from control agar media 
(blue chromatogram line) and from CMB-CS001 (black chromatogram line) [Zorbax SB-C8 column 90% H2O/10% 
MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra colours displayed 
correspond to the coloured peak in the chromatogram inset 
The biological screenings on microbial extracts analysed through HPLC-DAD-MS permitted a 
prioritisation of microbial isolates capable of producing bioactive molecules.  
2.4.2 Biological profiling 
 
The biological screenings on microbial extracts analysed by HPLC-DAD-MS permitted a 
prioritisation of microbial isolates capable of producing bioactive metabolites. The microbial 
solvent extracts described in the previous chemical profiling section were resuspended in 5% 
DMSO/PBS 1X  (1 mg/mL) for antibacterial and cytotoxicity assays. For antibacterial activity, each 
crude extract was screened against the Gram-negative bacteria Escherichia coli (ATCC 25922) and 
Pseudomonas aeruginosa (ATCC 27853), the Gram-positive bacteria Staphylococcus aureus 
(ATCC 25923) and Candida albicans (ATCC 90028) using a turbidimetric based assay (see 
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experimental section). For cytotoxic activity, crude extracts were screened against SW-620 (colon 
cancer) and NCI-H460 (lung cancer) cell lines using MTT assay (see experimental section). In 
addition to these two biological assays, the cone snail microbial extracts obtained from strains 
isolated from venom duct were subjected to a neuroactivity FLIPR (Fluorescence Imaging Plate 
Reader) based assay to identify inhibitors or potentiators of voltage-gated calcium channels (Cav) 
and neuronal nicotinic acetylcholine receptors (nAChR) (see experimental section). This latter 
assay is routinely used to screen cone snail venoms for neuroactive peptides.   
 
2.4.2.1 Antibacterial 
  
For antibacterial activity, fungal isolates recovered from wasp and centipedes displayed the 
strongest activity. Table 2.2 shows prioritised strains and selected examples of isolates showing a 
low viability percentage. The HPLC-DAD-MS analysis of such fungal extracts had revealed a 
prolific production of metabolites, seen by the abundant signals measured at two wavelengths, 210 
and 254 nm. Prioritised fungal strains, CMB-W031, CMB-W045 and CMB-W001 were subjected 
to culture optimization followed by scaled up cultivations, the chemical analysis and 
characterization of these fungal strains are the subject of Chapter 3, 4 and 6 respectively.  
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Table 2.2 Selected antibacterial screening results for selected prioritised microbial strains. Extract was tested at  
concentrations of 1 mg/mL 
Strain code  % viability 
 P. aeruginosa 
ATCC 27853 
B. subtilis 
ATCC 6633 
S. aureus 
ATCC 25923 
E. coli 
ATCC 25922 
CMB-W013 20 10 50 45 
CMB-W024 60 10 30 100 
CMB-W025 30 60 60 20 
CMB-W031* 5 5 5 5 
CMB-W038 30 30 20 20 
CMB-W041 10 80 80 80 
CMB-CE042 10 15 50 50 
CMB-W001* 60 15 30 30 
CMB-CE045* 5 5 45 10 
CMB-CE049 70 90 90 70 
CMB-W013 10 30 100 100 
CMB-CE026 10 10 25 30 
CMB-SP032 50 80 60 50 
CMB-CE006 15 15 15 15 
CMB-CE001 20 20 15 1 
CMB-SC001 50 30 40 60 
CMB-CS100* 20 40 20 20 
Oxytetracycline (0.1µM) ( positive 
control) 
5 5 5 5 
 *Selected and chemically investigated for this PhD thesis 
2.4.2.2 Antifungal 
 
The antibacterial screening carried out on cone snail microbial extracts showed antifungal activity 
when assayed against C. albicans ATCC 90028 (Table 2.3). A full description on the biological 
screening prioritised strains and the chemical investigation on cone snail derived microbes is 
described in chapter 5. The genome analysis on a selected strain derived from the stomach of a cone 
snail is described in chapter 7. 
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Table 2.3 Selected antifungal screening results for prioritised microbial strains. Extract was tested at  concentrations of 
1 mg/mL 
 
Strain code C. albicans  (% viability ) 
CMB-W031* 10 
CMB-CS038* 10 
CMB-CS132 10 
CMB-CS145 10 
CMB-CS150 10 
CMB-CS143 15 
CMB-W024 20 
CMB-W025 15 
CMB-W038 10 
CMB-W041 40 
CMB-W042 30 
CMB-W043 35 
CMB-CE001 50 
CMB-SC016 15 
Ketoconazole (0.1µM) (+control) 5 
 *Selected and chemically investigated for this PhD thesis 
2.4.2.3 Neuroactivity 
 
Out of the 160 cone snail microbial extracts screened for neuro-activity using FLIPRTETRA 
technology 14 hits were identified displaying inhibition or potentiating measurements 
corresponding to specificity to bind to voltage-gated calcium channels (Cav) and neuronal nicotinic 
acetylcholine receptors (nAChR) (Table 2.4).  
Table 2.4 Selected neuroactivity screening results for prioritised microbial strains. Extract test concentrations at 1 
mg/mL 
Strain code Channel or receptor  Response 
CMB-CS036 CaV Inhibitor 
CMB-CS142 CaV  Inhibitor 
CMB-CS180 α7AChR (choline control) Inhibitor 
CMB-CS005 α7AChR  Inhibitor 
CMB-CS008 α7AChR  Inhibitor 
CMB-CS049 α2β3AChR (nicotine control) Inhibitor 
CMB-CS051 α2β3AChR Inhibitor 
CMB-CS150* α2β3AChR Inhibitor 
CMB-CS030 CaV Potentiator 
CMB-CS100 α7AChR Potentiator 
CMB-CS123 α7AChR Potentiator 
CMB-CS038 α7AChR Potentiator 
CMB-CS098 α7AChR Potentiator 
 *Selected and chemically investigated for this PhD thesis. Control used for these experiments are described in 
the experimental section 
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2.4.2.4 Cytotoxicity 
 
For cytotoxicity, microbial isolates recovered from wasp, centipedes and cone snails displayed the 
strongest cytotoxic activity (Table 2.5). The prioritised strains CMB-W031, CMB-W045 and CMB-
W001 and CMB-CS038 were subjected to culture optimization followed by scaled up cultivations. 
The chemical analysis and characterization of these microbial strains are the subject of Chapter 3, 4 
and 5 and 6. 
Table 2.5 Selected cytotoxity screening results for prioritised microbial strains. Extract was tested at  concentrations of 
1 mg/mL 
 
Strain code % viability 
  SW-620   NCI-H460 
CMB-W031* 5 10 
CMB-W024 20 25 
CMB-W025 15 20 
CMB-W038 30 30 
CMB-W041 25 25 
CMB-W042 25 25 
CMB-W043 30 30 
CMB-W045* 5 5 
CMB-W049 35 35 
CMB-W013 25 25 
CMB-CE026 15 20 
CMB-SP032 20 20 
CMB-CE006 10 10 
CMB-CE001 30 30 
CMB-CS132 25 25 
CMB-CS038* 15 15 
CMB-CS145 25 25 
Vinblastine (0.1µM) ( positive 
control) 
5 5 
SW-620, Human colon cancer cell line, NCI-H460, Human lung cancer cell line. *Selected and chemically 
investigated for this PhD study 
 
2.4.3 Venomous animal microbial genome sequencing 
 
In addition to biological and chemical profiling, selected cone snail-derived microbes were 
subjected to full genome sequencing. The criteria for selection of strains (five venom duct derived 
cone snail microbes) subjected to genome sequencing was based on the neuroactivity identified in 
the FLIPRTETRA assays (see above). The high molecular weight genomic DNA was isolated from 
broth cultures (100 mL) of one Bacillus sp. (CMB-CS100), two Streptomyces sp. (CMB-CS150 and 
CMB-CS022) and two alphaproteobacteria (CMB-CS008, CMB-CS005) using a standard 
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phenol:chloroform extraction method. Genomic DNA was sequenced using Ilumina sequencing 
platform. The details on genome sequencing and assembly are described in chapter 7. Assembled 
genomes were used for two main purposes: (1) to search for conotoxin-like sequences as discussed 
in chapter 5, and (2) Genome mining for novel biosynthetic gene clusters in Bacillus sp. (CMB-
CS100) as discussed in chapter 7. Conotoxin-like sequences were searched in bacterial assembled 
genomes with “ConoSorter”, a conotoxin sequence database/platform used widely in the conotoxin 
discovery pipeline.  The genome mining of Bacillus sp. (CMB-CS100) was carried out using 
publicly available databases and genome mining tools discussed in Chapter 7. 
2.5 Summary and conclusions 
 
The study successfully assembled a library of 363 microbial isolates from venomous Australian 
animals, while biological and chemical profiling prioritised three wasp-derived (CMB-W045, 
CMB-W001 and CMB-W045) and two cone snail derived (CMB-CS100, CMB-CS038) isolates 
(Figure 2.11).   
 1 wasp 2 centipedes 10 cone snails 1 spider 1 scorpion 
36 fungi 80 actinobacteria 247 unicellular bacteria 
Chapter 3  (CMB-W031)  1 fungi 
Chapter 4 (CMB-W045)  1 fungi 
Chapter 5 (CMB-CS038) 2 actino  
   (CMB-CS150) 
Chapter 6 (CMB-W001)  1 fungi 
Chapter 7 (CMB-CS100) 
1 unicellular bacteria 
Genome mining 
Scale-up cultivation  
chemical investigation 
363 microbial isolates 
Biological Profiling 
300 isolates 
  
Chemical Profiling 
300 isolates  
Genome sequencing 
5 isolates 
  
 
Figure 2.11 Schematic representation of venomous animal-derived CMB strain prioritization  
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• Chapter 3 Describes the chemical investigation of Aspergillus sp. (CMB-W031) leading to 
the discovery of a new first in class natural product waspergillamide A (3.24).  
•  Chapter 4 Details the chemical investigation of Talaromyces sp. (CMB-W045) leading to 
the discovery of new siderophores and azaphilones. 
•  Chapter 5 Describes the chemical investigation of cone snail Streptomyces sp. (CMB-
CS038, and CMB-CS150) leading to the identification of antifungal polyketide tetramates.  
• Chapter 6 Describes the chemical investigation of Quambalaria sp. (CMB-W001) leading 
to an insect contact sex pheromone. 
• Chapter 7 Describes a genome analysis approach of the cone snail associated Bacillus sp. 
(CMB-CS100) leading to the identification of a new lantipeptide gene cluster. 
 
To select the microorganisms to study for this PhD, we relied heavily on the bioassays described in 
this chapter but also in those chemical profiles with prolific production of metabolites. In some 
cases while activity was detected, the production of metabolites observed in the HPLC-DAD-MS 
chromatograms was low. We do not discard the isolates which may posses an interesting 
biosynthetical potential, especially unicellular bacteria and their chemistry may be investigated 
using other techniques when a fair amount of material can be detected in the HPLC-DAD-MS 
chromatograms.  While not all the interesting chemistry could be investigated in this study, other 
prioritised isolates displaying bioactivity in our assays are currently under investigation by other 
PhD students. 
2.6 Experimental  
2.6.1 General experimental 
 
Glucose was purchased from Biochemicals (Sydney, NSW, Australia); yeast extract from Merck 
(Darmstadt, Germany); peptone from Oxoid (Basingstoke, Hampshire, UK); Marine agar, ISP-4 
agar from BD Diagnostics (Burlington, NC, USA); soluble starch, malt extract, mannitol, sucrose 
and agar from Sigma-Aldrich. Analytical-grade solvents were used for solvent extractions and solid 
phase extractions (SPE). Solvents used for HPLC-DAD-MS purposes were of HPLC grade supplied 
by Labscan or Sigma-Aldrich and filtered/degassed through 0.45 µm polytetrafluoroethylene 
(PTFE) membrane prior to use. Venomous specimens and microorganisms were manipulated under 
sterile conditions provided by a Laftech class II biological safety cabinet and incubated in MMM 
Friocell incubators or Innova 42 incubator shakers with temperature set at 26.5 °C.  
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2.6.2 Chemical profiling experimental 
High performance liquid chromatography-diode array-mass spectrometry (HPLC-DAD-MS) data 
were acquired on an Agilent 1100 series separation module equipped with an Agilent 1100 series 
HPLC/MSD mass detector and diode array multiple wavelength detector. Electrospray ionization 
mass spectrometry (ESIMS) experiments were carried out on an Agilent 1100 series LC/MSD 
(quadrupole) instrument in both positive and negative modes. 
2.6.3 Biological profiling experimental 
 
Antimicrobial assay. Antimicrobial activities were measured against the Gram-positive bacteria 
Staphylococcus aureus (ATCC 25923) and Bacillus subtilis (ATCC 6633), the Gram-negative 
bacteria Escherichia coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853) by the broth 
micro-dilution method. The test was performed (in triplicate) in 96-well microtiter plates by serial 
dilution in tryptic soy broth (TSB) for bacteria and Sabouraud broth for fungi, respectively. 
Microbial crude extracts were tested (1 mg/mL). An aliquot (20 µL) of each was transferred to a 96-
well microtiter plate, followed by freshly prepared microbial broth (180 µL, 104–105 CFU/mL cell 
density). The plates were incubated at 26.5 °C for 24 h. The optical density of each well was 
measured spectrophotometrically at 600 nm by using POLARstar Omega plate reader (BMG 
LABTECH, Offenburg, Germany). Broth medium with and without microbial inoculation were 
tested as negative controls. Oxytetracycline was used as positive control.  
 
Antifungal assay. Antifungal activity was measured against C. albicans using the broth micro-
dilution method as indicated for antimicrobial assays. Ketoconazole was used as positive control. 
The viability % was determined based on spectrophotometrical results. 
 
Cytotoxicity assay. Cytotoxicity assays were carried out using the MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) method as previously described75 by using adherent NCIH460 
(human large cell lung carcinoma) and SW-620 (human colorectal adenocarcinoma). Cells were 
harvested with trypsin and dispensed into 96-well microtitre assay plates at 2,000 cells/well and 
incubated for 18 h at 37 °C with 5% CO2 (to allow cells to attach). Crude extracts were dissolved in 
5% DMSO in PBS (v/v) and aliquots (20 µL) and were tested with a final concentrations of 1 
mg/mL. Vinblastine was used as positive control and negative control wells were treated with 5% 
aqueous DMSO. After 68 h incubation at 37 °C with 5% CO2, an aliquot (20 µL) of MTT in PBS (4 
mg/mL) was added to each well (final concentration of 0.4 mg/mL), and the microtitre plates 
incubated for a further 4 h at 37 °C with 5% CO2. After this final incubation the medium was 
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aspirated and precipitated formazan crystals were dissolved in DMSO (100 µL/well). The 
absorbance of each well was measured at OD580 nm with a (POLARstar Omega plate, BMG 
LABTECH, Offenburg, Germany). 
Neuro-activity assay. Neuro-activity assays were carried out on SH-SY5Y human neuroblastoma 
cell line, cells were maintained at 37 °C and 5% CO2 in RPMI media containing 15% FBS and 2 
mM L-glutamine and routinely passaged at a 1:5 dilution every 3–5 days using 0.25% 
trypsin/EDTA (Gibco). Cultured SH-SY5Y cells were seeded at 100,000 cells per well in black-
walled 384-well imaging plates 48 h before the experiment, so that cells formed a confluent 
monolayer during the experiment. Seeding media was equivalent to that used to culture the cells. 
The FLIPR
TETRA 
system was used to measure the intracellular increases in calcium in response to 
choline, nicotine and KCl activating the α7 nAChRs, α2β3 nAChRs and CaV channels respectively 
expressed endogenously by SH-SY5Y cells. Cells were washed once with physiological salt 
solution (PSS; 5.9 mM KCl, 1.5 mM MgCl2, 1.2 mM NaH2PO4, 5.0 mM NaHCO3, 140 mM NaCl, 
11.5 mM glucose, 5 mM CaCl2, 10 mM HEPES, pH= 7.4) and loaded, at 37 °C for 30 min, with 
component A of the Calcium 4 assay kit (Molecular Devices), which contains the calcium 
fluorophore (Fluo-4) required for Ca
2+ imaging. After incubation with the calcium fluorophore, the 
cells were transferred to the FLIPR
TETRA (Molecular Devices) where intracellular calcium levels 
were measured using a cooled CCD camera with excitation at 470–495 nm and emission at 515– 
575 nm. Camera gain and intensity were adjusted for each plate of cells yielding a minimum of 
1000 arbitrary fluorescence units (AFU) as a baseline fluorescence value. Microbial organic 
extracts were added 5 min before applying activators, choline (30 mM) and N-(5-chloro-2,4-
dimethoxyphenyl)-N -(5-methyl-3-isoxazoly- l) urea (PNU-120596) (10 mM), nicotine and KCl. 
PNU-120596 is required to measure α7 nAChR activity on the FLIPR platform76 because the 
receptor’s kinetics are too fast to measure otherwise.77 As controls, the activity of CaV2.2 channels 
SH-was assessed in the presence of nifedipine (10 µM) after stimulation with KCl (90 mM) and 
CaCl2 (5 mM). Nicotine (50 µM) was used to activate endogenously expressed human α3β2, while 
endogenously expressed human α7 nAChR were activated using the α7 nAChR agonist choline 
(30 µM) in the presence of the allosteric modulator PNU120596 (10 µM; Sigma–Aldrich). 
Responses were normalized to baseline using ScreenWorks 3.2.0.14 (Molecular Devices). 
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3 Waspergillamide A: a new nitrated diketopiperazine from wasp-derived 
Aspergillus sp. (CMB-W031) 
 
The microbial cultivation of microbes associated with a single specimen of a Mud dauber wasp 
yielded 50 strains. Chemical and biological profiling of solvent extracts obtained from cultivation 
of these microbes allowed for the prioritisation of fungal isolate CMB-W031. The HPLC-DAD-MS 
analysis of CMB-W031 extract revealed > 25 metabolites, including a new nitrated 
diketopiperazine, waspergillamide A (3.24) and the previously reported metabolites, penicillic acid 
(3.29), dehydropenicillic acid (3.30), cycloanthranylproline (3.34), circumdatin E (3.35), 
circumdatin G (3.36) and stephadicin B (3.37). Waspergillamide A (3.24) contains a nitro benzoic 
group linked to a diketopiperazine ring through a glycine residue. All chemical structures were 
determined by detailed spectroscopic analysis with absolute configuration assigned to 3.24, 3.34, 
3.35 and 3.36 on the basis of a micro-scale hydrolysis followed by C3 Marfey’s analysis. This 
chapter describes the purification and structure elucidation of 3.24 and co-metabolites 3.29, 3.30, 
3.34 − 3.37. 
3.1 Introduction to nitrated metabolites from natural sources 
 
Nitrated metabolites contain a highly electronegative nitro functional group (NO2).78 The majority 
of commercially valuable nitrated compounds are synthetic and are typically used in the 
manufacture of rubber, dyes, drugs and agrochemicals. Although rare, nitrated compounds are also 
derived from natural sources with ~200 isolated from plants, eukaryotic and prokaryotic 
organisms.79 Microbes produce several clinically relevant nitrated metabolites,80 some of which are 
antibiotics such as chloramphenicol (3.1) isolated from Streptomyces venezuelae81-83 and 
everninomicin (3.2) produced by Micromonospora carbonaceae.84 
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A number of microbial derived nitrated metabolites with antibacterial and antifungal properties 
have been isolated from Streptomyces sp., Gram-negative bacteria and fungi. For example, orinocin 
(3.3), aureothin (3.4) and neoaureothin (3.5), thaxtomin A (3.6) have been isolated from S. orinoci, 
S. spectabilis and S. thioluteus85-88 and other Streptomyces sp. respectively.89 Gram-negative 
bacteria from the genera Pseudomonas, Burkholderia, Myxococcus and Enterobacter, are known to 
produce the antifungal pyrrolnitrin (3.7),90-93 whereas the fungus Pyricularia oryzae produces the 
antibacterials stephanosporin (3.8)94 and pyriculamide (3.9).95 A marine derived Aspergillus sp. has 
been reported to produce a nitrobenzoyl sesquiterpenoid 6β,9α-dihydroxy-14-p-
nitrobenzoylcinnamolide (3.10).96,97 
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Nitrated microbial metabolites reported from a Nocardia sp. ALAA 2000 obtained from a marine 
alga include ayamycin (3.11),98 phidolopin (3.12) and desmethylphidolopin (3.13).99,100 Microbes 
from extreme environments such as the Artic bacteria Salegentibacter sp. T436, produces several 
nitro isoflavones (3.14 − 3.16). 
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Other examples of natural nitrated metabolites include the anticancer agents aristolochic acid I 
(3.17) and aristolochic acid II (3.18) obtained from the plant Aristolochia sp.,101 and trans-2,2’, 
4,4’-tetramethyl-6,6’-dinitroazobenzene (3.19) from the plant Aconitum sungpanense.102 
O
O
R
NO2
CO2H
N
N
NO2
O2N
OH
NO2
OH
NO2
NH2
CO2H
NO2
OH
3.19
3.20 3.21 3.22
3.17 R = OCH3
3.18 R = H
 
 
Additionally nitrated metabolites have been found to function as signaling molecules, for example 
in ticks the nitrated metabolites 2-nitrophenol (3.20) and 4-methyl-2-nitrophenol (3.21)103 and in 
cardiovascular disease in which the levels of 3-nitrotyrosine (3.22) were found to be increased.104 
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Because natural nitrated metabolites are relatively rare in nature their nitration mechanisms have 
been the subject of several studies and are believed to be limited to two mechanisms, direct nitration 
with reactive nitrogen species (NO) and oxygenation of amines by specialised oxigenases.105-108 
Direct nitration includes an electrophilic attack from a reactive nitrogen species.107,109 The 
oxigenase-mediated nitration occurs via oxidation of a suitable amine precursor.110 Examples of 
both mechanism include the direct nitration of dioxapyrrolomycin (3.23)111 and thaxtomin A (3.6) 
(nitration with NO synthase)112 and oxygenase-mediated nitration of aureothin (3.4) (Figure 3.1).113 
 
O O
Cl
ClNH
Cl
Cl NO2
O O
Cl
ClNH
Cl
Cl
NO2
N
H
NH2
CO2H
N
H
NH2
CO2H
NO2
N
H
NO2
N
Me
Me
NH
O
OH
N
H
NO2
N
Me
Me
N
O
OH
HO
L-Arg
NO
TxtDO2, e-
TxtE
Fd and Fr
NADPH
O2
TxtA
TxtB
ATP
Mg2+
L-Phe
SAM
TxtC
Fd and Fr
O2
NADPH
a) DIRECT NITRATION
b) OXIGENATION OF AMINES
O CO2H
CO2HCO2H
OH NH2
CO2H
NO2
PABA
synthase AurF
PKS
O O
O
OMe
HO2N
3.23
3.6
3.4  
Figure 3.1 Examples of nitration mechanisms (a) Direct nitration of dioxapyrrolomycin (3.23) and thaxtomin A (3.6) 
(b) Oxygenase-mediated nitration of aureothin (3.4) 
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Microbes have proved their ability to synthesise nitrated metabolites with important 
ecological/pharmacological properties that have led to clinically relevant drugs. During our wasp-
derived microbial investigation we identified a rare nitrated fungal metabolite from Aspergillus sp. 
(CMB-W031), namely waspergillamide A (3.24), the structure of which was assigned by detailed 
NMR analysis supported by micro-scale hydrolysis and Marfey’s analysis. This chapter details our 
investigation into waspergillamide A (3.24) and its co-metabolites. 
 
3.2 Results and discussion  
 
3.2.1 Wasp-derived Aspergillus sp. (CMB-W031) 
a) b)
 
Figure 3.2 (a) Picture of Mud-dauber wasp (b) Picture of Aspergillus sp. (CMB-W031) cultivated in ISP-2 agar media 
and incubated 10 days at 26.5 °C  
A Mud dauber wasp was collected by Professor Rob Capon in the Brisbane area and transported to 
the Institute for Molecular Bioscience’s laboratory and was subjected to microbial cultivation 
(described in chapter 2). The fungal isolate CMB-W031 was recovered from the outer surface of the 
wasp. When cultivated on ISP-2 for 10 days at 26.5 °C, CMB-W031 presented a filamentous highly 
sporulated pale yellow fungus. For taxonomic identification, ISP-2 liquid media (100 mL) was 
inoculated, incubated at 26.5 °C for 10 days and the fungal mycelia was recovered by 
centrifugation. Genomic DNA was isolated using a blood and tissue DNA kit (QIAGEN). The 
Internal Transcribed Spacer 1 (ITS1), ITS2 and the 5.8S ribosomal DNA (rDNA) region was 
amplified by PCR using universal primers ITS1 and ITS4. The amplified DNA (~800 bp) was used 
as a query to BLAST against the standard GenBank nucleotide database returning 100% similarity 
to Aspergillus westerdijkiae strain DTO:178-I1 (accession number KP329736.1).  
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To study the phylogenetic relationship between reference strains of Aspergillus spp. and CMB-
W031, we constructed a phylogenetic tree using ITS DNA sequences from the Refseq BLAST 
(Figure 3.3) in which CMB-W031 showed a closer similarity to Aspergillus sclerotiorum NRRL 
415 (accession number NR_1312940.1). 
 
Aspergillus oryzae RIB40  [NW_001884680.1]
Aspergillus flavus ATCC 16883 [NR_111041.1]
Aspergillus parasiticus NRRL 502 [NR_121219.1]
Aspergillus nomius NRRL 13137 [NR_121218.1]
Aspergillus bombycis NRRL 26010 [NR_131261.1]
Aspergillus alliaceus NRRL 315 [NR_121331.1]
Aspergillus ochraceus NRRL 398 [NR_077150.1]
Aspergillus melleus CBS 546.65 [NR_103610.1]
Aspergillus ostianus ATCC 16887 [NR_077151.1]
Aspergillus sclerotiorum NRRL 415 [NR_131294.1]
CMB-W031
Aspergillus affinis ATCC MYA-4773 [NR_111684.1]
Aspergillus steynii CBS 112812 [NR_077197.1]
Aspergillus elegans CBS 102.14  [NR_077196.1|]
Aspergillus tanneri ATCC MYA-4905 [NR_111840.1]
Aspergillus wentii ATCC 1023 [NR_077152.1]
Aspergillus neoindicus NRRL 6134 [NR_131296.1]
Aspergillus ellipticus CBS 707.79 [NR_103605.1]
Neosartorya fischeri  NRRL 181 [NW_001509767.1]  
Figure 3.3 Phylogenetic tree obtained by PhyML Maximum Likelihood analysis of ITS DNA sequences using the 
optimal nucleotide substitution model determined by jModeltest2114 using UGENE115 showing the relationship of CMB-
W031 among selected reference strains (RefSeq GenBank) with their accession numbers indicated in braquets. 
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3.2.2 Culture optimization assays 
 
To determine the optimal culture conditions, the fungal isolate Aspergillus sp. (CMB-W031) was 
cultivated under several different media (Table 3.1). 
 
Table 3.1 Culture media conditions 
CULTURE MEDIA 
Liquid  Solid (agar) Grains 
YES Czapek Dox Pearl Barley 
MALT Oatmeal Brugol 
Czapek dox Acetomycin Jasmine rice 
 YES Basmati rice 
 
Small scale cultures were prepared in 10 cm plates for solid agar, 100 mL for liquid and 10 g for 
grain and incubated for 15 days at 26.5 °C. Each culture was extracted with MeOH (30 mL), dried 
in vacuo and analysed by HPLC-DAD-MS. The jasmine rice cultivation demonstrated an optimal 
production of metabolites, with a diversity of metabolites and enhanced yields. Thus, we selected 
jasmine rice to scale up our production and subjected their crude extract to detailed chemical 
investigation. 
3.2.3 Scale-up cultivation of Aspergillus sp. (CMB-W031)  
 
A pure agar culture of Aspergillus sp. (CMB-W031) was used to prepare a fungal spore suspension 
in a flask containing sterile water (100 mL). An aliquot (5 mL) of this suspension was used to 
inoculate Erlenmeyer flasks containing sterilised jasmine rice (20 g) and incubated at 25.6 °C for 15 
days. Following incubation, rice cultures were combined and extracted with acetone (3.4 L), dried 
in vacuo to yield a crude extract (136 g). The crude extract was serially partitioned with EtOAc, 
hexane and MeOH. The HPLC-DAD-MS analysis of the MeOH solubles (19.8 g) revealed a 
diverse set of signals with various UV-vis chromophores indicating the presence of metabolites 
potentially from several structural classes (Figure 3.4).  
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Figure 3.4 HPLC-DAD-MS (210 nm) chromatogram of CMB-W031 MeOH solubles fraction [Zorbax SB-C8 column 
90% H2O/10% MeCN (0.05% HCO2H) to 100% MeCN (0.05% HCO2H) at 1 mL/min over 15 min] UV-vis spectra 
colours displayed correspond to the coloured peak in the chromatogram inset 
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The MeOH soluble fraction was subjected to purification steps including solvent/solvent partition, 
VLC18 fractionation, semi-preparative and preparative HPLC to yield waspergillamide A (3.24), 
penicillic acid (3.29), dehydropenicillic acid (3.30), cycloanthranylproline (3.34), circumdatin E 
(3.35), circumdatin G (3.36) and stephadicin B (3.37) (Figure 3.5).  
 
CMB-W031
(grains JR)
136 g
20.9 g
(a)
(c)
(b)
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 (1 g)
hexane
2.7 g
4.5 mg  44.8 mg 72.2 mg
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2.0 mg
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Figure 3.5 General solvent/solvent partition scheme, C18 VLC, preparative and semi-preparative purification steps on 
acetone crude extract from jasmine rice culture of Aspergillus sp. (CMB-W031). (a) Extraction of Aspergillus sp. CMB-
W031 rice culture with acetone (1 ✕ 3.8 L), (b) EtOAc/H2O partition, (c) hexane/MeOH partition (d) C18 VLC from 90 
% H2O/MeCN (0.01% TFA) to 100 % MeCN (0.01 % TFA). (e) Semi-preparative HPLC: Zorbax-SB C18 column  (9.4 
mm × 250 mm, 5µm) 3.0 mL/min, 90 % H2O/MeCN (0.01%TFA) to 100 % MeCN (0.01 %TFA) over 30 min (f) 
Preparative HPLC: C18 Phenomenex Luna (9.4 mm × 250 mm, 10 µm) 20 mL/min, 90 % H2O/MeCN (0.01 %TFA) to 
100% MeCN (0.01 %TFA) over 45 min (g) Semi preparative HPLC: Zorbax-SB C18 column  (9.4 mm × 250 mm, 5µm) 
3.0 mL/min, 90 % H2O/MeCN (0.01 %TFA) to 100 % MeCN (0.01 %TFA) over 35 min 
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3.2.4 Structure elucidation of waspergillamide A (3.24) 
 
Waspergillamide A (3.24) was obtained from the semipreparative HPLC purification of the MeOH 
solubles of Aspergillus sp. (CMB-W031). The HRESI(+)MS revealed a pseudomolecular ion (m/z 
ion 455.1556 [M+Na]+) indicative of a molecular formula (C20H24N4O7, Δmmu -1.83) requiring 11 
double bond equivalents (DBEs). Waspergillamide A (3.24) displayed a UV-vis spectrum with a 
λmax at 254 (Figure 3.6). 
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Figure 3.6 UV-vis (DAD) spectrum of 3.24 with λmax at 254 nm.  
 
The planar structure of 3.24 was elucidated by 1D and 2D NMR (600 MHz, MeOH-d4) analysis. 
The 1H NMR data for 3.24 exhibited sp2 resonances suggestive of a para-substituted benzene (δH 
8.07 and 8.33, J = 9.0 Hz), an olefinic methine (δH 5.85, d, J = 10.4 Hz) and a deshielded methylene 
resonance (δH 4.02). Additional resonances were attributed to two tertiary (δH 1.54, 1.63) and two 
secondary methyls (δH 1.05, 1.07) (J = 6.6 Hz), the latter coupled to a common sp3 methine (δH 
2.75) (Figure 3.7). 
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Figure 3.7 1H NMR (600 MHz, MeOH-d4) spectra of 3.24* impurity signal 
(Z)Δ2,3 leucine 
3-hydroxy-valine 
glycine 
p-nitrobenzoic acid 
N
H
H
N
O
O
O
O
N
H
O
NO2
5 6
4
4
2
1
1
4
2
2
13
5
3
3
5
7
6
1
2 2-NH
2-NH
2-NH
Chapter 3 Waspergillamide A: a new nitrated diketopiperazine  
 51 
 
Figure 3.8 13C DEPT NMR (150 MHz, MeOH-d4) spectrum of 3.24 
 
The 13C NMR spectrum of 3.24 displayed resonances suggestive of four amide/ester moieties (δC 
163.9, 165.6, 168.9 and 170.0), four aromatic resonances connected with a p-disubstituted benzene 
moeity (δC 151.7, 141.0, 126.9 and 130.3) and two sp2 resonances attributed to trisubstituted double 
bonds (δC 128.2, 125.0) (Figure 3.8). 
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Table 3.2 NMR (600 MHz, MeOH-d4) data for 3.24 
 
Position δC(ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C 
HMBC 
δH, mult (J in Hz)  
DMSO-d6 
(Z)Δ2,3 leucine      
1 163.9 - - -  
2 126.9 - - -  
3 128.2 5.85, d (10.4) 4 5, 1 5.59, d (10.4) 
4 26.4 2.75, dq (10.4, 6.6) 6, 5, 3 2 2.80, dq (10.4, 5.6) 
5 22.7 1.07, d (6.6) 4 4, 6 0.92 (6.5) 
6 22.9 1.05, d (6.6) 4 3, 4 0.89 (6.5) 
3-hydroxy-
valine 
     
1 165.6 - - -  
2 63.7 4.34, s - 1, 3, 6 4.07, d (3.5) 
3 86.4  -   
4 23.8 1.63, s - 2, 3, 5 1.46, s 
5 23.0 1.54, s - 2, 3, 4 1.41, s 
glycine      
1 170.0 - - -  
2 43.6 4.02, s - 1, 1-PNB 3.85, d (3.6) 
p-nitro-benzene 
(PNB) 
     
1 168.9  - - -  
2 151.7 - - -  
3/7 130.3 8.07, d (9.0) 4/6 1, 2, 3, 7 8.04, d (9.0) 
4/6 125.0 8.33, d (9.0) 3/7 2, 4, 5, 6 8.30, d (9.0) 
5 140.8 - -   
 
Diagnostic 2D NMR correlations (Figure 3.9) established the planar structure for 3.24. The HSQC 
NMR (600 MHz, MeOH-d4) data (Figure 3.10) confirmed the presence of methyl, methylene and 
methines detected in the 1H NMR , and COSY data (Figure 3.11) confirmed correlations between 
aromatic protons in the para-nitro benzene ring and between the protons in (Z) Δ2,3 Leu. HMBC 
confirmed established the vicinity of the para-nitro benxene ring and the 3-hydroxy-valine (Figure 
3.12). 
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Figure 3.9 Structural components of 3.24, (Z) Δ2,3leucine (red), 3-hydroxy-valine (green), glycine (blue) and p-
nitrobenzene (orange) (right), 2D key correlations for 3.24 (left) 
Figure 3.10 HSQC NMR (600 MHz, MeOH-d4) spectrum of 3.24 
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Figure 3.11 COSY NMR (600 MHz, MeOH-d4) spectrum of 3.24 
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Figure 3.12 HMBC NMR (600 MHz, MeOH-d4) spectrum of 3.24 
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To establish the geometry of Δ2,3leucine we performed a ROESY NMR (600 MHz, DMSO-d6) 
experiment and the correlation between the 1-NH-leucine and Δ2,3leucine was indicative of a Z 
geometry (Figure 3.13).  
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Figure 3.13 ROESY NMR (600 MHz, DMSO-d6) of 3.24 
 
 
While the 1D and 2D NMR data supported the planar structure for 3.24, the absolute configuration 
of the 3-hydroxy-valine residue remained unresolved. To provide more evidence of this unusual 
structure, a sample of 3.24 (50 µg) was hydrolysed in 6 M HCl at 100 °C overnight to deliver a 
residue that was dried under N2 at 40 °C, resuspended in MeOH (0.1 mg/mL) and analysed using 
HPLC-DAD-MS. Three compounds detected by HPLC-DAD-MS were nominally identified as the 
DKP cyclo-(Z)Δ2,3-leucine-3-hydroxy-valine (3.25) ([M+H]+=227), glycinyl-4-nitrobenzamide 
(3.26) ([M+H]+=225) and residual 3.24 (Figure 3.14 and 3.15). It is interesting to note that under 
these hydrolysis condition the three amide bonds in 3.24 withstand hydrolysis whereas the ester 
bond was successfully hydrolysed, this may be because tert-butyl-type esters tend to be more 
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sensitive to acid hydrolysis. With this hydrolysis we obtained 3.26, which compound can be 
synthetically prepared, thus we synthesised the hydrolysis product and analysed it with HPLC-
DAD-MS against the hydrolysate product to compare their retention times. 
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Figure 3.14 HPLC-DAD-MS (254 nm) chromatogram, using C8 SB-Zorbax column 90 %H2O/MeCN (0.05% HCO2H) 
to 100% MeCN (0.05% HCO2H) over 15 min. The cyclo-((Z)Δ2,3-leucine-3-hydroxy-valine) (3.25) is the major 
component (red), glycinyl-4-nitrobenzamide (3.26) (blue) and residual 3.24 (green) 
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Figure 3.15 Schematic diagram of the acidic hydrolysis products of 3.24 using 6M HCl overnight at 100 °C: cyclo-
((Z)Δ2,3-leucine-3-hydroxy-valine)  (3.25) ([M+H]+= 227), glycinyl-4-nitrobenzamide (3.26) ([M+H]+= 225)  
 
3.2.4.1 Synthesis of glycinyl-4-nitrobenzamide (3.26)  
 
Synthesis of 3.26 was carried out using standard solid phase peptide synthesis by coupling p-
nitrobenzoic acid to H-Gly-Wang polysteryrene resin followed by TFA cleavage (Figure 3.16) (see 
experimental for  synthesis details).  
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Figure 3.16 Scheme for the solid phase synthesis of glycinyl-4-nitrobenzamide (3.26) 
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The synthetic product 3.26 and hydrolysed 3.24 were injected into HPLC-DAD-MS to confirm the 
identity of the moiety in the acid hydrolysate of 3.24. The m/z [M+H]+= 227 from the synthetic 3.26 
and hydrolysate 3.24 showed comparable retention times, confirming the identity of the glycinyl-4-
nitrobenzamide in waspergillamide A (3.24) (Figure 3.17). 
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Figure 3.17 HPLC-DAD-MS Zorbax-SB C18 column, 90% H2O/10% MeCN (0.05% HCO2H) to 100% MeCN (0.05% 
HCO2H), 4.6 × 150 mm, 5µm 1mL/min single ion extraction (EIS) of m/z 225 ([M+H]+) synthetic 3.26 and hydrolysate 
3.24  
3.2.5 C18 Marfey’s analysis on 3.24 
 
While the planar structure of 3.24 was established by 1D and 2D NMR analysis and synthesis of 
3.26 provided structure proof of the glycinyl-4-nitrobenzamide moiety, assignment of the chiral 
centre in 3-hydroxy-valine (exp. [α]D21= +13, c=0.038, MeOH) was unresolved. The configuration 
of 3-hydroxy-valine was identified by a C18 Marfey’s analysis. The acid hydrolysate of 3.24 (50 µg) 
was derivatised with L-FDAA and D-FDAA. In the absence of a true amino acid standard for 3-
hydroxy-valine in our amino acid stocks, the derivatised (3.24)-hydroxy-valine + L-FDAA and 
(3.24)-3-hydroxy-valine + D-FDAA HPLC elution times were compared with elution time order 
reported for 3-hydroxy-valine authentic standards found in previous literature reports. To find 
elution order of 3-hydroxy-valine from authentic standards reported in the literature we searched 
structures containing 3-hydroxy-valine. The metabolites yaku’amides reported by Ueoka et al. in 
2010 met the requirements to do this comparative analysis. 
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Yaku’amide A (3.27) and B (3.28) are cytotoxic linear peptides obtained from the marine sponge 
Ceratopsion sp.; their absolute configurations were determined by C18 Marfey’s analysis and found 
to contain one L-hydroxy-valine and one D-hydroxy-valine.116 
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
O O
H
OH
O
O R
O
O
O
O
O
O
O
O
H
OH
OH
O
H
N
O
N
H
O
NMe2
L 
OHIle Ile1 Gly Ile2 Val1 aIle OHVal1 OHVal2 Ile3 Ala Val2 Val3 Val CTA NTA 
D 
R = H (3.27)
R = CH3 (3.28)
 
 
To determine the configuration of 3-hydroxy-valine in yaku’amides, the 3-hydroxy-valine authentic 
standards (L and D) were synthesised de novo and derivatised with L-FDAA and analysed using a 
C18 column HPLC.  The L-hydroxy-valine + L-FDAA (78.3 min) was found to elute before D-
hydroxy-valine + L-FDAA (87.7 min) (Table 3.3).116 
 
Table 3.3 Retention times (Rt in min) for 3-hydroxy-valine D and L standards reported in literature report for 
yaku’amides and 3.24 hydrolysate   
Derivatised sample Rt (min)  Rt (min) 
Standard  78.3 (L-3-hydroxy-val + L-FDAA) 
= (D-3-hydroxy-val + D-FDAA) 
87.7 (D-3-hydroxy-val + L-FDAA) 
Hydrolysed 3.24 18.1 (3.24 + D-FDAA) 22.2 (3.24 + L-FDAA) 
 
To determine the configuration of 3-hydroxy-valine in 3.24, we derivatised 3.24 hydrolysate with L-
FDAA and D-FDAA and analysed both with HPLC-DAD-MS using a C18 column. A single ion 
extraction at m/z = 386 [M+H]+ (3-hydroxy-valine + L or D-FDAA) was performed and the 3.24 + 
D-FDAA (18.1 min) displayed an earlier retention time compared to 3.24 + L-FDAA  (22.2 min) 
(Table 3.3 and Figure 3.18).  
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(3.24)-3-hydroxy-valine-D-FDAA  
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Figure 3.18 C18 Marfey's HPLC-DAD-ESI(+)MS analysis using Zorbax-SB C18 column (150 × 4.6 mm, 5 µm, 1 
mL/min, 75% H2O/15%MeOH/5%MeCN (0.05% HCO2H) to 95% MeOH/5%MeCN (0.05% HCO2H). Blue line, single 
ion extraction chromatogram at m/z = 386 [M+H]+ for 3.24 + L-FDAA derivatised hydrolysates. Red line, single ion 
extraction chromatogram at m/z = 386 [M+H]+ for 3.24 + D-FDAA derivatised hydrolysates  
 
This elution order was compared with the 3-hydroxy-valine authentic standards reported in the 
yaku’amides publication. The standard L-aa-L-FDAA (which is a chemical surrogate for D-aa-D-
FDAA) elutes before D-aa-L-FDAA, and since 3.24 derivatised with D-FDAA elutes before its L-
FDAA derivative, it can be deduced that the absolute configuration of 3-hydroxy-valine is 3.24 is D. 
 
Our strategy is supported by Marfey’s analysis studies derived from previous work in our research 
group where the stereogenic relationships between Marfey’s derivatised amino acids (Figure 3.19) 
are well established. We know that achiral chromatographic systems cannot resolve enantiomeric 
pairs (L-L/D-D and L-D/D-L) and both pairs elute at comparable retention times (Figure 3.19), a 
strategy used when one of the standards is not available. In the case of 3.24 we lacked both 
standards of 3-hydroxy-valine and literature review on previous established stereochemistry 
(yaku’amides) permitted the comparisons with authentic standards and the assignment as D-3-
hydroxy-valine in waspergillamide A (3.24) (Figure 3.20). 
 
Chapter 3 Waspergillamide A: a new nitrated diketopiperazine  
 61 
L-amino acid + L-FDAA 
early Rt (min) 
L-amino acid + D-FDAA 
later Rt (min) 
D-amino acid + D-FDAA 
early Rt (min) 
D-amino acid + L-FDAA 
later Rt (min) 
 
=" ="
 
Figure 3.19 Expected retention times (Rt = min) and stereogenic relationships of Marfey’s (L-FDAA and D-FDAA) 
derivatised amino acids 
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Figure 3.20 Waspergillamide A (3.24) absolute configuration  
3.2.6 Additional chemistry from Aspergillus sp. (CMB-W031) 
 
The MeOH solubles from Aspergillus sp. (CMB-W031) yielded co-metabolites identified as 
penicillic acid (3.29), dehydropenicillic acid (3.30), cycloanthranylproline (3.34), circumdatin E 
(3.35), circumdatin G (3.36), and stephadicin B (3.37). The structures of co-metabolites were 
confirmed by detailed 1D and 2D NMR analysis and in the case of 3.34, 3.35 and 3.36 by Marfey’s 
analysis. 
3.2.6.1 Penicillic acid (3.29) and dehydropenicillic acid (3.30)  
 
Penicillic acid (3.29) and dehydropenicillic acid (3.30) were purified as indicated in Figure 3.4. The 
HRESI(+)MS of 3.29 revealed a dimeric ion (m/z 363.1032 [2M+Na]+), which afforded the 
molecular formula (C8H10O4, Δmmu 1.40). The 1H NMR (600 MHz, DMSO-d6) data for 3.29 
displayed resonances attributed to three sp2 methines (δH 5.40, 5.30, 5.13), a methoxy methyl (δH 
3.85), an aliphatic tertiary methyl (δH 1.65) and a broad deshielded exchangeable resonance (δH 7.8) 
(Figure 3.21). Detailed examination of the 2D NMR correlations (COSY, HSQC, HMBC) and 
literature comparison indicated that 3.29 was penicillic acid (Table 3.4).117 Penicillic acid (3.29) 
was first reported by Alsberg and Black in 1913 from Penicillium puberulum118 and from several 
species of Penicillium and Aspergillus.119,120 Structure of 3.29 has since been confirmed by 
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synthesis.121 Although 3.29 posesses a chiral centre it occurs naturally as the racemate most likely 
due to equilibrium between tautomeric forms (Figure 3.22). 
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Figure 3.21 1H NMR (600 MHz, DMSO-d6) for 3.29 
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Figure 3.22 Penicillic acid (3.29) tautomeric forms 
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Table 3.4 NMR (600 MHz, DMSO-d6) data for 3.29, comparison of experimental and literature117 data (shaded column) 
 
Position δC (ppm) δH , mult (J in 
Hz) 
1H-1H COSY 1H-13C HMBC δH , m (J in Hz)  
(literature)117* 
1 169.9 - - - - 
2 89.3 5.40, s - 1, 4 5.39, s 
3 179.3 - - - - 
4 102.7 - - - - 
4-OH  7.88, s - - - 
5 140.4  - - - 
6α 
6β 
115.3 5.12, br s 
5.30, br s 
7 - 5.16, s 
5.33, br s 
7 16.5 1.65, s 6a, 6b 4, 5, 6  1.65, s 
8 59.8 3.85, s - 3 3.84, s 
 *Experimental and literature experiments compared were both recorded in the same solvent. 
 
The HRESI(+)MS of 3.30 afforded a dimeric ion (m/z 367.1356  [2M+Na]+) indicative of the 
molecular formula (C8H12O4, Δmmu 0.80). Similarities between the 1H NMR spectra of 3.29 and 
3.30, including an olefinic methine (δH 5.32), a methoxy methyl (δH 3.85) and a broad exchangeable 
proton resonance (δH 7.55) suggested that 3.29 and 3.30 were closely related. A detailed analysis 
and comparison of 1D and 2D NMR data for 3.30 with 3.29 permitted the identification of the 3.30 
as dehydropenicillic acid (3.30) (Figure 3.23, Table 3.5). Dehydropenicillic acid (3.30) was first 
reported by Raphael in 1947 and its structure was confirmed by synthesis122 and since has been 
reported in a number of Aspergillus ochratoxin producing strains along with 3.29.123  
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Figure 3.23 1H NMR (600 MHz, DMSO-d6) for 3.30 
 
Table 3.5 NMR (600 MHz, DMSO-d6) data for 3.30 
 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1 170.1 - - - 
2 89.5 5.32, s - 1 
3 179.3 - - - 
4-OH - 7.55, s - - 
5 32.6 2.00, septet 6,7 6, 7, 3 
6 15.9 0.86, br s 5 - 
7 15.9 0.86, br s 5 - 
8 59.8 3.85, s - 3 
 
Penicillic acid (3.29) belongs to a group of mycotoxins including patulin, isopatulin and ascladiol 
with a simple 5-member ring. Mycotoxins of this class are considered carcinogenic and a potential 
health hazard.124 The proposed biosynthesis of 3.29 is via the O-methylation of orsenillic acid 
(3.31) to (3.32), which is decarboxylated and oxidised of 3.33 prior to ring cleavage/contraction to 
form 3.29 (Figure 3.24).125,126 
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Figure 3.24 Reported biosynthetic pathway for penicillic acid (3.29)125 
 
3.2.6.2 Cycloanthranylproline (3.34) 
 
Metabolite 3.34 was purified as indicated in Figure 3.4, as a pale yellow powder. The HRESI (+) 
MS of 3.3 yielded a m/z ion (239.0781 [M+Na]+) consistent with the molecular formula 
C12H12N2O2 (Δmmu 3.80). The 13C NMR (600 MHz, DMSO-d6) data for 3.34 displayed resonances 
attributed to two carbonyls (δC 170.9, 164.6), six sp2 olefinic or aromatic carbons (δC 136.4, 132.0, 
130.5, 126.8, 124.2, 121.3), a heteroatom substituted sp3 methines (δC 56.2, 46.7), and a meta di-
substituted aromatic ring (δH 7.13, 7.22. 7.50, 7.87), as well as several overlapping multiplets 
indicative of diasterostopic methylenes (δH 1.81- 3.45) (Figure 3.25, Table 3.6).  
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Figure 3.25 1H NMR (600 MHz, DMSO-d6) spectrum of 3.34 
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Table 3.6 NMR (600 MHz, DMSO-d6) data for 3.34 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1 25.8 a 2.48, m 
b 1.95, m 
11a 2, 11 
2 23.2 a 1.91, m 
b 1.81, m 
1, 3 3 
3 46.7 a 3.58, m 
b 3.46, m 
2, 3b 
3a 
1, 11a 
4 - - - - 
5 164.6 - - - 
5a 126.8 - - - 
6 130.5 7.77, d (8.0) 7 5, 8, 9a 
7 124.2 7.22, dd (8.0, 7.0) 6, 8 5a, 9 
8 132.0 7.50, dd (80, 7.0) 7, 9 6, 9a 
9 121.3 7.13, d (7.0) 8 5a, 7 
10-NH - 10.2 - 5a, 11a 
11 170.9 -  - 
11a 56.8 4.13, d (6.5) 1 1, 2, 3, 5, 11 
 
The HSQC data revealed the presence of three diasterostopic methylenes, which show correlation to 
each other in the COSY NMR spectra. The final planar structure of 3.34 was assembled using 
HMBC NMR correlations (Figure 3.26). 
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Figure 3.26 2D NMR (600 MHz, DMSO-d6) correlations for 3.34 
 
NMR comparisons identified the planar structure of 3.34 as cycloanthranylproline, previously 
isolated from a myxomycete in 2004,127 however the configuration of cycloathranylproline (3.34) 
was not resolved at that time. To determine the absolute configuration of our wasp-derived 
Aspergillus sp. (CMB-W031) 3.34 we used a micro scale C3 Marfey’s analysis. The acid-
hydrolysate of 3.34 was derivatised with D-FDAA (Marfey’s reagent) as well as authentic standards 
of both D-Pro and L-Pro. The resulting diasterostopic derivatives were analysed by HPLC-DAD-MS 
(Figure 3.27). Comparison with derivatised authentic standards confirmed that 3.34 bears an L-
proline residue.  
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Figure 3.27 C3 Marfey's HPLC-DAD-ESI(+)MS analysis using C3 Zorbax, SB column (150 × 4.6 mm, 5 µm, 1 mL/min, 
75% H2O/15%MeOH/5%MeCN (0.05% HCO2H) to 95% MeOH/5%MeCN (0.05% HCO2H). Blue line, single ion 
extraction at m/z = 368 [M+H]+ for D-proline + D-FDAA. Red filled line, single ion extraction at m/z = 368 [M+H]+ for 
L-proline + D-FDAA co-injected with 3.34 
 
3.2.6.3 Circumdatin E (3.35) 
 
Metabolite 3.35 was purified as indicated in Figure 3.4. The HRESI(+)MS of 3.35 yielded the 
pseudomolecular m/z ion 363.1219 [M+Na]+ and afforded the molecular formula C20H17N3O4 
(Δmmu 1.35). The 2D NMR (600 MHz, DMSO-d6) data for 3.35 provided evidence for the 
benzodiazepine core structure and a proline residue, in accordance with other circumdatins-like 
structures. 1H NMR data comparisons for 3.34 and 3.35 indicated that 3.35 incorporated two 
additional meta coupled aromatic resonances (δH 6.89 and 7.04) (J = 2.8) (Figure 3.28). A 2D NMR 
data analysis supported structure elucidation of a planar structure for 3.35 consistent with 
circumdatin E (Figure 3.28, Figure 3.29 and Table 3.7). The experimental optical rotation 
measurement for 3.35 is broadly in accord to the literature value reported for circumdatin E [exp. 
[α] D 21 = −105.3 (c=0.061, MeOH; lit. [α] D 22 = −90.0 (c=0.007, MeOH)].128  
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Figure 3.28 1H NMR (600 MHz, DMSO-d6) spectrum of 3.35 
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Figure 3.29 HSQC NMR (600 MHz, DMSO-d6) spectrum of 3.35 
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Table 3.7 NMR (600 MHz, DMSO-d6) data for 3.35, comparison of experimental and literature data128 (shaded column) 
Position δC (ppm) δH , mult (J in Hz) 1H-1H 
COSY 
1H-13C 
HMBC 
δH , mult (J in 
Hz)(literature)128*  
1 - - - - - 
2 163.6 - - - - 
3 - - - - - 
4 129.0 7.82, dd (7.6, 1.6) 5 6, 8, 2 7.81, m  (7.4, 1.9) 
5 128.3 7.57, m 4 - 7.56, m 
6 130.6 7.63, m 7 4,8 7.63, m 
7 128.3 7.57, m 6 - 7.58, m 
8 133.4 - - - - 
9 - - - - - 
10 161.2 - - - - 
11 - - - - - 
12 98.1 7.04, d (2.8) 14 10, 14 7.07, d (2.5) 
13 - - - - - 
14 107.8 6.89, d (2.8) 12 15 6.87, br s  
15 154.4 - - -  
16 - - - -  
17 - - - -  
18 150.9 - - -  
19 58.7 4.59, dd (8.0, 1.9) 20a 18, 20, 21 22 4.60, d (6.9) 
20 26.4 2.07, m 
3.24, m 
20b, 19 
20a 
18, 21 
18, 22 
2.04, m 
3.21, m 
21 23.5 1.95, m 
2.13, m 
 
21b 
 
20 
1.93, m 
2.11, m 
22 46.1 3.45, m 
3.59, m 
22b, 21b 
22a 
21 
21, 20 
3.44, m 
3.58, m 
23-NH - 9.80, s  - -  
24 55.6 3.82, s  13 3.81, s 
 *Experimental and literature experiments compared were both recorded in the same solvent 
 
The absolute configuration of the Pro residue in 3.35 was established for the first time using the 
aforementioned C3 Marfey’s analysis, where standard amino acids, D-Pro and L-Pro, a micro scale 
hydrolysate of 3.35 (50 µg) were derivatised with D-FDAA (Marfey’s reagent), leading to an 
HPLC-DAD-MS comparison (Figure 3.30).  Using this approach 3.35 was determined to posses an 
L-Pro residue.  
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0 10 20 30 40 50
Rt (min)
D-Proline-D-FDAA m/z 368
L-Proline-D-FDAA  m/z 368
 
Figure 3.30 C3 Marfey's HPLC-DAD-ESI(+)MS analysis using C3 Zorbax, SB column (150 × 4.6 mm, 5 µm, 1 mL/min, 
75% H2O/15%MeOH/5%MeCN (0.05% HCO2H) to 95% MeOH/5%MeCN (0.05% HCO2H). Green line, single ion 
extraction at m/z = 368 [M+H]+ for D-proline + D-FDAA. Red filled line, single ion extraction at m/z = 368 [M+H]+ for 
L-proline + D-FDAA co-injected with 3.35. 
 
3.2.6.4 Circumdatin G (3.36) 
 
The HRESI(+)MS of 3.35 revealed a pseudomolecular ion (m/z ion 330.0851 [M+Na]+) indicative 
of a molecular formula C17H13N3O3 (Δmmu 0.40). Analysis of 1D and 2D NMR data for 3.36 
(Figure 3.31, Table 3.8) with comparisons to 3.34 and 3.35 confirmed 3.36 as circumdatin G, first 
reported in 2001 from the fungus Aspergillus ochraceus.129 The optical rotation measurement for 
3.36 was comparable to the value reported in the literature [exp. [α] D 26 = -68.2 (c=0.016, MeOH) 
lit. [α] D 26 = -21.7 (c=0.19, MeOH)].129 
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Figure 3.31 1H NMR (600 MHz, DMSO-d6) for 3.36 
Table 3.8 NMR (600 MHz, DMSO-d6) data of 3.36, comparison of experimental and literature129 data (shaded column) 
Position δC (ppm) δH , mult (J in Hz) 1H-1H 
COSY 
1H-13C 
HMBC 
δH, mult (J in 
Hz)(literature)129* 
1-NH - 8.77, d (5.7) 19 3 - 
2 166.8 - - - - 
3 133.2 - - - - 
4 128.8 7.79, dd (7.8, 1.5) - 6, 8 7.80, dd (8.0, 1.5) 
5 128.7 7.59a - - 7.60 
6 130.7 7.66, ddd (7.8, 6.8 
1.5) 
7 4, 8 7.68, ddd (8.0, 7.0, 1.5) 
7 128.7 7.59a 6 3 7.62  
8 131.4 - - - - 
9  - - - - 
10 161.1 - - - - 
11 122.0 - - - - 
12 116.6 7.62, dd (8.0, 1.5) 13 10 7.59 
13 128.0 7.41, dd (8.0, 8.0) 12, 14 15 7.37, dd (8.0, 8.0) 
14 119.4 7.31, dd (8.0, 1.5) 13, 15 12 7.24, dd (8.0, 1.5)  
15 155.1     
15-OH - 9.78, br s - - - 
16 134.7 - - - - 
17 - - - - - 
18 153.1 - - - - 
19 49.4 4.29, q (7.0) 20 10, 18, 20 4.41, q (6.5) 
20 15.1 1.58, d (7.0) 19, 1 18, 16 1.72, d (6.5) 
aoverlapping signals *Experimental and literature experiments compared were both recorded in the same 
solvent. 
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The absolute configuration of the Ala residue in 3.36 was established with C3 Marfey’s 
analysis, using standard amino acids L-Ala, D-Ala and a micro scale hydrolysate of 3.36, both 
derivatised with D-FDAA (Marfey’s reagent) and analysed by HPLC-DAD-MS. Ion extraction of L-
Ala + D-FDAA (m/z 341 [M + H]+) demonstrated the incorporation of a L-alanine residue (Figure 
3.32). 
0 10 20 30 40 50
Rt (min)
L-Ala-D-FDAA m/z 341
D-Ala-D-FDAA m/z 341
 
Figure 3.32 C3 Marfey's HPLC-DAD-ESI(+)MS analysis using C3 Zorbax, SB column (150 × 4.6 mm, 5 µm, 1 mL/min, 
75% H2O/15%MeOH/5%MeCN (0.1% HCO2H) to 95% MeOH/5%MeCN (0.1% HCO2H). Black line, single ion 
extraction at m/z = 341 [M+H]+ for D-alanine + D-FDAA. Red filled line, single ion extraction at m/z = 341 [M+H]+ for 
L-alanine + D-FDAA co-injected with 3.36. 
3.2.6.5 Stephadicin B (3.37) 
 
Metabolite 3.37 was isolated as a yellowish solid and the HRESI(+)MS revealed a pseudomolecular 
ion (m/z ion 913.3817 [M+Na]+) indicative of the molecular formula (C52H54N6O8, Δmmu 7.83). A 
literature search led to the dimeric N-hydroxyindole alkaloid stephacidin B (3.37). The 
HRESI(+)MS and 13C NMR (150 MHz, DMSO-d6) of 3.37 were compared with literature values 
for stephadicin B, the values were comparable to 3.37 (Figure 3.33 and Table 3.9).130 Stephacidin B 
(3.37) has been isolated from Aspergillus ochraceus strain WC76466 from India,131 from a marine 
Aspergillus sp.,132 and from another Aspergillus ochraceus strain.133 Stephadicin B (3.37) is known 
to have cytotoxic activity against various human cancer cell lines, including androgen-sensitive 
human prostate adenocarcinoma cells LNCaP (IC50 value of 0.06 µM).134 In our hands, 3.37 showed 
cytotoxicity against human lung (NCI-H460) and colon (SW-620) carcinoma cells (IC50 of 5.0 µM 
and 5.4 µM respectively).  
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Figure 3.33 1H NMR (600 MHz, DMSO-d6) for 3.37 
 
Table 3.9 13C NMR (150 MHz, DMSO-d6) data for 3.37, comparison of experimental and literature130 data (shaded 
column) 
δC (experimental)  
 
δC (literature)130* 
 
174.4 175.1 
173.3 173.8 
167.1 167.5 
166.5 167.0 
152.4 153.0 
151.2 152.2 
148.3 148.8 
140.4 140.9 
140.0 140.2 
132.0 132.2 
129.7 130.4 
129.5 130.2 
128.2 128.6 
122.6 122.9 
119.0 119.5 
118.0 118.6 
116.7 116.2 
115.6 116.1 
114.7 115.3 
111.1 111.7 
109.8 110.3 
104.0 104.5 
3.37
O
N
N
H
O
N
O
OH
H
H
N
N
N
O
O
H
O
H
O
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97.5 98.0 
75.5 76.3 
74.7 75.2 
69.6 70.2 
68.4 68.9 
65.2 65.7 
64.0 64.7 
61.3 61.9 
57.6 58.5 
45.9 46.5 
45.4 44.3 
43.9 44.0 
43.6 43.3 
42.8 43.2 
37.5 38.2 
34.8 35.0 
29.3 29.8 
29.1 29.4 
28.9 28.6 
28.0 28.0 
27.3 27.7 
27.2 27.2 
27.0 27.0 
26.6 26.7 
26.2 26.6 
26.0 26.3 
24.5 24.9 
24.0 24.5 
19.1 19.4 
15.9 16.3 
*Experimental and literature experiments compared were both recorded in the same solvent. 
3.3 Conclusions  
 
This study reports the isolation and characterisation of the new structure waspergillamide A (3.24) 
and revealed the absolute configurations assignments of known members of the circumdatin 
structure class. Waspergillamide A (3.24) is a first class tetrapeptide bearing a diketopiperazine 
linked to a p-nitroaromatic via glycine moiety. Waspergillamide A (3.24) is non-cytotoxic (IC50 > 
30 µM) and non-antibacterial (IC50 > 30 µM) in our standard assays. The biosynthetic pathway for 
the production of 3.24 is currently under investigation within our research group. We are also 
continuing the search for other members of the waspergillamide A (3.24) structure class in 
remaining Aspergillus sp. (CMB-W031) extracts.  
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3.4 Experimental  
 
3.4.1 General experimental 
 
Specific optical rotations ([α]D) were measured on a JASCO P-1010 polarimeter in a 100 × 2 mm 
cell at 22 °C. UV-vis spectra were obtained on a Varian Cary 50 UV-visible spectrophotometer 
with 1 cm pathway quartz cells. Optical density (OD) and fluorescence of 96-well microtitre plates 
were measured at room temperature on a POLARstar Omega microtitre plate reader. NMR spectra 
were acquired on a Bruker Avance 600 MHz spectrometer and referenced to residual solvent proton 
and carbon signals of the deuterated solvent. ESIMS experiments were carried out on an Agilent 
1100 series LC/MSD (single quadrupole) instrument. High-resolution ESIMS spectra were obtained 
on a Bruker micrOTOF mass spectrometer by direct infusion in MeCN at 3 µL/min using sodium 
formate clusters as an internal calibrant. Liquid chromatography-diode array-mass spectrometry 
(LC-DAD-MS) data were acquired on an Agilent 1100 series separation module equipped with an 
Agilent 1100 series LC/MSD mass detector and diode array multiple wavelength detector. Semi-
preparative HPLC was performed using Agilent 1100 series LC instruments with corresponding 
detectors, fraction collectors and software inclusively. Pure compounds eluting from semi-
preparative HPLC were dried on a Christ freeze dryer. Microorganisms were manipulated under 
sterile conditions provided by a Laftech class II biological safety cabinet and incubated in MMM 
Friocell incubators or Innova 42 incubator shakers with temperature set at 26.5 °C. NMR chemical 
shift calculation and MM2 energy minimization were carried out on ACD/Labs 7.0 and 
ChemBio3D Ultra 13.0 software, respectively.  
 
3.4.2 Fungal strain collection  
The fungus Aspergillus sp. (CMB-W031) was isolated from the outer tissue of a Mud-dauber wasp 
collected in 2012 from Brisbane, Queensland. Freshly collected wasp specimens were transported 
to the laboratory in sealed container, after which it was rinsed in sterile water. Tissue was 
homogenised using a mortar and pestle and applied to ISP2 agar plates (comprising 2% glucose, 1% 
peptone, 0.5% yeast extract, and artificial seawater) and the plates sealed with parafilm and 
incubated for 3 – 4 weeks. A pure culture of CMB-W031, obtained by single-colony serial transfer 
on agar plates was cryo-archived at –80 °C in 20% aqueous glycerol. 
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3.4.3 Fungal strain taxonomy  
 
Genomic DNA from this isolate was extracted from the mycelia using the DNeasy Plant Mini Kit 
(QIAGEN) as per the manufacturers protocol. The rRNA genes were amplified by PCR using the 
universal primers ITS 1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS 4 (5ʹ 
TCCTCCGCTTATTGATATGC-3ʹ) purchased from Sigma-Aldrich. The PCR mixture (50 µL) 
contained genomic DNA (1 µL, 20–40 ng), four deoxynucleoside triphosphates (dNTP, 200 µM 
each), MgCl2 (1.5 mM), primer (0.3 µM each), 1 U of Taq DNA polymerase (Fisher Biotec) and 
PCR buffer (5 µL, 10×). PCR was performed using the following conditions: initial denaturation at 
95 °C for 3 min, 30 cycles in series of 94 °C for 30 s (denaturation), 55 °C for 60 s (annealing) and 
72 °C for 60 s (extension), followed by one cycle at 72 °C for 6 min. The PCR products were 
purified with PCR purification kit (QIAGEN) and sequenced. ITS DNA sequence (~800 bp) was 
subjected to GenBank BLAST returning a 100% homology to Aspergillus westerdijkiae strain 
DTO:178-I1 (accession number KP329736.1). 
 
3.4.4 Chemical profiling 
 
 Aspergillus sp. (CMB-W031) was cultivated for 15 d in one petri dish (10 cm) containing ISP-
2 agar. After cultivation, the IPS-2 agar was extracted with EtOAc:MeOH (30 mL) and the organic 
phase concentrated in vacuo to yield a crude extract (10 mg). A solution of crude extract prepared 
in MeOH (1 mg/mL) was subjected to HPLC-DAD-ESI(±)MS analysis (Zorbax SB-C8 column, 150 
× 4.6 mm column, 5 µm, 1 mL/min gradient elution from 90% H2O/MeCN to 100% MeCN over 15 
min, with constant 0.05% HCO2H modifier). 
3.4.5 Production, isolation and characterization of 3.24, 3.29, 3.30, 3.34 − 3.37 
 
A spore suspension of Aspergillus sp. (CMB-W031) was prepared by diluting a loop of spores 
into an Erlenmeyer flask (250 mL) containing sterile water (50 mL) and mixed at 200 rpm at 26.5 
°C for 10 min. Forty 250 mL Erlenmeyer flasks containing sterile jasmine rice (20 g) were 
inoculated with the homogenised aqueous spore suspension  (5 mL) and incubated at 26.5 °C for 15 
d, after which the rice was extracted with acetone (3 × 3400 mL) and concentrated in vacuo at 40 
°C to afford the crude extract (136 g). The crude extract was then sequentially triturated to yield 
EtOAc (116 g) and aqueous (20.9 mg) soluble fractions. The EtOAc fraction was triturated again to 
yield hexane (2.7 g) and MeOH (19.8 g) soluble material.  
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The MeOH solubles were subjected to SPE fractionation (GracePure C18 Max, 10% stepwise 
gradient elution from 10% H2O/MeOH to 100% MeOH) to yield 17 Fractions. Fraction 2  (4.5 mg) 
was subjected to HPLC fractionation (Zorbax SB-C8 column, 250 × 9.4 mm, 5 µm, 3 mL/min 
gradient elution from 10% to 100% H2O/MeCN over 45 min, with constant 0.01% TFA modifier) 
to yield penicillic acid (3.29) and dehydropenicillic acid (3.30). Fraction 5  (44.8 mg) was subjected 
to HPLC fractionation (Zorbax SB-C8 column, 250 × 9.4 mm, 5 µm, 3 mL/min gradient elution 
from 70% to 60% H2O/MeCN over 15 min, with constant 0.01% TFA modifier) to yield 
circumdatin E (3.35), circumdatin G (3.36), waspergillamide A (3.24) cycloanthranylproline (3.34). 
The remaining MeOH solubles SPE fractions are under chemical investigation. 
 
 waspergillamide A (3.24). white solid [α]D21 +13.7 (c 0.21, MeOH); UV-vis (MeOH) λmax (log 
ε) 275 (3.73) nm; NMR (600 MHz, MeOH-d4) see Figure 3.7 and Table 3.2; ESI(+)MS m/z 433 [M 
+ H]+, ESI(−)MS m/z 431 [M − H]–; HRESI(+)MS m/z 455.1544 [M + Na]+ (calcd for 
C20H24H4O7Na+, 455.1543). 
 penicillic acid (3.29). pale white solid; [α]D22 –11.1 (c 0.18, MeOH); UV-vis (MeOH) λmax (log 
ε) 276 (3.13), 285 (3.01) nm; NMR (600 MHz, DMSO-d6) see Figure 3.21 and Table 3.4; 
ESI(+)MS m/z 171 [M + H]+, ESI(−)MS m/z 169 [M − H]–; HRESI(+)MS m/z 193.1080 [M + Na]+ 
(calcd for C8H10O4Na+ 193.0540). 
 dehydropenicillic acid (3.30). Colourless oil; [α]D21 –4.3 (c 0.16, MeOH); UV-vis (MeOH) λmax 
(log ε) 274 (3.16), 285 (3.11) nm; NMR (600 MHz, DMSO-d6) see Figure 3.23 and Table 3.5; 
ESI(+)MS m/z 173 [M + H]+, ESI(−)MS m/z 171 [M − H]–; HRESI(+)MS m/z 195.0618 [M + Na]+ 
(calcd for C8H12O4Na+, 195.0633). 
  cycloanthranylproline (3.34). Yellow solid; [α]D21 –11.1 (c 0.038, MeOH); UV-vis (MeOH) 
λmax (log ε) 276 (3.43), 285 (3.35) nm; NMR (600 MHz, DMSO-d6) see Figure 3.25 and Table 3.6; 
ESI(+)MS m/z 217 [M + H]+, ESI(−)MS m/z 215 [M − H]–; HRESI(–)MS m/z 215.0716 [M – H]– 
(calcd for C12H11N2O2−, 215.0821). 
 circumdatin E (3.35). Colourless oil; [α]D21 –105.31 (c 0.061, MeOH); UV-vis (MeOH) λmax 
(log ε) 276 (3.76), 284 (3.75), 300 (3.58), 340 (3.37), 354 (3.30) nm; NMR (600 MHz, DMSO-d6) 
see Figure 3.28 and Table 3.7; ESI(+)MS m/z 364 [M + H]+, ESI(−)MS m/z 362 [M − H]–; 
HRESI(+)MS m/z 386.1094 [M + Na]+ (calcd for C20H17N3O4Na+, 386.1122). 
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 circumdatin G (3.36). Yellow solid; [α]D21 –68.25 (c 0.016, MeOH); UV-vis (MeOH) λmax (log 
ε) 278 (3.66), 286 (3.61), 326 (3.36), 342 (3.26) nm; NMR (600 MHz, DMSO-d6) see Figure 3.31 
and Table 3.8; ESI(+)MS m/z 308 [M + H]+, ESI(−)MS m/z 306 [M − H]–; HRESI(+)MS m/z 
330.0837 [M + Na]+ (calcd for C17H13N3O3Na+, 307.0849). 
 stephacidin B (3.37). Yellow solid; [α]D21 –5.0 (c 0.1, MeCN); UV-vis (MeOH) λmax (log ε) 274 
(3.95), 284 (3.90) nm; NMR (600 MHz, DMSO-d6) see Figure 3.33 and Table 3.9; ESI(+)MS m/z 
891 [M + H]+, ESI(−)MS m/z 889 [M − H]–; HRESI(+)MS m/z 913.3794 [M + Na]+ (calcd for 
C52H54N6O8Na+, 913.3901). 
3.4.6 Acid-mediated hydrolysis 
 
Sample of 3.24 (50 µg) was treated for 16 h with 6 M HCl at 100 °C, dried under N2 at 40 °C and 
redissolved in MeOH (50 µL) prior to HPLC-DAD-ESI(±)MS analysis (Zorbax SB-C8 column, 150 
× 4.6 mm column, 5 µm, 1 mL/min gradient elution from 90% H2O/MeCN to 100% MeCN over 15 
min, with constant 0.05% HCO2H modifier).  
 
3.4.7 Synthesis of 3.26 
 
The Fmoc-Gly-Wang polystyrene resin (0.1 mmol, loading 0.61 mmol/g), pre-swollen in DMF, was 
treated with 50% piperidine / DMF (1 × 1 min, then 1 × 2 min) then washed with DMF. A solution 
of 4-nitrobenzoic acid, HBTU, DIEA (0.4 mmol each) in DMF was added to the resin and allowed 
to stand for 20 min. The resin was washed successively with DMF, DCM / MeOH (1:1) and dried. 
Cleavage from the resin was achieved by treatment with 95% TFA / 5% H2O at room temperature 
for 2 h. After most of the cleavage solution was evaporated under a stream of N2, the product was 
redissolved in MeCN / H2O, filtered and lyophilised to give (3 mg) of a colourless oil ESI-MS (m/z) 
= 225.18 [M+H]+. A total of 19 mg of 3.26 were obtained as a colourless oil with 80% yield, 
calculated based on the initial resin loading.  
3.4.8 Marfey’s analysis  
 
Samples of waspergillamide A (3.24), cycloanthranylproline (3.34), circumdatin E and G (3.35 and 
3.36) (50 µg) in 6 M HCl (100 µL) were heated to 110° C in sealed vials for 24 h, after which 
hydrolysates were evaporated to dryness at 40 °C under a stream of dry N2. The resulting 
hyrolysates were treated with 1 M NaHCO3 (20 µL) and L-FDAA (1-fluoro-2-4-dinitrophenyl-5-L-
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alanine amide, 1% solution in acetone, 50 µL) at 40 ° C for 1 h. Samples were neutralised with 1 M 
HCl (20 µL), diluted with MeCN (810 µL) and analysed by HPLC-ESIMS (Agilent Zorbax SB-C3 
or C18 column, 5 µm, 150 × 4.56 mm, 50 ° C, 1 mL/min, 55 min linear gradient elution from 
80:15:5 to 35:60:5 (H2O:MeOH:MeCN) with isocratic 0.05% HCO2H modifier). Authentic amino 
acids L-Ala, D-Ala, D-Pro and L-Pro were derivatised with L-FDAA and D-FDAA, and analysed 
with the aforementioned HPLC-ESIMS conditions. 
 
3.4.9 Bioassays 
 
Antimicrobial assay. Antimicrobial activities were measured against Gram-positive bacteria 
Staphylococcus aureus (ATCC 25923) and Gram-negative bacteria Escherichia coli (ATCC 
25922), Pseudomonas aeruginosa (ATCC 27853) by the broth micro-dilution method. The test was 
performed (in triplicate) in 96-well microtiter plates by serial dilution in tryptic soy broth for 
bacteria and Sabouraud broth for fungi, respectively. Test compounds were prepared and serially 
(ten-fold) diluted in 10% DMSO. An aliquot (20 µL) of each dilution was transferred to a 96-well 
microtiter plate, followed by freshly prepared microbial broth (180 µL, 104–105 cfu/mL cell 
density) to give a final test compound concentration ranging from 32 to 0.125 µg/mL. The plates 
were incubated at 37 °C for 24 h for bacteria and at 26.5 °C for 48 h for yeast. The optical density 
of each well was measured at 600 nm using a microtitre plate spectrophotometer (POLARstar 
Omega plate, BMG LABTECH, Offenburg, Germany). Broth medium with and without microbial 
inoculation were used as negative controls, with tetracycline. The minimum inhibitory 
concentration (MIC50) was determined as the lowest concentration of a test compound that inhibits 
50% of microorganism growth. The MIC50 (µM) for positive control tetracycline against 
Staphylococcus aureus (ATCC 25923) was 0.26 µM and for Gram-negative bacteria Escherichia 
coli (ATCC 25922) was 0.12 µM and Pseudomonas aeruginosa (ATCC 27853) was 0.26 µM. 
Antifungal assay Antifungal activity was measured against Candida albicans (ATCC 90028) 
with the broth micro-dilution method described above for antimicrobial assay. For positive control 
ketoconazole the MIC50 was 0.22 µM. 
 
Cytotoxicity assay. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay was modified from that previously described15 using adherent NCI-H460 (human lung 
carcinoma), SW-620 (human colorectal adenocarcinoma). Briefly, cells were harvested with trypsin 
and dispensed into 96-well microtitre assay plates at 2,000 cells/well and incubated for 18 h at 37 
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°C with 5% CO2 (to allow cells to attach). Compounds were dissolved in 5% DMSO in PBS (v/v) 
and aliquots (20 µL) were tested over a series of final concentrations ranging from 10 nM to 30 µM. 
Control wells were treated with 5% aqueous DMSO. After 68 h incubation at 37 °C with 5% CO2, 
an aliquot (20 µL) of MTT in PBS (4 mg/mL) was added to each well (final concentration of 0.4 
mg/mL), and the microtitre plates incubated for a further 4 h at 37 °C with 5% CO2. After this final 
incubation the medium was aspirated and precipitated formazan crystals dissolved in DMSO (100 
µL/well). The absorbance of each well was measured at OD580 nm at r.t. on a POLARstar Omega 
microtitre plate reader. IC50 values were calculated using Prism 5.0 (GraphPad Software Inc., La 
Jolla, CA), as the concentration of analyte required for 50% inhibition of cancer cell growth 
(compared to negative controls). All experiments were performed in duplicate. Vinblastin was used 
as a positive control for the MTT assay showing an IC50 value of 0.05 µM for NCIH460 lung 
cancer cell line and 0.01 µM for SW620 colon cancer cell line. 
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4  New siderophores and azaphilones from the wasp-derived fungi 
Talaromyces sp. (CMB-W045) 
 
Chemical and biological profiling of solvent extracts obtained from cultivation of microbes 
associated with the outer surface of a specimen of Mud dauber wasp allowed for the prioritisation 
of fungal isolate CMB-W045. The HPLC-DAD-MS analysis of an extract prepared from CMB-
W045 revealed the production of > 15 metabolites including new siderophores and azaphilones. 
Chemical investigation of the water soluble partition of the extract identified the new siderophores 
5N-deoxydimerumic acid (4.11), 5ʹN-deoxydesferricoprogen (4.13), and 5ʹN,5N-
dideoxydesferricoprogen (4.14) and previously reported siderophores dimerumic acid (4.9), 
elutherazine B (4.10) and desferricoprogen (4.12). Chemical investigation of the MeOH soluble 
partition of the extract yielded the azaphilones, mitorubrin (4.33) and three new azaphilone 
analogues 4.34 – 4.36.  
 
All chemical structures were determined by detailed spectroscopic analysis with absolute 
configurations assigned to 4.9 – 4.14 on the basis of micro-scale hydrolysis followed by C3 
Marfey’s analysis. Siderophores 4.9 – 4.14 were tested with a calcein-Fe (III) complex (CAFe) 
assays to measure their iron affinity with 4.9, 4.12 and 4.13 exhibiting the highest iron affinity. 
 
The results and discussion section of this chapter are divided into three parts: 
 
• PART I: Describes the taxonomy investigation of wasp-derived fungal isolate (CMB-W045) 
and outlines its chemical investigation 
• PART II: Introduction to siderophores, structure elucidation of 4.9 – 4.14 and iron binding 
assay results  
• PART III: Introduction to azaphilones, structure elucidation of 4.33 – 4.36 and investigation 
of their absolute configuration 
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4.1 Results and discussion 
4.1.1 PART I: Wasp-derived Talaromyces sp. (CMB-W045) 
 
a) b)
 
 
Figure 4.1 (a) Picture of a Mud-dauber wasp (b) Picture of Talaromyces sp. (CMB-W045) cultivated in ISP-2 agar 
media and incubated 10 days at 26 °C  
 
One Mud Dauber wasp (Figure 4.1) collected by Professor Rob Capon in the Brisbane area was 
transported to the Institute for Molecular Bioscience’s laboratory (described in chapter 2). The 
fungal isolate Talaromyces sp. (CMB-W045) was recovered from the outer surface of the wasp. 
When cultivated in ISP-2 agar media for 10 days at 26.5 °C, Talaromyces sp. (CMB-W045) 
exhibited a yellow and green filamentous morphology (Figure 4.1). Genomic DNA was isolated 
using a blood and tissue DNA kit (QIAGEN). The Internal Transcribed Spacer 1 (ITS1), ITS2 and 
the 5.8S ribosomal DNA (rDNA) region were amplified by PCR using universal primers ITS1 and 
ITS4. The amplified DNA (~800 bp) was used as a query to BLAST against the standard nucleotide 
GenBank database showed 100% similarity to Penicillium resedanum TDV151 (GenBank 
accession number KF494149.1). However, the observation that the majority of the NCBI BLAST 
hits were Talaromyces spp. prompted us to establish a more reliable taxonomy for CMB-W045, 
thus we performed the BLAST against a RefSeq database instead. With the BLAST against the 
RefSeq the CMB-W045 ITS DNA sequence showed 100% similarity to Talaromyces palmae 
(accession number NC_003888.3). To study the phylogenetic relationship between similar 
Talaromyces spp., Penicillium spp. and CMB-W045, we constructed a phylogenetic tree using 27 
ITS DNA sequences from the Refseq BLAST. This phylogenetic analysis permitted the taxonomy 
assignment of Talaromyces sp. to the wasp-derived fungi CMB-W045, since it showed more 
similarity to Talaromyces spp. whereas Penicillium spp. was clearly outgrouped (Figure 4.2). 
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Penicillium erubescens NRRL 6223 [NR_121245.1]
Penicillium pimiteouiense NRRL 25542 [NR_121258.1]
Penicillium  jamesonlandense [NR_119570.1]
Penicillium  aethiopicum CBS 484.84 [NR_111155.1 ]
Penicillium chermesinum NRRL 2048  [NR_121310.1]
Talaromyces stipitatus ATCC 10500 [NW_002990118.1]
Talaromyces purpureogenus CBS 286.36 [NR_121529.1]
Talaromyces aurantiacus CBS 314.59 [NR_103681.1]
Talaromyces calidicanius CBS 112002 [NR_103665.1]
Talaromyces stollii CBS 408.93 [NR_111781.1 ]
Talaromyces viridulus CBS252.87 [NR_103663.1
Talaromyces duclauxii  CBS 322.48 [NR_121526.1]
Talaromyces apiculatus CBS 312.59  [NR_121530.1]
Talaromyces aculeatus CBS 289.48  [NR_103679.1]
Talaromyces palmae CBS 442.88 [NC_003888.3] 
Talaromyces rugulosus CBS 371.48 [NR_103676.1] 
Penicillium paxilli CBS 360.48 [NR_111483.1 ]
Penicillium hirayamae CBS 229.60 [NR_111672.1 ]
Talaromyces islandicus  CBS 338.48 [NR_103664.1]
Talaromyces brunneus CBS 227.60  [NR_111688.1 ]
Talaromyces variabilis  CBS 385.48 [NR_103670.1]
Talaromyces proteolyticus  CBS 303.67 [NR_103685.1]
Talaromyces piceae  CBS 361.48 [NR_111690.1 ]
Talaromyces radicus CBS 100489  [NR_103666.1]
Talaromyces loliensis CBS 643.80 [NR_103680.1]
Talaromyces phialosporus CBS 233.60 [NR_103664.1]
CMB-W045
 
Figure 4.2 Phylogenetic tree obtained by PhyML Maximum Likelihood analysis of ITS DNA sequences using the 
optimal nucleotide substitution model determined by jModeltest2114 using UGENE115 showing the relationship of CMB-
W045 among selected reference strains (RefSeq GenBank) with their accession numbers indicated in brackets 
 
4.1.1.1 Culture optimization assays 
 
To determine the optimal culture conditions, the fungal isolate Talaromyces sp. (CMB-W045) was 
cultivated under several different media conditions with jasmine rice demonstrating optimal 
production of metabolites. A scale-up fermentation using jasmine rice was conducted to isolate and 
characterise fungal metabolites.  
 
4.1.1.2  Scale-up cultivation of Talaromyces sp. (CMB-W045)  
 
Chapter 4 New siderophores and azaphilones  
 85 
A scale-up cultivation of Talaromyces sp. (CMB-W045) in jasmine rice media was extracted with 
acetone to yield a crude extract (63.4 g) that was subjected to a solvent partition to yield water 
soluble (44.8 g) and EtOAc soluble (11.9 g) fractions. Both fractions were subjected to fractionation 
using C18 vacuum liquid (VLC) and semipreparative HPLC chromatography (Figure 4.3). HPLC of 
the water soluble fraction yielded siderophores 4.9 – 4.14, while C18 VLC and HPLC of EtOAc 
yielded azaphilones 4.33 – 4.36. 
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(grains JR)
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(a)
(c)
(b)
Methanol 
 11.9 g
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2.0 mg
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   (4.13)
1.0 mg
  
   (4.14)
(g)
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  (4.33)
0.6 mg
  (4.34)
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1.5 mg
  (4.35)
1.0 mg
  (4.36)
H2O
 
 
Figure 4.3 General solvent/solvent partition scheme for Talaromyces sp. (CMB-W045). (a) Solvent extraction of rice 
culture with acetone (1 ✕ 3800 mL), (b) EtOAc/H2O partition   (c) hexane/ MeOH partition (d) C18 SPE Stepwise 
gradient from 100% H2O to 100% MeOH (e) Semi preparative HPLC: Zorbax SB CN column  (9.4 mm ✕ 250 mm, 
5µm) 3.0 mL/min, 90 % - 80 % H2O/MeCN (0.01 %TFA) over 30 min (f) C18 VLC from 90 % H2O/MeCN (0.01% 
TFA) to 100 % MeCN (0.01 % TFA) (g) and (h) Semi preparative HPLC: Eclipse XDB C18  (9.4 mm ✕ 25 cm, 5 µm) 
3.0 mL/min, elution from 50% - 40 % H2O/MeCN (0.01% TFA) over 30 min 
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4.1.2 PART II: Siderophores 
4.1.2.1 Introduction to siderophores 
 
The two most common oxidation states in which iron exists in the environment are ferric (Fe2+) and 
ferrous (Fe3+). This property makes iron useful as a catalyst for essential metabolic processes in all 
living organisms. In the environment, iron reacts with oxygen and forms insoluble oxides, which 
are inert to microbial uptake. To overcome this limitation microbes use small molecules called 
siderophores. Such small molecules (< 1,500 Da) are iron scavengers that solubilise iron (Fe3+) 
from the environment and transport Fe3+ into the cell.135,136 Microbes produce different structural 
classes of siderophores including hydroxamates (eg. 4.1), catecholates (eg. 4.2) and carboxylates 
(eg. 4.3).  
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Many fungi produce hydroxamates, which have a common N5-acetyl-N5-hydroxyornithine unit. 
Hydroxamates include four families namely fusarinines (eg. 4.4), coprogens (eg. 4.5), ferrichromes 
(eg. 4.6) and rhodotorulic acids (eg. 4.7) (Figure 4.4). The rhodotorulic acids consist of N5-acetyl-
N5-hydroxyornithine moieties in a diketopiperazine ring. Fusarines have an acetylated N5-acetyl-
N5-hydroxyornithine, while coprogens have two fusarinine moieties in a diketopiperazine ring. 
Ferrichromes are cyclic and have additional amino acids (glycine, alanine and serine) besides the 
N5-acetyl-N5-hydroxyornithine unit (Figure 4.4). 
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Figure 4.4 Representative chemical structures of fungal siderophores (4.4 – 4.7)137 
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The siderophore-mediated iron uptake in fungi can be carried out by four mechanisms: shuttle 
mechanism, hydrolytic mechanism, taxicab mechanism and reductive mechanism (Figure 4.5). In 
the shuttle mechanism, the siderophore-Fe3+ complex crosses the membrane and releases the Fe2+ in 
the cell, then the the iron-free siderophore is excreted out of the cell. In the hydrolytic mechanism, 
the siderophore-Fe3+ is degraded inside the cell and the siderophore hydrolysates are excreted out of 
the cell. In the taxicab mechanism, the siderophore-Fe3+ complex does not enter the cell, rather the 
iron is transported across the membrane to intracellular ligands. In the reductive mechanism, the 
reduction occurs at the membrane and the Fe2+ crosses the membrane into the cell (Figure 4.5). 
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Figure 4.5 Mechanisms of siderophore iron uptake across the cytoplasmic membrane in fungi. Figure is adapted from 
Helm et al.138 
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Biosynthesis of fungal siderophores follows two main pathways: NRPS dependent and non−NRPS 
dependent. Since fungi often synthesise hydroxamates, their biosynthetic pathway has been the 
subject of extensive studies. The hydroxamate biosynthesis begins with L−ornithine as a starter unit 
which is hydroxylated by the enzyme L−ornithine N5−oxygenase to N5−hydroxy−L−ornithine and 
an acyl group is added by N5−transacylases to yield the hydroxamate group. From this hydroxamate 
group, the biosynthesis follows a ribosomal peptide synthase (NRPS) pathway linking hydroxamate 
groups and other amino acids (Figure 4.6). 
L-ornithine
N5-hydroxy-L-ornithine
N5-acyl-N5-hydroxy-L-ornithine
rhodotorulic acid
HydroxyferricrocinCoprogen
coprogen B fusarinine C ferrichromes
Triacetylfusarinine
Amino acids
Acyl-CoA
L-ornithine N5-oxigenases
 N5-transacylases
NRPS
Transacetylases Hydroxylase
Acetyl-CoA
! 
Figure 4.6 Biosynthetic pathways for fungal siderophores. Figure from Plattner et al.139 
 
Siderophores have useful applications in medicine, agriculture, biosensor technology and microbial 
ecology. In medicine, siderophores have been used in drug delivery systems as antibiotic carriers,140 
malaria treatment,141-143 and reduction of over-proliferating cancer cells.143-145 Siderophores have 
important applications in cancer therapy by clearing excess iron,146 or in diseases like thalassemia 
and anemia. Siderophores have value in clearing the aluminium overload after dialysis.141  
 
In agriculture, siderophores promote plant growth promotion and are useful as biocontrol agents 
and bioremediation of heavy metals. For example, the plant-associated bacteria Pseudomonas spp. 
and E. coli produce the growth promoting siderophore pyoverdine (4.8).147,148 Some siderophores 
remove heavy metals and metalloids contaminants such as Cr3+, Al3+, Cu+, and Pb2+ from soil.149,150 
Siderophores have seen to increase and promote the growth of microbial communities in soil as 
well as unculturable microbes in the laboratory.151 
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In our chemical investigation of wasp-derived Talaromyces sp. (CMB-W045) we identified a series 
of siderophores and azaphilones. Siderophores included three known structures such as dimerumic 
acid (4.9), elutherazine B (4.10) and desferricoprogen  (4.12) and three new structures including 
5N-deoxydimerumic acid (4.11), 5ʹN-deoxydesferricoprogen (4.13) and 5ʹN,5N-
dideoxydesferricoprogen (4.14). All chemical structures were determined by detailed 1D and 2D 
NMR analysis and their absolute configurations were assigned on the basis of micro-scale 
hydrolysis followed by C3 Marfey’s. 
4.1.2.2  Siderophores 4.9 – 4.14 
 
An HPLC-DAD-MS analysis of the water soluble partition detected six components (Figure 4.7), 
which were purified by semi-preparative HPLC and were eventually identified as dimerumic acid 
(4.9), elutherazine B (4.10), 5N-deoxydimerumic acid (4.11), desferricoprogen (4.12), 5ʹN-
deoxydesferricoprogen (4.13), 5ʹN, 5N-dideoxydesferricoprogen (4.14) (Figure 4.7). The structures 
of 4.9 – 4.14 were determined de novo by detailed spectroscopic analysis and chemical 
derivatisations (C3 Marfey’s method).  
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Figure 4.7 HPLC-DAD-MS (254 nm) chromatogram of water soluble partition of CMB-W045 using Zorbax SB CN 
column (9.4 mm × 250 mm, 5µm) with a 3.0 mL/min from 90% - 80% H2O/MeCN (0.01% TFA)  
 
The ESI(+)MS and UV-vis λmax obtained from the HPLC-DAD-MS analysis of the six peaks 
suggested that 4.9 – 4.14 were related structures since their Uv-vis (λmax  218) was comparable and 
their m/z ions difference was suggestive of the presence of additional oxygens in a related structure 
(Table 4.1). From analysis of 1D and 2D NMR data, we identified previously reported siderophores 
dimerumic acid (4.9), elutherazine B (4.10) and desferricoprogen (4.12) and three new analogues. 
 
Table 4.1 ESI(+)MS and UV-vis λmax of 4.9 –  4.14 
Metabolite λmax ESI(+)MS ESI(˗)MS 
4.9 218 485.1 [M+H]+ 483.2  [M˗H]˗ 
4.10 218 453.2 [M+H]+ 451.1 [M˗H]˗ 
4.11 218 469.2 [M+H]+ 467.1 [M˗H]˗ 
4.12 218 769.2 [M+H]+ 767.3 [M˗H]˗ 
4.13 218 753.2 [M+H]+ 751.2 [M˗H]˗ 
4.14 218 737.3 [M+H]+ 735.3 [M˗H]˗ 
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4.1.2.3 Dimerumic acid (4.9)  
 
HRESI(+)MS analysis of 4.9 returned a pseudo-molecular m/z ion [M + Na]+ indicative of a 
molecular formula C22H36N4O8 (Δmmu + 1.4) requiring 7 double bond equivalents (DBEs). The 1H 
spectrum (Figure 4.8) and 13C NMR (600 MHz, DMSO-d6) data of 4.9 showed the presence of 18 
protons and 11 carbons, suggesting a measure of symmetry. Two fragments from the structure of 
4.9 were elucidated with 1D and 2D NMR technique (600 MHz, DMSO-d6) (Figure 4.9). A 
sequence of COSY correlations starting from the H-2 methine (δH 3.85) to the H-5 methylene (δH 
3.49) established the connectivity from C-2 (δC 53.8) to C-5 (δC 46.8). Analysis of HMBC data 
showed correlations from H-2 and H-3 to a carbonyl carbon C-1 (δC 167.8). A deshielded methine 
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doublet (δH 8.12) was attributed to a 2-NH and HMBC correlations to C-2 (δC 53.8) suggested an 
ornithine moiety. COSY correlations linked the 10-OH (δH 4.54), H-10 (δH 3.53) and H-9 (δH 2.24) 
established the C-10 (δC 63.3) to C-9 (δC 43.9) residue. HMBC correlations from H-10 and H-9 to 
C-8 (δC 151.1) and from 8-CH3 to C-7 (δC  118.4) position the olefinic moeity it as indicated. The E 
Δ7,8 configuration was evidenced by a ROESY correlations between H-7 and H-9. An HMBC 
correlation from the H-5 methine to C-6 carbonyl (δC 166.6) indicated connectivity between the two 
substructures as elucidated from the COSY and ROESY data. The substructures obtained from 
these NMR correlations and the HRES(+)MS were searched in available databases and returned 4.9 
as dimerumic acid.  
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Figure 4.8 1H NMR (600 MHz, DMSO-d6) for 4.9 
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Figure 4.9 2D NMR (600 MHz, DMSO-d6) key correlations for 4.9 
 
Table 4.2 NMR (600 MHz, DMSO-d6) data for 4.9 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 1H-1H ROESY 
1, 1' 167.8 - - - - 
2, 2' 
53.8 3.85, m 3a/3b, 3'a/3'b, 2-NH/2'-NH 
1/1', 3/3', 4/4' - 
2-NH, 2'-NH  8.12, d (1.6) 2, 2' 1/1' - 
3a, 3'a 
30.4 1.68, m 2/2' 1/1', 4/4', 5/5', 5-NOH/5'-NOH 
- 
3b, 3'b  1.66, m - - - 
4, 4' 22.2 1.66, m 5/5' 3/3' - 
5, 5' 46.8 3.49, t (6.2) 4/4' 3/3', 4/4', 6/6' - 
5-NOH, 5'-
NOH 
- 9.62, s - - - 
6, 6' 166.6 - - - - 
7, 7' 118.4 6.21, s - - 9/9' 
8, 8' 151.1 - - - - 
8-Me, 8'-Me 18.5 2.01, br s - 7/7', 8/8', 9/9' - 
9, 9' 
43.9 2.24, t (6.6) 10/10' 7/7', 8/8', 10/10', 8-Me/8'-Me 
7/7' 
10, 10' 
63.3 3.53, dt (5.2, 6.6) 9/9', 10-OH/10'-OH 
8/8', 9/9' - 
10-OH, 10'-
OH 
- 4.54, t (5.2) 10/10' 9/9' - 
 
Dimerumic acid (4.9) is a 2,5-diketopiperazine symmetrically disubstituted with N-
hydroxyornithine and trans-dehydromevalonic acid units. Dimerumic acid (4.9) was first reported 
by Emery in 1965,152 later obtained by Diekmann in 1970 from Fusarium dimerum153 and was also 
identified in 1982 from the soil plant pathogen Verticillum dahliae.154 Dimerumic acid (4.9) has 
also been identified from Monascus fermented products and shown to have antioxidant, anti-
inflammation properties as well as prevent cancer cell invasion by reducing oxidative stress.155  
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Although 4.9 has been isolated from several sources its absolute configuration remained 
unresolved, here we determined the absolute configuration of 4.9 by C3 Marfey’s ( see section 
4.1.2.9). 
 
4.1.2.4 Elutherazine B (4.10) 
 
The HRESI(+)MS analysis of 4.10 returned a pseudo-molecular ion m/z [M + Na]+ indicative of a 
molecular formula C22H36N4O6 (Δmmu + 0.08) requiring 7 double bond equivalents (DBEs). Since 
we had determined that 4.9 was the siderophore dimerumic acid and the HPLC-DAD-MS data 
suggested that all six metabolites (4.9 – 4.14) were related structures we anticipated 4.10 would 
have a related structure. We identified similar 1D and 2D NMR (600 MHz, DMSO-d6) resonances 
in 4.9 as in 4.10. (Figure 4.10) and determined the structure as the diketopiperazine elutherazine B. 
The 1H NMR (600 MHz, DMSO-d6) data was in accordance with literature values (Table 4.3) as 
well as its optical rotationlit. [α]25D 0 (c 0.09, MeOH); exp. [α]25D 0 (c 1.01, MeOH). Elutherazine B 
(4.10) was first isolated in 2010 from the plant Acanthopanax senticosu,156 and the NMR reported 
in the literature is consistent with our results yet the absolute configuration then was unresolved. In 
this study we determined its absolute configuration using a micro-scale C3 Marfey’s analysis 
described in section 4.1.2.9. 
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Figure 4.10 2D NMR key correlations for 4.10 
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Table 4.3 NMR (600 MHz, DMSO-d6) data of 4.10, comparison of experimental and literature157 data (shaded column) 
Pos. δC δH, mult (J 
in Hz) 
COSY HMBC δH, mult (J in Hz) 
(literature)157* 
1, 1' 167.8 - - - - 
2, 2' 53.8 3.79, m 3a/3b, 3'a/3'b, 
2-NH/2'-NH    
1/1', 3/3', 4/4' 3.80, m 
2-NH, 2'-
NH    
- 8.13, d (1.2) 2, 2' 1/1' 8.14 
3a, 3'a 30.8 1.68, m 2/2' 1/1', 4/4', 5/5', 5-
NOH/5'-NOH 
1.67, m 
3b, 3'b  1.61, m   1.58, m 
4, 4' 24.8 1.44, m 5/5' 3/3' 1.43, m 
5, 5' 43.6 3.51, m 4/4' 3/3', 4/4', 6/6' 3.53, m 
5-NH, 5'-
NH 
- 7.75, t (5.6) - - 7.76 
6, 6' 165.9 - - - - 
7, 7' 119.8 a - - 5.62, s 
8, 8' 149.3 - - -  
8-Me, 8'-
Me 
17.8 2.06, br s - 7/7', 8/8', 9/9' 2.06, s 
9, 9' 37.9 2.17, t (6.5) 10/10' 7/7', 8/8', 10/10', 8-
Me/8'-Me 
2.17, t (6.3) 
10, 10' 59.1 3.51, m 9/9', 10-
OH/10'-OH 
8/8', 9/9' 3.51, m 
10-OH, 
10'-OH 
- 4.54, br s 10/10' 9/9' - 
a signal not observed *Experimental and literature experiments compared were both recorded in the same solvent. 
4.1.2.5 5N-deoxydimerumic acid (4.11) 
 
The HRESI(+)MS analysis of 4.11 returned a pseudo-molecular ion m/z [M + Na]+ indicative of a 
molecular formula C22H36N4O7 (Δmmu, − 3.1) requiring 7 double bond equivalents (DBEs). The 
1D and 2D NMR (600 MHz, DMSO-d6) data for 4.11 were comparable with previously identified 
resonances for 4.9 and 4.10 structures. Detailed assignments confirmed 4.11 as a new analogue of 
dimerumic acid (4.11) having NH at position 5 instead of OH. The optical rotation of 4.11 ([α]22D 
‒9.0, c 0.07, MeOH) was measured and its absolute configuration was established by C3 Marfeys 
(section 4.1.2.9). 
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Figure 4.11 2D NMR key correlations for 4.11 
Table 4.4 NMR (600 MHz, DMSO-d6) data for 4.11 
Position δC 
(ppm) 
δH , mult (J in 
Hz) 
1H-1H COSY 1H-13C HMBC 1H-1H 
ROESY 
1, 1' 167.8 - - - - 
2, 2' 53.8 3.79, m 3a/3b, 3'a/3'b, 
2-NH/2'-NH  
1/1', 3/3', 4/4'  
2-NH, 2'-NH  8.13, d (1.6) 2, 2' 1/1' - 
3a, 3'a 30.8 1.68, m 2/2' 1/1', 4/4', 5/5', 5-NOH/5'-
NOH 
- 
3b, 3'b  1.58, m   - 
4, 4' 24.8 1.58, m 5/5' 3/3' - 
5, 5' 43.6 3.51, m 4/4' 3/3', 4/4', 6/6' - 
5'-NOH  9.60, s  - - 
5-NH  7.74, t (5.6) 6/6' - - 
6, 6' 167.7 - - - - 
7, 7' 119.8 6.21, s - - 9, 9' 
8, 8' 149.2 - - -  
8-Me, 8'-Me 18.3 2.02, br s - 7/7', 8/8', 9/9'  
9, 9' 37.9 2.20, t (6.6) 10/10' 7/7', 8/8', 10/10', 8-Me/8'-
Me 
7, 7' 
10, 10' 59.2 3.51, m 9/9', 10-
OH/10'-OH 
8/8', 9/9' - 
10-OH, 10'-
OH 
- 4.54, br s 10/10' 9/9' - 
 
4.1.2.6 Desferricoprogen (4.12)  
 
HRESI(+)MS analysis of 4.12 returned a pseudo-molecular ion m/z [M + Na]+ indicative of a 
molecular formula C35H56N6O13 (Δmmu + 4.7) requiring 11 double bond equivalents (DBEs). The 
1H NMR spectra for 4.12 displayed similarity to the NMR spectra for 4.9 - 4.11. Structure 
elucidation using 1D and 2D NMR spectra confirmed that 4.12 consists of a 2,5-diketopiperazine 
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moiety disubstituted with N-hydroxyornithine and trans-dehydromevalonic acid units. Literature 
review on related siderophore structures d HRESI-MS data, and 1D and 2D NMR spectra indicated 
that 4.12 is desferricoprogen, a siderophore with three N-hydroxyornithine residues and trans-
dehydromevalonic acid units.157 Desferricoprogen has been previously isolated from Penicillium 
chrysogenum and Neurospora crassa.158 The experimental optical rotation measurement ([α]25D ‒9.6, 
c 0.16, MeOH) was in accordance with the literature ([α]25D ‒10.5, c 0.19, MeOH) for 
desferricoprogen.159 
 
 
 
 
 
  
 
 
 
Figure 4.12 1H NMR (600 MHz, DMSO-d6) spectrum of 4.12 
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Figure 4.13 2D key NMR correlations for 4.12 
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Table 4.5 NMR (600 MHz, DMSO-d6) data for 4.12 
Position δC (ppm) δH , mult (J in 
Hz) 
1H-1H COSY 1H-13C 
HMBC 
1H-1H 
ROESY 
1, 1' 167.9 - - - - 
2, 2' 53.8 3.81, m 3a/3b, 3'a/3'b, 2-
NH, 2'-NH    
1/1' - 
2-NH, 2'-NH    - 8.12, br s 2, 2' - - 
3a, 3'a 30.4 1.67, m 2/2' 1/1' - 
3b, 3'b  1.59, m - - - 
4, 4' 23.1 1.59, m 5/5' - - 
5, 5' 46.8 3.49, t (5.5) 4/4' 6/6' - 
5-NOH, 5'-NOH - 9.63, s - - - 
6, 6' 166.6 - - - - 
7, 7' 116.2 6.22, s - - 9/9' 
8, 8' 151.2 - - - - 
8-Me, 8'-Me, 18-
Me 
18.2 2.02, br s - 9/9'/19, 
8/8'/18 
- 
9, 9', 19 43.8 2.23, t (6.7) 10/10'/20 8/8'/18 7/7', 17 
10, 10', 20 59.2 3.53, m 9/9'/19, 10'-OH, 
20-OH 
8/8'/18 - 
10'-OH, 20-OH - 4.55, t (5.2) 10', 20 9', 19 - 
11 172.1 - - - - 
12 51.9 4.16, m 13a, 13b, 12-
NHAc (-NH) 
11 - 
12-NHAc  - 8.24, d (7.4) 12 - - 
12-NHAc (-CO) 169.6 - - - - 
12-NHAc (-Me) 22.2 1.84, s - 12-NHAc (-
CO) 
- 
13a 28.0 1.64, m 12 12-NHAc (-
CO) 
- 
13b - 1.53, m - - - 
14 62.4 4.16, m 13a, 13b, 15 11, 15 - 
15 39.3 2.39, t (6.6) 14 17 - 
15-NOH - 9.67, s - - - 
16 166.3 - - - - 
17 117.1 6.22, s - - 19 
18 148.7 - - - - 
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4.1.2.7 5ʹN-deoxydesferricoprogen (4.13) 
 
HRESI(+)MS analysis of 4.13 returned a pseudo-molecular ion ([M + Na]+) indicative of a 
molecular formula (C35H56N6O12, Δmmu + 1.1) requiring 7 double bond equivalents (DBEs). 
Structure elucidation of 4.13 was carried out by detailed 1D and 2D NMR analysis (Figure 4.14 and 
Table 4.6). While the optical rotation of 4.13 was measured ([α]22D ‒10.9, c 0.13, MeOH), its 
absolute configuration was determined using C3 Marfey’s analysis. 
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Figure 4.14 1H NMR (600 MHz, DMSO-d6) for 4.13 
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Figure 4.15 2D key NMR (600 MHz, DMSO-d6) correlations for 4.13 
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Table 4.6 NMR (600 MHz, DMSO-d6) data for 4.13 
Position δC (ppm) δH , mult (J in 
Hz) 
1H-1H COSY 1H-13C HMBC 
1, 1' 167.9 - - - 
2, 2' 53.6 3.80, m 3a/3b, 3'a/3'b, 2-NH, 2'-
NH    
1/1' 
2-NH, 2'-NH    - 8.12, br s 2, 2' - 
3a, 3'a 30.4 1.68, m 2/2' 1/1' 
3b, 3'b  1.59, m - - 
4, 4' 22.6 1.59, m 5/5' - 
5, 5' 46.5 3.49, m 4/4' 6/6' 
5-NOH, 5'-NOH - 9.64, s - - 
6, 6' 166.6 - - - 
7, 7' 116.6 6.22, s - - 
8, 8' 151.5  - - 
8-Me, 8'-Me, 18-
Me 
18.2 2.02, br s - 9/9'/19, 8/8'/18 
9 43.4 2.17, t (6.6)   
9', 19 43.6 2.23, t (6.4) 10'/20 8'/18 
10, 10', 20 59.0 3.53, m 9/9'/19, 10'-OH, 20-OH 8/8'/18 
10'-OH, 20-OH - 4.54, m 10', 20 9'/19 
11 172.1 - - - 
12 51.6 4.16, m 13a, 13b, 12-NHAc (-
NH) 
11 
12-NHAc (-NH) - 8.24, d (7.2) 12 - 
12-NHAc (-CO) 169.6 - - - 
12-NHAc (-Me) 22.2 1.83, s 12-NHAc (-CO) 12-NHAc (-CO) 
13a 27.8 1.68, m 12 12-NHAc (-CO) 
13b - 1.53, m - - 
14 62.1 4.16, m 13a, 13b, 15 11, 15 
15 38.7 2.39, m 14 17 
15-NH - 7.73, t (5.1) - - 
16 166.3 - - - 
17 116.6 6.22, s - - 
18 149.7 - - - 
 
4.1.2.8 5ʹN,5N-dideoxydesferricoprogen (4.14) 
 
HRESI(+)MS analysis of 4.14 returned a pseudo-molecular ion ([M + Na]+) indicative of a 
molecular formula (C35H56N6O11, Δmmu ‒ 0.9) requiring 7 double bond equivalents (DBEs). The 
1D and 2D NMR (600 MHz, DMSO-d6) data for 4.14 were comparable with previously identified 
siderophores 4.12 and 4.13 data (Figure 4.16 and Table 4.7). The optical rotation of 4.14 was 
measured ([α]22D ‒10.9, c 0.13, MeOH) and the absolute configuration was determined using C3 
Marfey’s analysis . 
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Figure 4.16 1H NMR (600 MHz, DMSO-d6) for 4.14 
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Table 4.7 NMR (600 MHz, DMSO-d6) data for 4.14 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1, 1' 167.7 - - - 
2, 2' 54.2 3.79, m 3a/3b, 3'a/3'b, 2-NH, 2'-
NH    
1/1' 
2-NH, 2'-NH    - 8.13, s 2, 2' - 
3a, 3'a 31.3 1.60, m 2/2' 1/1' 
3b, 3'b - 1.44, m -  
4, 4' 25.5 1.59, m 5/5'  
5, 5' 47.0 3.51, m 4/4' 6/6' 
5'-NOH - 9.63, s - - 
5-NH - 7.75, t (5.6) 6 - 
6, 6' 166.6 - - - 
7, 7' 116.2 6.22, s - - 
8, 8' 151.2 - - - 
8-Me, 8'-Me, 18-
Me 
18.2 2.08, br s - 9/9'/19, 8/8'/18 
9 44.2 2.23, t (6.7)   
9', 19 44.0 2.17, t (6.5) 10'/20 8'/18 
10, 10', 20 59.4 3.51, m 9/9'/19, 10'-OH, 20-OH 8/8'/18 
10'-OH, 20-OH - 4.50, m 10', 20 9', 19 
11 172.1 - - - 
12 52.3 4.16, m 13a, 13b, 12-NHAc (-NH) 11 
12-NHAc (-NH) - 8.23, d (6.6) 12 - 
12-NHAc (-CO) 170.0 - - - 
12-NHAc (-Me) 28.7 1.83, s - 12-NHAc (-CO) 
13a 26.0 1.68, m 12 12-NHAc (-CO) 
13b - 1.44, m   
14 62.8 4.16, m 13a, 13b, 15 11, 15 
15 39.3 2.39, brt  14 17 
15-NH - 7.75, t (5.6) 16 - 
16 166.3 - - - 
17 117.1 6.22, s - - 
18 148.7 - - - 
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4.1.2.9  C3 Marfey’s for 4.9 – 4.14 
 
While the planar structures of 4.9 – 4.14 were established by 1D and 2D NMR analysis, their 
absolute configurations were determined using C3 Marfey’s analysis, where standard amino acids, 
L-Orn + D-FDAA and D-Orn + D-FDAA and a micro scale hydrolysate of 4.9 – 4.14 (50 µg) were 
derivatised with D-FDAA enabling an HPLC-DAD-MS comparison. The single ion extraction at 
m/z = 637 [M + H]+ for derivatised hydrolysates of 4.9 – 4.14 were comparable to the L-Orn + 
FDAA standard retention time (Figure 4.17). This analysis permitted the assignment of an S 
configuration to 4.9 – 4.11, at positions C-2 and C-2' and an S configuration for 4.12 – 4.14, at 
positions C-2 and C-2' and C-12. 
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Figure 4.17 C3 Marfey’s HPLC-DAD-ESI(+)MS analysis (Zorbax, SB-C3 column 150 × 4.6 mm, 5 µm, 50 °C, 1 
mL/min, gradient over 55 min from 80:15:5 H2O:MeOH:MeCN to 35:60:5 H2O:MeOH:MeCN with an isocratic 0.05% 
v/v formic acid modifier. (a – f) Single ion extraction chromatograms at m/z = 637 [M+H]+ for derivatised with D-
FDAA hydrolysates of 4.9 – 4.14 compared to an authentic standards of (g) (solid line) for m/z = 637, L-Orn + D-FDAA 
(Rt = 24.8 min) and (dotted line) for m/z = 637, D-Orn + D-FDAA (Rt = 28.5 min)  
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4.1.2.10 Iron binding assay and oxidation rate measurements on siderophores 4.9 – 4.14  
 
To investigate the metal chelation capacity and antioxidant potential of siderophores 4.9 – 4.14, we 
carried out a calcein-Fe (III) complex (CAFe) assay. The CAFe assay uses the fluorescent chelator 
calcein with high affinity for Fe (III), which upon the binding interruption between the iron and the 
calcein fluorescent is detected and this effect is often used to quantify labile iron concentrations in 
biological media.160 A competing equilibrium between candidate iron chelators and the complex 
calcein-Fe (III) (CAFe) can be used to assess the relative affinity of putative chelators of CAFe 
complex and releasing fluorescent calcein which was quantified fluorometrically. In CAFe assays, 
dimerumic acid (4.9), desferricoprogen (4.12) and 5ʹN-deoxydesferricoprogen (4.13) exhibited 
strong affinity to Fe (III) (Figure 4.18). To determine their rate of oxidation, 4.9, 4.12 and 4.13 were 
subjected to a DHR (Dihydrorhodamine) oxidation assay in which 4.12 exhibited a higher effect on 
oxidation at a lower concentration (Figure 4.19).  
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Figure 4.18 Fluorescence recovery of calcein-iron (CAFe, µM as a function of chelator concentration) for 4.9– 4.14. 
*overlapping  
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Figure 4.19 Effect of 4.9, 4.12, 4.13 chelators on the rate of DHR oxidation catalyzed by iron/ascorbate in HBS/Chelex 
buffer (pH 7.4) 
 
4.1.3 PART III: Azaphilones 
 
4.1.3.1 Introduction to azaphilones  
 
Azaphilones are a large family of polyketides with a common oxygenated pyroquinone bicyclic ring 
called isochromene (Figure 4.20). Biosynthesis of azaphilones is carried out through polyketide 
synthase (PKS) and fatty acid pathways. PKS synthesises the polyketide chain using acetic acid and 
five malonic acid as substrates and a fatty acid chain is added by a transesterification reaction.161  
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Figure 4.20 Structure of the azaphinoloid scaffold: isochromene 
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Fungi from a wide range of different species are known to synthesise azaphilones.162,163 A recent 
review described 373 different azaphilones produced by 23 genera from 13 families of fungi.164 
Azaphilones are classified into structural groups including citrinins, speciferinone, austdiols, 
helotalins, bulfarialactones, sequoiatones, trichoflectins, hydrogenated azaphilones, ascochitine, 
chaetoviridins, pulvilloric acid-type, berkelic acid and nitrogenated azaphilones.165 The most well 
studied azaphilone structural group is the citrinin group inclusive of 30 structures. Citrinin 
derivatives examples include monomeric pentameric, dimeric, trimeric forms among others (eg. 
4.15 –) (Figure 4.20).166-168  
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Figure 4.21 Citrinin derivatives  
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In our investigation of fungal extracts from wasp-derived Talaromyces sp. (CMB-W045) we 
encountered several hydrogenated azaphilones. Hydrogenated azaphilones can have a benzoyl 
substitution on positions C-6, C-7 or C-8, or/and lack the benzoyl group at position C-8, examples 
are included in Figure 4.22 (eg. 4.23 – 4.32).165  
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Figure 4.22 Examples of types of hydrogenated azaphilone. No substitution in C-6, C-7, or C-8 (4.23-4.25). Benzoyl 
substitution in C-7 (4.26-4.30) C-6 benzoyl substitution (4.31) and C-8 benzoyl substitution (4.32) 
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Hydrogenated azaphilones have been isolated mostly from the genus Emericella, Hypoxylon, 
Penicillium and Talaromyces.165 Often azaphilones have been shown to exhibit biological 
properties, for example, the sequoiamonascins (4.24 – 4.25) with anticancer properties,169 
monomethyl-(S)-mitorubrin (4.26) and 4’-hydroxy-3’-methoxy-(S)-mitorubrin (4.27) have 
antifungal properties170 and falconesin D, B and J (4.28 – 4.30) obtained from Emericella sp. have 
antibacterial properties.171 Deacetylisowortmin (4.31) and (+)-mitorubrinic acid (4.32) are C-6 and 
C-8 benzoyl substituted hydrogenated azaphilones with antifungal172 and antimicrobial activity 
respectively.156 Many of these biological properties have been attributed to the ability of 
azaphilones to react with amino groups (amino acids, proteins and nucleic acids).173-179  
 
In our chemical analysis of Talaromyces sp. (CMB-W045) solvent extracts we identified four 
hydrogenated azaphilones and their chemical structures were determined by detailed spectroscopic 
analysis.  
4.1.3.2  Identification and structure elucidation of 4.33 – 4.34 
 
The semipreparative HPLC purification of MeOH solubles of Talaromyces sp. (CMB−W045) 
culture extract (Figure 4.3) yielded four azaphilones including the known structure (+)-mitorubrin 
(4.33) and three unreported analogues of 4.33, namely CMB-W045-X1 (4.34), CMB-W045-X2 
(4.35) and CMB-W045-X3 (4.36). All azaphilone planar chemical structures were determined by 
detailed 1D and 2D NMR analysis and the absolute configuration of 4.33 was assigned on the basis 
of chiroptical and circular dichroism (CD) measurements and literature comparisons. The 
configuration of C-6 in azaphilones 4.34 − 4.35 and of C-3 in 4.35 and 4.36 was investigated using 
previous literature reports, energy minimisation calculations, Newman projection and J values 
(discussed in section 4.1.3.7).  
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The following sections will describe the structure elucidation of 4.33 − 4.36. 
4.1.3.3 Mitorubrin (4.33) 
 
HRESI(+)MS analysis of 4.33 returned a pseudo-molecular ion m/z ([M + Na]+) indicative of a 
molecular formula (C21H18O7, Δmmu –1.9) requiring 13 double bond equivalents (DBEs). The 1H 
NMR data of 4.33 (Figure 4.23) revealed resonances for a typical AB spin system (δH 6.24, H-6''; 
δH 6.15, H-4'') with the coupling constant of 2.2 Hz, representing meta protons of a benzene 
nucleus. The two downfield signals (δH 10.31, 3''-OH; δH 10.27, 4''-OH) displayed HMBC 
correlations to oxygen-bearing carbons (δC 162.7, C-3''; 162.3, C-5'') suggesting presence of two 
hydroxyl groups attached to an aromatic ring system. A singlet (δH 2.45, 7''-CH3) with HMBC 
correlations to carbons in an aromatic system (δC 104.7, C-2''; 111.1, C-6''; 142.5, C-7'') was 
consistent with a methyl attached to an aromatic ring system. The 1H NMR signal splitting patterns 
and COSY correlations indicated the presence of a terminal propylene moiety (δH 6.27, H-1'; 6.54, 
H-2' and 1.91, 3'- CH3). The configuration of the propylene moiety was established as E based on 
large coupling constant between H-1' and H-2' (J = 15.3 Hz). HMBC correlation from the olefinic 
singlet (δH 6.61, H-4) and doublet (δH 5.61, H-5) to C-4a (δC 114.2) and from H-5 to C-4 (δC 108.4) 
confirmed the diene backbone. The correction between the diene moiety to the rest of the molecule 
was established based on HMBC correlations from the olefinic H-4 to C-1' (δC 122.5) (Figure 4.24) 
 
The 1H NMR downfield singlet (δH 8.29) (H-1) was indicative of a connection to an electronegative 
oxygen atom, HMBC correlations to C-1' (δC 122.5) and carbons C-8a and C-4a (δC 143.3 and δC 
114.2) confirmed the connection of the downfield singlet to the conjugated diene moeity. The two-
component substructure elucidated by 1D and 2D NMR key correlations indicated the presence of a 
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propylene moiety and a bicyclical azaphilone core attached to an orsellinic acid moiety through an 
ester bond. A detailed spectroscopic data comparison with the NMR spectrum of (+)-mitorubrin 
provides support for the above interpretation of the spectrum of 4.33 (Table 4.8). The optical 
rotation of 4.33 was measured ([α]23D +21.8, c 0.05, MeOH) and was found to be consistent to the 
literature value ([α]20D +13.7, c 0.19, MeOH) reported for (+)-mitorubrin.180,181 
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Figure 4.23 1H NMR (600 MHz, DMSO-d6) for 4.33 
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Figure 4.24 2D NMR (600 MHz, DMSO-d6) correlations of 4.33 
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Table 4.8 NMR (600 MHz, DMSO-d6) data of 4.33, comparison of experimental and literature180 data (shaded column) 
Position δC (ppm) δH, mult (J in 
Hz) 
1H-1H 
COSY 
1H-13C HMBC δH, mult, (J in Hz)  
(literature)180* 
1 155.2 8.29, s  4a, 8a 8.25, s 
2 - - - - - 
3 155.1 - - - - 
4 108.4 6.61, s - 4a, 5, 1' 6.57, s 
4a 114.2 - - 3, 5, 9, 13 - 
5 106.4 5.61, d (1.1)  4, 4a, 7 5.61 
6 191.1 - - - - 
7 85.1 - - - - 
8 192.3 - - - - 
8a 143.3 - - - - 
7-Me 22.0 1.54, s - 6, 7 1.57, s 
1' 122.5 6.27, dd (15.3, 
1.5) 
2’ 3' 6.21, d (16.0) 
2' 135.2 6.51, dq (15.3, 
6.9) 
1', 3' 3' 6.55, dq (16.0, 6.0) 
3' 18.3 1.91, dd (6.9, 
1.5) 
1', 2' 1' 1.89, d (6.0) 
1'' 168.1 - - - - 
2'' 104.7 - - - - 
3'' 162.7 - - - - 
4'' 100.5 6.15, d (2.2) 6'' 2'', 5'', 6'' 6.19, d (2.0) 
5'' 162.3 - - - - 
6'' 111.1 6.24, d (2.2) 4'' 2'', 4'', 7''-Me 6.28, d (2.0) 
7'' 142.5 - - - - 
3''-OH - 10.31, s - 2'', 3'', 4'' 10.4, s 
5''-OH - 10.27, s - 4'', 5'', 6'' 10.3, s 
7''-Me 22.6 2.45, s - 2'', 6'', 7'' 2.40, s 
*Experimental and literature experiments compared were both recorded in the same solvent. 
The configuration of the C-7 of mitorubrin (4.33) has been previously determined using CD circular 
dichroism (CD) spectroscopy curves.180,181 For this type of azaphilones it has been established that 
the Cotton effect at the longest wavelength depends on the stereochemistry at C-7 [(+) for α-methyl; 
for (−): β-methyl].181,182 The positive and negative Cotton effects at 340 and 380 wavelengths 
corresponds to 7S and 7R respectively.182 The experimental optical rotation of 4.33 and the NMR 
data comparison had defined 4.33 as (+)-mitorubrin while the configuration of C-7 was confirmed 
with the experimental CD measurement showing a positive cotton effect at λmax (Δε) 350 (+48.53) 
consistent with literature CD λmax (Δε) 368 (+5.7) indicating a 7S configuration.181 
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As co-metabolites of (+)-mitorubrin (4.33), we identified three new analogues from the MeOH 
solubles of Talaromyces sp. (CMB-W045) extracts namely azaphilones CMB-W045-X1 (4.34), 
CMB-W045-X2 (4.35), CMB-W045-X3 (4.36). Their structures were elucidated by detailed 
spectroscopic analysis and NMR comparisons with 4.33.  
 
4.1.3.4 CMB-W045-X1 (4.34) 
 
HRESI(+)MS analysis of 4.34 returned a pseudo-molecular ion m/z [M–H]– indicative of a 
molecular formula C21H20O9 (Δmmu –1.6) requiring 10 double bond equivalents (DBEs). The NMR 
spectra of 4.36 showed similarity to 4.33 with a structural arrangement of an orsellinic acid moiety 
attached to a bicyclical azaphilone core by an ester linkage (Figure 4.25). In 4.34 the propylene C-
3’ bears a carboxylic acid (δC 169.9). The geometry of the propylene moiety was defined as E on 
the basis of the magnitude of the coupling between H-1’ and H-2’ (J = 16.0 Hz). 
 
Azaphilone CMB-W045-X1 (4.34) was identified as a new azaphilone analogue of 4.33 with two 
chiral centres at positon C-7 and C-6, and showed a positive optical rotation ([α]22D +22.4, c 0.05, 
MeOH). The configuration of C-6 was deduced based on biosynthetic grounds and comparison to 
models representing possible structure supported by energy minimisation calculations, Newman 
projection and J values (discussed in section 4.1.3.7). 
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Figure 4.25 1H NMR (600 MHz, MeOH-d4) spectrum of 4.34 
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Table 4.9 NMR data (600 MHz, MeOH-d4) for 4.34 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1  65.3 a 5.04, dd (13.5, 1.5) 1 a 3, 4a 
 - b 4.80, m 1 b  
2 - - - - 
3 a - - - 
4  111.5 5.85, s - 5, 1’ 
4a 147.5 - -  
5  32.9 a 3.10 (19.5, 1.7) 6, 5b 4, 6, 7, 8a 
  b 2.81 (19.5, 3.3) 6, 5a  - 
6 78.4 5.61, dd (3.3, 1.7) 5a, 5b - 
7 75.9 - - - 
7-Me 24.0 1.43, s - 6, 7, 8 
8 197.6 - - - 
8a 118.9 - - - 
1' 137.1 7.04, d (16.0) 2' 3, 4, 3' 
2' 125.3 6.36, d (16.0) 1' 3, 3' 
3' 169.9 - - 1' 
1'' 172.1 - - - 
2'' 105.7 - - - 
3'' 164.5 - - - 
4'' 102.1 6.13, d (2.5) - 2'', 3'', 5'', 6'' 
5'' 166.7 - - - 
6'' 112.7 6.14, d (2.5) - 4'', 5'', 7''-Me 
7'' 145.2 - - - 
7''-Me 24.0 2.24 s - 2'', 6'', 7'' 
asignal not observed 
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Figure 4.26 2D NMR (600 MHz, MeOH-d4) key correlations for 4.34 
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4.1.3.5 CMB-W045-X2 (4.35) 
 
HRESI(+)MS analysis of 4.35 returned a pseudo-molecular ion m/z [M + Na]+ indicative of a 
molecular formula C23H28O8 (Δmmu –1.1) requiring 10 double bond equivalents (DBEs). The 1D 
and 2D NMR data for 4.35 exhibited similarities with NMR data for 4.33, suggesting the structural 
arrangement of an orsellinic acid moiety attached to a bycyclical azaphilone core by an ester 
linkage. In 4.35 the diastereotopic methylene H-4 (δH 2.35, 2.21) was assigned as the adjacent to the 
terminal propylene moiety based on the COSY correlations. The most deshielded diastereotropic 
methylene in 4.35 was assigned as H-1 (δH 4.56, 4.30). This assignment was further supported by 
HMBC correlations observed between H-3 and the quaternary carbon C-4a (δC 149.6). The 
diastereotropic methylene (δH 2.69, 2.53) was assigned to the H-5 in the azaphilone core, as 
supported by the HMBC correlations to methylene carbon C-4 (δC 36.6), two quaternary carbons (δC 
149.6, C-4a; δC 83.4, C-7) and the methine carbon C-6 (δC 69.8). Compared to 4.33, azaphilone 4.35 
has an additional acetate group attached to the sp3 (δC 69.8). The singlet at δH 2.69 corresponds to a 
methyl showing HMBC correlation to a carbonyl carbon (δC 170.1) in the acetyl group at the C-6. 
The optical rotation for 4.35 returned a negative value ([α]23D −100, c 0.06, MeOH). The 
stereochemistry of C-6 was deduced based on biosynthetic grounds, energy calculations, Newman 
projection and J values (discussed in section 4.1.3.7). 
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Figure 4.27 1H NMR (600 MHz, CDCl3) spectra of 4.35 
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Figure 4.28 2D NMR (600 MHz, CDCl3) key correlations for 4.35 
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Table 4.10 NMR data (600 MHz, CDCl3) for 4.35 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1 63.6 α 4.56, dd (16.0, 3.0) 1 b 3, 4a, 8a 
 - β 4.30, dd (16.0, 3.0) 1 a - 
2 - - - - 
3 73.6 4.06, ddd (1.6, 3.5, 11.0) 1', 4a, 4b 2' 
4  36.6 α 2.35, d (17.0, 11.0) 3, 4b 4a, 6 
  β 2.21, d (17.0, 3.5) 4a - 
4a 149.6   - 
5 115.6 α 2.69 dd (17.0, 6.2) 6, 5b 4, 4a, 6, 7 
 - β 2.53 dd (17.0, 10.3) 6, 5a - 
6 69.8 6.17, dd (10.3, 6.2) 5a, 5b - 
6-OAc 21.2 2.06, s - - 
7 83.4 - - - 
7-Me 17.6 1.54, s - 6, 7, 8 
8 191.6 - - - 
8a 130.4 - - - 
1' 130.3 5.51, dd (15.6, 1.6) 2', 3 3, 4, 3' 
2' 129.3 5.78, dq (15.6, 6.5) 1', 3' 3, 3' 
3' 18.1 1.72, d (6.5) 1', 2' 1' 
1'' 170.0 - - - 
2'' 105.9 - - - 
3'' 165.7 - - - 
3''-OH - 11.0, s - 2'', 3'', 4'' 
4'' 101.6 6.21, d (2.4) - 2'', 3'', 5'', 6'' 
5'' 160.6 - - - 
5''-OH - 10.27, s - 4'', 5'', 6'' 
6'' 111.6 6.18, d (2.4) - 4'', 5'', 7''-Me 
7'' 144.1 - - - 
7''-Me 24.3 2.46, s - 2'', 6'', 7'' 
 
4.1.3.6   CMB-W045-X3 (4.36) 
 
The HRESI(+)MS analysis of 4.36 returned a pseudo-molecular ion ([M + Na]+) indicative of a 
molecular formula (C21H20O7, Δmmu – 4.1) requiring 12 double bond equivalents (DBEs). The 1H 
and COSY NMR data of 4.36 showed the presence of a CH˗CH2 component. The sp3 methine (δH 
4.96, H-3) was a part of the bicyclical azaphilone core deduced by HMBC correlations from H-1 
(δH 8.02) to C-3 (δC 78.1) also observed in mitorubrin (4.33). The diastereotropic methylene H-4α 
and H-4β (δH 2.99 and 2.90) was assigned as the bycyclical azaphilone core based on HMBC 
correlations from H-4 to quaternary carbons (δC 143.3, C-8a; δC 147.5, C-4a) and the methine 
carbons (δC 161.56, C-1; δC 127.1, C-1'). The 1D and 2D NMR correlations confirmed the planar 
structure of 4.36 as a new analogue of 4.33 with an orsellinic acid moiety connected to a bicyclical 
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azaphilone core by an ester bond. The optical rotation measurement of 4.36 ([α]23D −68.0, c 0.06, 
MeOH) was indicative of a chiral metabolite. The stereochemistry of C-6 was deduced based on 
biosynthetic grounds, energy calculations, Newman projection and J values (discussed in section 
4.1.3.7). 
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Figure 4.29 1H NMR (600 MHz, DMSO-d6) spectra of 4.36 
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Figure 4.30 2D NMR (600 MHz, DMSO-d6) key correlations for 4.36 
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Table 4.11 NMR (600 MHz, DMSO-d6) data of 4.36 
 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1 161.56 8.02, s  3, 4a, 8a 
2 - - - - 
3 78.1 4.96, m 1', 4a - 
4 32.4 α 2.95, dd (16.9, 3.6) 1, 3, 5 4a, 8a, 1, 1' 
 - β 2.86, dd (16.9, 11.0) - - 
4a 147.5 - - 3, 5, 9, 13 
5 115.6 5.90, d (1.1)  4, 7, 8a 
6 191.0 - - - 
6-OAc     
7 85.0 - - - 
8 192.4 - - - 
8a 143.3 - - - 
7-Me 22.4 1.52, s - 6, 7, 8 
1' 127.1 5.67, dd (14.9, 1.2)  2', 3' 3, 4, 3' 
2' 131.8 5.95, dq (14.9, 6.0) 1', 3' 1, 3, 3' 
3' 17.8 1.73, d (6.0) 1', 2' 1', 2' 
1'' 168.1 - - - 
2'' 105.1 - - - 
3'' 162.7 - - - 
4'' 100.3 6.18, d (2.0)  2'', 3'', 5'', 6'' 
5'' 162.4 - - - 
5''-OH - 10.27, s - 4'', 5'', 6'' 
6'' 111.1 6.24, d (2.0)  2'', 4'', 5'', 7''-
Me 
7'' 142.5 - - - 
3''-OH - 10.37, s - 2'', 3'', 4'' 
5''-OH - 10.27, s - 4'', 5'', 6'' 
7''-Me 22.6 2.45, s - 2'', 6'', 7'' 
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4.1.3.7 Investigation of the absolute configuration of 4.33 − 4.36 
 
The absolute configuration of the C-7 of 4.33 was established by CD, optical rotation measurement 
and comparison with previous literature reports.183 A common biosynthetic pathway is likely to 
occur between mitorubrin (4.33) and its co-metabolites (4.34 − 4.36), thus we based the C-7 
configuration assignment under these biosynthetic grounds as 7S. This assignment leaves us with 
two possibilities for the configurations at C-6 for azaphilones 4.34 and 4.35, (6S or 6R) and two 
possibilities for the configurations at C-3 for azaphilones 4.35 and 4.36 (3S or 3R).  
 
Firstly, we determined the C-3 configuration for 4.35 and 4.36 (3S or 3R) by searching previous 
literature reports on similar structure and their configurational assignments. We found 
phomoeuphorbins A and C (4.37 and 4.38), isolated from the endophytic fungi Phomopsis 
euphorbiae in 2008.184 The configuration of C-3 of phomoeuphorbins was established by ROESY 
correlations and coupling constants measurements, in which the magnitude of the coupling 
constants for 4.37 (3J H-4a, H-3 = 4.8 Hz and 3J H-4b, H-3 6.8 Hz) was assigned as 3R and for 4.38 (3J H-4a, 
H-3 = 12.5 Hz and 3J H-4b, H-3 = 3.4 Hz) was assigned as 3S. The experimental coupling constant value 
of 4.35 (3J H-4a, H-3 = 11.0 Hz and 3J H-4b, H-3 = 3.5 Hz) and for 4.36 (3J H-4a, H-3 = 11.0 Hz and 3J H-4b, H-3 
= 3.6 Hz) obtained from the 1H NMR spectrum matches values coupling constants for 4.38 
indicating the configuration of both 4.35 and 4.36 was 3S.  
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Since we had established the configuration of C-7 based on biosynthetic grounds, we investigated 
the configuration of C-6 by creating modeling configuration possibilities for 4.35 (4.35a and 4.35b) 
and 4.34 (4.34a and 4.34b) using energy minimisation calculations (MM2) and Newman 
projections. We deduced their torsion angles obtained from their coupling constants displayed in the 
1H NMR spectra using the Karplus equation,185 in which the dihedral angle and vicinal proton 
coupling constants (3J) are dependant upon. The magnitude of 3J coupling determines the spatial 
orientation between the two protons, with large coupling for protons 180° and 0° dihedral angles 
(anti orientation) and small coupling for protons with a 90° (gauche orientation).185,186 The graphic 
representation of the Karplus equation (Figure 4.31) provides values for 3JH,H as function of the 
dihedral angles. 
 
Ha
Hb
dihedral angle = 
q$
3J = 7 -11 Hz
q$
3J = 2 -5 Hz
q$
3J = 0 -2 Hz
q$
3J = 7 -11 Hz
HH
H
H
H
H
H
H
 
Figure 4.31 Graphic representation of Karplus equation186 
 
The configuration C-6 models for the two structural possibilities 4.35a (3S, 6S, 7S) and 4.35b (3S, 
6R, 7S) were subjected to energy minimization calculations permitting the visualization of their 
proton position in space (Figure 4.32). In model 1, the expected value for 3J H-5a, H-6 will be small 
(≤7 Hz), since the protons are in gauche orientation (60°), and 3J H-5b, H-6 value will be large (≥10 
Hz), since the protons are in an anti orientation (180°). In model 2, the expected value for 3J H-5a, H-6 
and 3J H-5b, H-6 will be small (≤7 Hz) since they are both in gauche orientation (60°). The 
experimental coupling constant value of 3J H-5b, H-6 (10.3 Hz) and 3J H-5a, H-6 (6.2 Hz) obtained from 
1H NMR spectrum of 4.35 confirmed an anti and gauche orientation, respectively (model 4.35a), 
thus permitted the absolute configuration assignment of 3S, 6S, 7S.  
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Figure 4.32 Two configuration models for 4.35 Model 1: for (a) 3S, 6S, 7S configuration (4.35a) (b) energy 
minimisation (MM2) (c) Newman projection showing structure spatial arrangement and the expected 3J H-5a, H-6 and 3J H-
5b, H-6 values Model 2: for (d) 3S, 6R, 7S configuration (4.35b) (e) energy minimisation (MM2) and (f) Newman 
projection 
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Likewise, to investigate the configuration of C-6 for 4.34 we created models for the two structural 
possibilities 4.34a (6S, 7S) and 4.34b (6R, 7S) and performed energy minimization calculations and 
Newman projection (Figure 4.33). In model 3, the expected value for 3J H-5a, H-6 and 3J H-5b, H-6 will 
be both small (2 − 5 Hz), since the protons are both in gauche orientation (60°). In model 4, the 
expected value for the coupling constants 3J H-5b, H-6 will be small (2 − 5 Hz), since the protons are in 
gauche orientation (60°) and 3J H-5a, H-6 will be large (≥ 10 Hz) since the protons are in anti 
orientation (180°). The experimental coupling constant value of 3J H-5a, H-6 (3.3 Hz) and 3J H-5b, H-6 
(3.3 Hz) obtained from 1H NMR spectrum of 4.34 confirmed a gauche orientation for both protons 
(model 4.34a), thus permitted the absolute configuration assignment of 6S, 7S. 
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Figure 4.33 Two configuration models for 4.34 Model 3: for (a) 6S, 7S configuration (4.34a) (b) energy minimisation 
(MM2) (c) Newman projection showing spatial arrangement and their expected 3J H-5a, H-6 and 3J H-5b, H-6 values Model 4: 
for (d) 6R, 7S configuration (4.34b) (e) energy minimisation (MM2) and (f) Newman projection 
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4.2 Conclusions 
 
The wasp-derived Talaromyces sp. (CMB-W045) yielded new siderophores and azaphilone 
analogues CMB-W045-X1 (4.34), CMB-W045-X2 (4.35) and CMB-W045-X3 (4.36). The new 
siderophores 4.9 and 4.12 exhibited highest affinity to iron in CAFe assays. Siderophores 4.9 − 4.14 
and azaphilones 4.33 − 4.36 were non-cytotoxic (IC50 >30 µM) (against SW-620 and NCI-H420 
cancer cell lines) and non-antibacterial (IC50 > 30 µM) (against Gram-negativebacteria Escherichia 
coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853), the Gram-positive bacteria 
Staphylococcus aureus (ATCC 25923) and Candida albicans (ATCC 90028) in our biological in-
house assays. The wide range of applications of siderophores and the identification of new 
siderophores with high iron affinity highlights the importance of the study and exploration for new 
siderophores that could expand our understanding of their chemical diversity and biology. 
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4.3 Experimental  
 
4.3.1 General experimental 
 
CD spectra were recorded at 22 °C on a JASCO J-810 polarimeter. All other general experimental 
details used for experiments described in this chapter are included in general experimental for 
chapter 3. 
4.3.2 Fungal strain collection 
The fungus Talaromyces sp. (CMB-W045) was isolated from the outer surface of a Mud-dauber 
wasp collected in 2012 from Brisbane, Queensland. Freshly collected wasp specimen was 
transported to the laboratory in sealed container, after which it was rinsed in sterile water. Tissue 
was homogenised using a mortar and pestle and applied to ISP2 agar plates (comprising 2% 
glucose, 1% peptone, 0.5% yeast extract) and the plates sealed with parafilm and incubated for 3 – 
4 weeks. A pure culture of CMB−W045, obtained by single-colony serial transfer on agar plates 
was cryopreserved at –80 °C in 20% aqueous glycerol. 
4.3.3 Fungal strain taxonomy  
 
The PCR conditions used for ITS amplification of CMB-W045 are as described in experimental 
section for chapter 3.  
 
4.3.4 Phylogenetic tree  
 
ProtTest server was used to determine the optimal substitution model for the sequences using the 
critical Akaike Information Criterion (cAIC) generated for each model. The JC69 model was used 
to infer phylogeny ITS sequences. Sequence alignments were produced with the MUSCLE 
program. Trees were constructed using the UGENE program using the aforementioned models. 
Trees were visualised using Ugene’s tree view 
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4.3.5 Production, isolation and characterization of 4.9 – 4.14 and 4.33 – 4.36 
 
A seed culture of Talaromyces sp. (CMB-W045) was prepared by inoculating a Erlenmeyer flask 
(250 mL) containing sterile water (50 mL) and homogenised at 200 rpm at 26.5 °C for 10 min. 
Forty 250 mL Erlenmeyer flasks containing sterile jasmine rice (20 g) inoculated with homogenised 
suspension (5 mL) were incubated at 26.5 °C for 15 d, after which the rice was extracted with 
acetone (3 × 3400 mL) and concentrated in vacuo at 40 °C to afford the crude extract (63.4 g). The 
crude extract was then sequentially triturated to yield MeOH (11.9 g), aqueous (44.8 mg) soluble 
material.  
The MeOH soluble partition was subjected to SPE fractionation (GracePure C18 Max, 10% stepwise 
gradient elution from 10% H2O/MeOH to 100% MeOH) to yield 16 Fractions. One fraction 
subjected to semi-preparative HPLC (Zorbax SB CN column 9.4 × 2.5 cm, 5µm, 3.0 mL/min 
gradient elution from 90%H2O/MeCN (0.01 % TFA) to 100% MeCN (0.01 % TFA) over 30 
yielded dimerumic acid (4.9), elutherazine B (4.10), N-deoxydimerumic acid (4.11), 
desferricoprogen (4.12), 5ʹN-deosydesferricoprogen (4.13), 5ʹN,5N-dideoxydesferricoprogen (4.14). 
Fraction [-1-2-8] (16.6 mg) was subjected to HPLC purification (Zorbax SB-C8 column, 250 × 9.4 
mm, 5 µm, 3 mL/min gradient elution from 10% to 100% H2O/MeCN over 45 min, with constant 
0.01% TFA modifier) to yield azaphilones, mitorubrin (4.33) and a new azaphilone analogue (4.34). 
Second fraction (53.7 mg) was subjected to HPLC fractionation (Zorbax SB-C8 column, 250 × 9.4 
mm, 5 µm, 3 mL/min gradient elution from 70% to 60% H2O/MeCN over 15 min, with constant 
0.01% TFA modifier) to yield two new azaphilones (4.35 and 4.36). 
 dimerumic acid (4.9). Colorless powder; [α]D22 –15.6 (c 0.1, MeOH); UV-vis (MeOH) λmax (log 
ε) 216 (4.45) nm; NMR (600 MHz, DMSO-d6) see Figure 4.8 and Table 4.2; ESI(+)MS m/z 485.1 
[M + H]+, ESI(−)MS m/z 483.2 [M − H]–; HRESI(+)MS m/z 507.2411 [M + Na]+ (calcd for 
C22H36N4O8Na+, 507.2425). 
 5N-deoxydimerumic acid (4.10). Colorless powder; [α]D22 –9.0 (c 0.07, MeOH); UV-vis 
(MeOH) λmax (log ε) 215 (4.25) nm; NMR (600 MHz, DMSO-d6) see Table 4.3; ESI(+)MS m/z 
469.2 [M + H]+, ESI(−)MS m/z 467.1 [M − H]–; HRESI(+)MS m/z 491.2508 [M + Na]+ (calcd for 
C22H36N4O7Na+, 491.2476). 
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 elutherazine B (4.11). Colorless powder; [α]D22 0 (c 0.09, MeOH); UV-vis (MeOH) λmax (log ε) 
215 (4.11) nm; NMR (600 MHz, DMSO-d6) see Table 4.4; ESI(+)MS m/z 453.2 [M + H]+, 
ESI(−)MS m/z 451.1 [M − H]–; HRESI(+)MS m/z 475.2526 [M + Na]+ (calcd for C22H36N4O6Na+, 
475.2527). 
 desferricoprogen (4.12). Colorless powder; [α]D22 –9.6  (c 0.16, MeOH); UV-vis (MeOH) λmax 
(log ε) 215 (4.42) nm; NMR (600 MHz, DMSO-d6) see Figure 4.12 and Table 4.4; ESI(+)MS m/z 
769.2 [M + H]+, ESI(+)MS m/z 791 [M + Na]+, ESI(−)MS m/z 767 [M − H]–; HRESI(+)MS m/z 
791.3750 [M + Na]+ (calcd for C35H56N6O13Na+, 791.3798). 
 5ʹN-deoxydesferricoprogen (4.13). Colorless powder; [α]D22 –10.9  (c 0.13, MeOH); UV-vis 
(MeOH) λmax (log ε) 215 (4.48) nm; NMR (600 MHz, DMSO-d6) see  Figure 4.14 and Table 4.5; 
ESI(+)MS m/z 753.2 [M + H]+, ESI(+)MS m/z 775 [M + Na]+, ESI(−)MS m/z 751 [M − H]–; 
HRESI(+)MS m/z 775.3744 [M + Na]+ (calcd for C35H56N6O12Na+, 775.3848). 
 5ʹN,5N-dideoxydesferricoprogen (4.14). Colorless powder; [α]D22 –10.9  (c 0.13, MeOH); UV-
vis (MeOH) λmax (log ε) 215 (4.62) nm; NMR (600 MHz, DMSO-d6) see Figure 4.16 and Table 4.6; 
ESI(+)MS m/z 737.3 [M + H]+, ESI(−)MS m/z 735.3 [M − H]–; HRESI(+)MS m/z 759.4097 [M + 
Na]+ (calcd for C35H56N6O11Na+, 759.3899). 
 mitorubrin (4.33). Yellow solid; [α]D21 +13.7 (c 0.19, MeOH); UV-vis (MeOH) λmax (log ε) 260 
(3.57), 301 (3.39) nm; NMR (600 MHz, DMSO-d6) see Figure 4.23  and Table 4.8; ESI(+)MS m/z 
383 [M + H]+, ESI(−)MS m/z 381 [M − H]–; HRESI(+)MS m/z 405.0965 [M + Na]+ (calcd for 
C21H18O7Na+, 405.0945). 
 CMB-W045-X1 (4.34) Yellow solid; [α]D21 +22.4 (c 0.05, MeOH); UV-vis (MeOH) λmax (log ε) 
360 (3.90), 306 (3.67), 375 (3.49) nm; CD (MeOH) λmax (Δε) 207.5 (–11.6), 285.5 (+1.0) nm; NMR 
(600 MHz, MeOH-d4) Figure 4.25 and Table 4.9; ESI(+)MS m/z 417 [M + H]+, ESI(−)MS m/z 415 
[M − H]–; HRESI(+)MS m/z 415.1025 [M - H]– (calcd for C21H20O9−, 415.1029). 
 CMB-W045-X2 (4.35). Yellow solid; [α]D21 –100.0 (c 0.03, MeOH); UV-vis (MeOH) λmax (log 
ε) 265 (3.65), 306 (3.46) nm; CD (MeOH) λmax (Δε) 207.5 (–11.6), 285.5 (+1.0) nm; NMR (600 
MHz, CDCl3) see Figure 4.27 and Table 4.10; ESI(+)MS m/z 431 [M + H]+, ESI(−)MS m/z 429 [M 
− H]–; HRESI(+)MS m/z 453.0855 [M + Na]+ (calcd for C23H26O8Na+, 453.0856). 
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 CMB-W045-X3 (4.36). Colourless oil; [α]D21 –68.0 (c 0.06, MeOH); UV-vis (MeOH) λmax (log 
ε) 214 (4.43), 265 (4.00), 306 (3.96) nm; NMR (600 MHz, DMSO-d6) see  Figure 4.29 and Table 
4.11; ESI(+)MS m/z 385 [M + H]+, ESI(−)MS m/z 383 [M − H]–; HRESI(+)MS m/z 407.1143 [M + 
Na]+ (calcd for C21H20O7Na+, 407.1101). 
4.3.6 C3 Marfey’s analysis  
 
Samples of siderophores 4.9 − 4.14 (50 µg) in 6 M HCl (100 µl) were heated to 110° C in seal vials 
for 24 h, after which hydrolysates were evaporated to dryness at 40 ° C under a stream of dry N2. 
The resulting hyrolysates were treated with 1 M NaHCO3 (20 µl) and L-FDAA (1-fluoro-2-4-
dinitrophenyl-5-L-alanine amide, 1% solution in acetone, 50 µl) at 40 ° C for 1 h. Samples were 
neutralised with 1 M HCl (20 µl), diluted with MeCN (810 µl) and analysed by HPLC-ESIMS 
(Agilent Zorbax SB-C3 column, 5 µm, 150 × 4.56 mm, 50 ° C, 1 mL/min, 55 min linear gradient 
elution from 80:15:5 to 35:60:5 (H2O:MeOH:MeCN) with isocratic 0.1 % v/v formic acid 
modifier). Authentic amino acids D-Orn and L-Orn were derivatised with D-FDAA and analysed 
with the aforementioned HPLC-ESIMS. 
4.3.7 Bioassays 
Antibacterial Assay. See methodology in experimental section for chapter 3. 
 
Cytotoxycity assay. See methodology in experimental section for chapter 3. 
 
Calcein-Fe (CAFe) Assay. Metabolites 4.9 – 4.14 were prepared and serially diluted in DMSO (0 to 
1 mM), and an aliquot (5 mL) of each dilution was dispensed into 96-well, flat microtiter plates in 
duplicate. An aliquot (95 mL) of 2 mM calcein-Fe complex (CAFe) in HBS: DMSO (50:50, v/v) 
was then dispensed into each well to give a final analyte concentration ranging from 0 to 50 mM. 
HBS (Hepes Buffered Saline) was prepared by dissolving HEPES (20 mM) and NaCl (150 mM) in 
distilled H2O, washed with Chelex(R)-100 (0.01 g/mL) (pH= 7.4. CAFe was prepared by dissolving 
FeSO4 in aqueous calcein in order to reach a final concentration of 10 mM in both Fe and calcein. 
Assay plates were incubated at r.t. in the dark overnight, after which the fluorescence of each well 
was measured at r.t. using a POLARstar Omega microtitre plate reader (top reading; λexc/λem = 
485/530 nm; gain 850). A calibration curve was generated using desferrioxamine (DFO) (0 to 2 
mM) as the positive control. The apparent binding constant (Kapp) was calculated from the 
following equation.187 
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Kapp = [CA][Fe(chelator)3] 
[CAFe][chelator]3Kdiss(CAFe) 
 
where Kdiss(CAFe) = 1.0×10-24 
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5 Exploring the chemical and biosynthetic diversity of cone snail-derived 
microbes   
5.1 Introduction 
 
Cone snails are marine molluscs that comprise a large genus called Conus. Their cone-shaped 
shells have unique patterns used as taxonomy determinants (Figure 5.1). Cone snails prey on 
fish, worms, or other snails using venoms composed of mainly small peptides (< 5 kDa) called 
conotoxins or conopeptides synthesised in the venom duct (Figure 5.1b).188 Conotoxins have 
diverse neuronal targets, many of which are implicated in human diseases.189 The stability, target 
specificity and diversity of conotoxins has made them attractive molecules for drug 
development.189 One such conopeptide, MVIIA marketed under the name Prialt is already in 
clinical use as a pain therapeutic.190 In recent studies cone snails collected in the Philippines have 
been shown to harbour associated microbe producers of neuro-active small molecules.191,192  
 
venom bulbesophagus
venom duct
radular sheath
pharynx
proboscis
harpon
b)a)
 
Figure 5.1 (a) Indo-Pacific cone snails, left to right: C.geographus, C. textile, C. betullinus.188 (b) Schematic diagram of 
cone snail venom apparatus. From Halai et al.193 
 
There are currently over 800 different identified species of cone snails with most of the diversity 
concentrated in the Indo-Pacific region (Figure 5.1). Australia is a diversity hotspot for these 
molluscs with 166 species, of which 133 are found in Queensland. As part of our studies on 
venomous animal-associated microbes we collected cone snails from the Great Barrier Reef, 
Australia. We isolated microbes from five different species and investigated their ability to 
produce natural products with antibacterial, cytotoxic and/or neuro-active properties. We also 
investigated a possible involvement of venom duct-derived microbes on the production of 
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conotoxins. Our investigation on ~150 microbial isolates obtained from five cone snail species 
was focused on the following questions (Q1): 
• Q1: Do cone snail-derived microbes produce novel and/or bioactive small molecules? 
• Q2: Do these small molecules exhibit biological properties?  
• Q3: Do cone snail-derived microbes produce or modify conotoxins? 
 
To address each question we performed the following:  
• A1: Crude extracts obtained from cone snail-derived microbes were subjected to chemical 
profiling leading to the detection of small molecules  
• A2: Crude extracts obtained from cone snail-derived microbes were subjected to biological 
profiling using CaV channel and nicotinic receptor modulator FLIPRTETRA based assays 
• A3: Cone snail-derived microbes were subjected to genomic profiling with a view to 
detecting conotoxin–like sequences using the database ConoServer.194,195  
 
During the chemical investigation of Streptomyces sp. strains, we detected the production of 
metabolites referred as polycyclic tetramate macrolactams (PTMs). PTMs are microbial 
metabolites with a polycyclic structure incorporating 5-5, 5-5-6 or 5-6-5 fused carbocycles along 
with a macrolactam ring and a tetramic acid moiety (5.1) (Figure 5.2).  
HN
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Figure 5.2 Structure of cylindramide (5.1) highlighting PTM moieties: fused carbon rings (orange), tetramic acid (blue) 
and macrolactam (green) 
 
PTMs have been isolated from marine and terrestrial sourced microbes from soil, sponges, plants, 
insects and microbes. Many PTMs described are reported to exhibit antifungal activity while other 
exhibit cytotoxic and nematocidal activity.196-203 Table 5.1 shows a list of previously isolated PTMs, 
their source and bioactivity. 
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Table 5.1 Examples of PTMs, source and their reported bioactivity 
PTM Source Bioactivity 
 Eukaryotic organism   
cylindramide (5.1) Halichondria cylindrata (sponge) Cytotoxicity204 
discodermide A (5.2) Discodermia dissoluta (sponge) Cytotoxic/Antifungal201 
geodin A Mg salt (5.3) Geodia (sponge) Nematocidal203 
 Environmental microbe  
clifednamides (5.4 – 5.5) Streptomyces sp. JV178 (soil) Undetermined* 
ikarugamycin (5.6) Streptomyces sp. (soil) Antifungal202 
 Associated microbe  
alteramide A (5.7) Alteromonas sp. (associated with sponge) Cytotoxic, Antifungal205 
dihydromaltophilin (HSAF) 
(5.8) 
Lysobacter enzymogenes C3 (associated with 
grass) 
Antifungal206 
frontalamides A and B (5.9 – 
5.10) 
Streptomyces sp. SPB78 (associated with 
Southern Pine Beetle) 
Antifungal207 
xanthobaccin A (5.11) Stenotrophomonas sp. SB-K88 (associated with 
root of sugar beet) 
Antifungal208 
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PTM biosynthetic genes are found across phylogenetically different bacteria.207 Interestingly, many 
PTMs have been discovered as metabolites of microbes associated with higher eukaryotic 
organisms, for example frontalamides (5.9 − 5.10) were obtained from the southern pine beetle-
associated Streptomyces sp. SPB78, xanthobaccin A (5.11) was produced by Stenotrophomonas sp. 
strain SB-K88 obtained from the root of sugar beet,208 and alteramide A (5.7) was produced by 
Alteromonas sp. obtained from the marine sponge Halichondria okadai.205 All isolated PTMs 
exhibit a highly similar structure, which is assembled by a hybrid PKS/NRPS system. The 
biosynthesis of the PTM backbone is carried out by the PKS module which generates two 
polyketide chains207 and  the NRPS module connects them to L-ornithine207,209,210 (Figure 5.3). 
PTMs biosynthetic genes have been expressed in E.coli211 and in vitro production of individual 
functional PKS and NRPS enzymes has been achieved.212 
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Figure 5.3 Schematic representation of the hybrid PKS/NRPS biosynthetic assembly line of PTMs framework. For 
PKS: ketosynthase (KS), acyl–transferase (AT), dehydrogenase (DH), ketoreductase (KR), acylcarrier protein (ACP). 
For NRPS: adenylation (A), peptide carrier protein (PCP), thioesterase (TE). Figure from Li et al.212 
 
In our study, Streptomyces spp. associated with different cone snail species were found to produce 
PTM metabolites. To our knowledge, our study is the first to identify the production of PTMs from 
cone snail-associated Streptomyces sp. Additionally, we identified comparable PTM chemical 
profiles among Streptomyces sp. obtained from different cone snail species. Even more noteworthy, 
despite isolation of marine-derived fungi in our research group from many marine substrates (eg. 
sand, molluscs, fish, algae), all our cone snail samples were largely deficient of fungal species 
suggesting an innate antifungal defence strategy. This chapter will describe three aspects of our 
cone snail study: (i) the identification of common antifungals across different cone snail species and 
their structure elucidation, (ii) the outcomes of biological screening on extracts from the cone snail 
using FLIRP based assay, and (iii) the search for conotoxin-like sequences in selected microbial 
genomes using ConoServer.  
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5.2 Results and discussion 
 
5.2.1 Cone snails: collection and strains prioritisation 
 
We collected five species of cone snails (C. miles, C. ebraeus, C. flavidus, C. coronatus, C. 
emaciatus) (Figure 5.4) and transported them to the laboratory alive in local ocean water kept at 
~26 °C. Their taxonomy was determined based on the shell outer patterning. The five cone snail 
species belong to three different family groups including virgiconus (C. emaciatus and C. flavidus), 
rhizoconus (C. miles) and virroconus (C. coronatus and C. ebraeus).213  
C.#coronatus# C.#miles# C.#flavidus# C.#ebraeus# C.#emaciatus#
Lady Musgrave Island, Great Barrier Reef, Australia 
 
Figure 5.4 Photo showing cone snail shell patterns of the five cone snail species used for this study. Cone snails were 
collected from the Lady Musgrave Island at the Great Barrier Reef  
 
Microbes were isolated from dissected venom duct, stomach foot and hepatopancreas of cone snails 
(Figure 5.5a) to yield ~150 isolates including non-sporulating unicellular bacteria (70%), 
sporulating Actinobacteria (30%) and filamentous fungi (0.5%). The very low levels of fungi was 
particularly noteworthy. Actinobacteria (especially Streptomyces) are well known for their ability to 
produce bioactive chemistry, producing more than 50% of all known antibiotics.214 Bearing this in 
mind, we firstly focused on cone snail-derived Streptomyces sp., which we identified by their 
characteristic sporulating macroscopic morphology (Figure 5.5b). 
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Figure 5.5 (a) Anatomy of cone snail specialised tissue sections  (b) M1 agar plate of microbial cultivation of cone snail 
tissue, Streptomyces spp. colony is indicated with an (red arrow). 
 
The observation that Streptomyces obtained from different cone snail species showed a highly 
similar morphology on ISP-4 agar plates prompted us to investigate whether different cone snail 
species harbour closely related Streptomyces. We selected one Streptomyces sp. from each cone 
snail species (a total of five strains) showing a similar morphology and were subjected to taxonomic 
investigation using with 16S rRNA universal primers. Sequenced 16S DNA was BLASTed against 
Refseq GenBank database and revealed a close homology to Streptomyces griseus subsp. griseus 
strain NRRL F-5621 (accesion number NZ_JOGU01000154.1) (Table 5.2). To get an insight on the 
sequence similarity between the five selected cone snail-derived selected Streptomyces, we 
constructed a phylogenetic tree was using the 16S rRNA partial sequences and sequences from ref 
Streptomyces spp. reference strains from Refseq GenBank. The phylogenetic tree suggests that 
although the Streptomyces spp. obtained from different cone snails are closely related they are not 
identical strains (Figure 5.6). The cone snail-derived Streptomyces are divided into two subgroups 
in the phylogenetic tree where CMB-CS132, CMB-138 and CMB-CS143 are more similar to each 
other than CMB-CS038 and CMB-CS145. 
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Table 5.2 16S rRNA for cone snail-derived Streptomyces sp. closest Refseq GenBank match  
Strain code Cone snail 
(species) 
Tissue 16S rRNA (GenBank)  % 
ID 
Accession no. 
CMB-
CS138 
C. ebraeus hepatopancreas Streptomyces griseus subsp. 
griseus strain NRRL F-5621 
100% NZ_JOGU01000154.1 
CMB-
CS145 
C.flavidus stomach Streptomyces griseus subsp. 
griseus strain NRRL F-5621 
99% NZ_JOGU01000154.1 
CMB-
CS143 
C.coronatus stomach Streptomyces griseus subsp. 
griseus strain NRRL F-5621 
94% NZ_JOGU01000154.1 
CMB-
CS038 
C.miles stomach Streptomyces griseus subsp. 
griseus strain NRRL F-5621 
99% NZ_JOGU01000154.1 
CMB-
CS132 
C.emaciatus hepatopancreas Streptomyces griseus subsp. 
griseus strain NRRL F-5621 
99% NZ_JOGU01000154.1 
 
CMB-CS132
CMB-CS138
CMB-CS143
CMB-CS038
CMB-CS145
Streptomyces coelicolor A3(2) [NC_003888.3]
Streptomyces lividans TK24 [NZ_CP009124.1]
Streptomyces violaceorubidus NRRL B-16381 [NZ_JODM01000100.1]
Streptomyces olivaceus  NRRL B-3009 [NZ_JOFH01000101.1]
Streptomyces ambofaciens ATCC 23877 [NZ_CP012382.1]
Streptomyces albus DSM 41398 [NZ_CP010519.1]
Streptomyces griseus subsp. griseus NRRL F-5621 [NZ_JOGU01000154.1]
Streptomyces griseofuscus NRRL B-5429 [NZ_JOFU01000122.1]
Streptomyces iakyrus NRRL ISP-5482 [NZ_JNXI01000062.1]
Streptomyces nodosus ATCC 14899 [NZ_CP009313.1]
Streptomyces aureofaciens NRRL B-2183 [NZ_JODU01000077.1]
Streptomyces violaceoruber NRRL S-12 [NZ_JOCE01000095.1] 
Streptomyces lividans 1326 [NZ_CM001889.1]
Streptomyces chartreusis NRRL 12338 [NZ_JH164840.1]
Streptomyces  albidoflavus NRRL B-1271 [NZ_JOII01000085.1]
Streptomyces alboflavus NRRL B-2373 [NZ_JNXT01000131.1]
Streptomyces ruber NRRL ISP-5378 [NZ_JOAQ01000088.1]
Streptomyces sclerotialus NRRL B-2317 [NZ_JODX01000045.1]
 Streptomyces aurantiacus J A 4570 [NZ_AOPZ01000103.1]
Streptomyces griseus subsp. griseus  NRRL F-5618  [NZ_JOGN01000124.1]
Streptomyces albus J1074 [NC_020990.1]
 
Figure 5.6 Maximum Likelihood phylogenetic tree using the optimal nucleotide substitution model determined by 
jModeltest114 using UGENE115 showing the relationships among five selected cone snail-derived Streptomyces spp. 16S 
DNA (CMB-CS138, CMB-CS145, CMB-CS143, CMB-CS038, CMB-CS132) among selected reference Streptomyces 
spp. strains from the RefSeq GenBank database, their accession numbers are indicated in braquets 
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5.2.2 Diagnostic NRPS and PKS PCR 
 
To explore if NRPS and PKS genes could be detected from cone snail-derived Streptomyces sp. we 
used degenerate primers to amplify adenylation and ketosynthase domains described by Ayuso et 
al. in 2005.215 Several NRPS and PKS clusters could be contained within a bacterial genome, thus 
such primers are expected to amplify different NRPS and PKS genes. We used this PCR to evaluate 
the use of degenerate primers as a preliminary diagnostic tool in providing a biosynthetic insight 
into the Streptomyces before subjecting the strains to chemical investigation. The PCR yielded 
expected amplified fragments for NRPS (700 bp) and PKS (1.4 kb) (Figure 5.7) consistent to those 
reported by Ayuso et al.,215 for all five of our cone snail-derived selected strains. 
1 kb
ladder    1      2       3        4       5         
700 bp
1.4 kb
NRPS PKS I1 kb
ladder  1      2       3      4      5         
 
Figure 5.7 Picture of a 1% agarose gel of PCR fragments of NRPS (primers A3F and A7R) and PKS I (KF1 and M6R) 
Lane 1: CMB-CS138, Lane 2: CMB-CS145, Lane 3: CMB-CS143, Lane 4: CMB-CS038, Lane 5: CMB-CS132 
 
We sequenced the DNA and obtained sequences for NRPS but not for PKS. We hypothesise that 
the NRPS PCR may have amplified one dominant adenylation NRPS domain, which was not the 
case for the ketosynthase PKS domain. We worked with the NRPS sequences and performed a 
BLAST search against the standard nucleotide GenBank, which revealed a similarity to NRPS 
genes in Streptomyces albus J1074 genome for all five strains (Table 5.3). The Streptomyces albus 
J1074 strain is commonly used as a heterologous host for expression of secondary metabolite gene 
clusters because it was believed to lack endogenous secondary metabolites.216,217 However, recent 
genome mining on Streptomyces albus J1074 revealed several silent biosynthetic gene clusters, 
including NRPS-PKS clusters for PTMs and antimycin. The genome mining of Streptomyces albus 
J1074 by Olano et al., in 2013 was successful in activating/enhancing gene clusters of 6-epi-
alteramide A (5.12) and 6-epi-alteramide B (5.13).218  
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The PCR diagnostic approach was carried out as an exercise to explore the possibility of using 
degenerate primers to reveal any biosynthetic capacity of the cone snail-derived Streptomyces spp.. 
This investigation suggested that all selected cone snail-derived Streptomyces may share a 
biosynthetic potential with each other and with Streptomyces albus J1074 for at least one 
metabolite, and may produce similar compounds to 5.12 and 5.13. This became relevant further in 
our chemical studies to somehow predict possible co-metabolites produced by cone snail-derived 
Streptomyces (discussed in section 5.2.3.3). To investigate and identify shared chemistry among 
cone snail-derived Streptomyces, these five selected strains were subjected to chemical 
investigation. 
 
Table 5.3 GenBank Blast result of NRPS DNA amplified fragment of each Streptomyces sp. obtained from five 
different cone snail species 
Strain code Cone snail source 
(species) 
Closest Ref seq GenBank 
match 
%ID  
NRPS 
Accession  no. 
CMB-CS138 C. ebraeus Streptomyces albus J1074 94% NC_020990.1 
CMB-CS145 C. flavidus Streptomyces albus J1074 94% NC_020990.1 
CMB-CS143 C. coronatus Streptomyces albus J1074 94% NC_020990.1 
CMB-CS038 C. miles Streptomyces albus J1074 94% NC_020990.1 
CMB-CS132 C. emaciatus Streptomyces albus J1074 94% NC_020990.1 
 
NH
NH
O
OH
O O
OH
HO
H
H
6-epi-alteramide A (5.12)
NH
NH
O
O O
OH
HO
H
H
6-epi-alteramide B (5.13)  
 
5.2.3 PKS and NRPS secondary metabolites from cone snail-derived Streptomyces spp. 
 
All five selected cone snail-derived Streptomyces spp. (CMB-CS038, CMB-CS145, CMB-CS132, 
CMB-CS143 and CMB-CS138) were cultivated in ISP-4 agar and incubated at 26.5 °C for 5 days. 
They all exhibited a green morphology, which yielded extracts displayed antifungal activity. 
Chemical profiling (HPLC-DAD-MS) of these 5 extracts revealed the production of common 
secondary metabolites, observed by comparable signals in HPLC-DAD-MS (Rt = 8.0 to 13.0 min), 
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UV-vis chromophores (λmax 220 and 323) and ESI-MS m/z ions (m/z 526 [M+H]+, m/z 513 [M+H]+ 
and m/z 511 [M+H]+) for all five selected isolates (Figure 5.8).  
 
Chemical profile (LC-MS and UV-vis) of cone snail-derived Streptomyces sp. hinted to the 
production of polycyclic tetramate macrolactams (PTMs) displaying a characteristic UV signal and 
known for their antifungal properties. This finding was consistent to the diagnostic PCR using 
degenerate primers that had led to the PTMs structures 5.12 and 5.13. To confirm the production of 
PTMs from cone snail derived Streptomyces sp., we carried out a detailed chemical investigation by 
subjecting Streptomyces sp. (CMB-CS038) to a scale-up cultivation and detailed chemical 
investigation.  
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Figure 5.8  HPLC-DAD-MS (254 nm) chromatogram of cone snail-derived Streptomyces sp. extracts cultivated on ISP-
4 agar. UV-vis spectra and their respective m/z ions  
5.2.3.1 Scale-up cultivation of Streptomyces sp. (CMB-CS038) 
 
The cone snail-derived Streptomyces sp. (CMB-CS038) was recovered from the cultivation of 
stomach homogenate from cone snail C. miles (Figure 5.9).  
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Figure 5.9 (a) Picture of cone snail C. miles (b) Streptomyces sp. (CMB-CS038) cultivated in ISP-4 agar media after 10 
days incubation at 26.5 °C  
 
The scale-up cultivation of Streptomyces sp. (CMB-CS038) was achieved on ISP-4 agar plates (400 
plates), incubated for 10 days at 26 °C and extracted with organic solvents (EtOAc:MeOH (3:1)). 
The extract was dried in vacuo, resuspended in MeOH (5 mL), dried under N2 at 40 °C to obtain a 
final dried extract (820 mg). An aliquot of the extract (1 mg/mL) was prepared for HPLC-DAD-MS 
analysis to confirm the presence of signals of expected PTM-like metabolites eluting between Rt = 
8.0 to 13.0 min with UV-vis chromophores of λmax 220 and 323 (Figure 5.10).  
!
8 10 12 14
200
400
600
Retention time (min)
A
bs
or
ba
nc
e 
at
 2
54
 n
m
 (m
A
U
) B
E/FA
C/D
 
Figure 5.10 HPLC-DAD-MS chromatogram of Streptomyces sp. CMB-CS038 Zorbax-SB C8 column 4.6 × 150 mm, 5 
µM, 10% H2O/MeCN (0.05 % HCO2H) to 100% MeCN  (0.05 % HCO2H) at 1 mL/min over 15 min.  
The crude extract was partitioned between hexane (20 mL) and MeOH (20 mL). The MeOH 
solubles were dried under N2 at 40 °C and subjected to two sequential C8 Sep-Pack (30% 
H2O/MeCN to 100 % MeCN) fractionations (Figure 5.11). A semipreparative HPLC purification 
yielded the major compound B (5.14). The major constituent was recovered in sufficient quantity 
(~1 mg) to acquire 1D and 2D NMR spectra while the remaining co-metabolites were recovered in 
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low yields (<0.5 mg).  Compound B was identified as dihydromaltophilin (HSAF) (5.14), which 
structure was determined by detailed spectroscopic analysis and literature comparisons. 
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(b)
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Figure 5.11General fractionation scheme of Streptomyces sp. (CMB-CS038) to obtain 5.14 (a) EtOAc: MeOH (3:1) 
extraction (b) hexane:MeOH partition (c) and (d) C8 Sep-Pack (30% H2O/MeCN to 100 % MeCN) (e) semipreparative 
HPLC purification Zorbax-SB C3 column (250 × 9.4, 5 µm, 3 mL/min, gradient elution 10% H2O/MeCN (0.01% TFA) 
to 100 % MeCN (0.01% TFA)) over 40 min 
5.2.3.2 Dihydromaltophilin (5.14) 
 
HRESI(-)MS analysis of 5.14 afforded a pseudomolecular (m/z 511 [M-H]-) consistent with the 
molecular formula C29H39N2O6 requiring 11 DBEs. The planar structural elucidation of 5.14 was 
assigned by detailed 1D and 2D NMR analysis. The 1H NMR (600 MHz, MeOH-d4) data for 5.14 
displayed two methyl (δH 0.90 and 1.10) and four olefinic (δH 7.38, 6.36, 6.03, 5.80) resonances 
(Figure 5.12 and Table 5.4). The coupling constants between the olefinic protons suggested a Δ25,26 
Z configuration (J = 11.6 Hz) and an Δ10,11E configuration (J = 14.0 Hz). The 2D HSQC spectrum 
permitted the assignments of many 1H NMR resonances despite abundant overlapping methylene 
resonances between 0.8 to 4.0 ppm (Figure 5.13). The planar structure of 5.14 was assembled de 
novo based on 1D and 2D NMR (Figure 5.14) and confirmed by a detailed comparison to 
previously reported PTMs. The NMR resonances for 5.14 were comparable to dihydromaltophilin, 
also known as HSAF (Table 5.4).219 
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Figure 5.12 1H NMR (600 MHz, MeOH-d4) spectrum of 5.14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 HSQC NMR (600 MHz, MeOH-d4) spectrum of diastereotopic 5.14, seven diastereoscopic methylenes are 
outlined with green boxes 
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Figure 5.14 2D NMR (600 MHz, MeOH-d4) key correlations for 5.14 
 
 
Table 5.4 NMR (600 MHz, MeOH-d4) data of 5.14, comparison of experimental and literature219 data (shaded column) 
Position δC 
(ppm) 
δH , mult (J in Hz) 1H-1H COSY 1H-13C 
HMBC 
1H-1H 
ROESY 
δH , mult (J in Hz) 
(literature)219* 
1        
2 37.7 3.47, m 
2.79, ddd (12.8, 12.8, 1.8) 
2b, 3b 
2a, 3a 
  a 3.48,a m 
b 2.79, br t (12.4) 
3 32.2 a 1.61, m 
b 1.36, m 
2b, 3b, 4 
2a, 3a, 4 
  a 1.63,d m 
b 1.29-1.36,e m 
4 72.2 3.96, ddd (6.4, 2.0, 2.0) 3b, 5, 3a 2  3.97, br, d (6.0) 
5 69.3 3.90, br s 4   3.92, br s 
6 NH      
7       
8       
9       
10  7.14 br d, (14.0) 11   7.13, d (13.2) 
11  6.63, br s 10, 12   6.65, br dd 
12 46.8 2.17, dddd (11.0, 11.0, 11.0, 
3.0) 
23, 11, 13a, 13b 14  2.08-2.19,b m 
13 43.1 a 1.91, ddd (12.8, 4.2, 3.0) 
b 1.32, m 
12, 13b, 14  
12, 13a, 14 
15  a 1.86-1.92,c m 
b 1.29-1.36,e m 
14 75.1 3.37, ddd (10.5, 10.5, 4.2) 15, 13b, 13a   3.36, m 
15 60.7 1.21, ddd (10.5, 10.0, 10.0) 14, 16, 22   1.23, q (10.0) 
16 59.8 1.87, ddd (11.0, 9.5, 9.5) 15, 17, 20 29, 14  1.86-1.92,c m 
17 47.9 1.35, m 16, 29   1.29-1.36,e m 
18 55.3 1.38, m 19a, 19b, 30   1.29-1.36,e m 
19 41.8 2.10, m 
0.86, ddd (11.7, 11.7, 11.7) 
18, 19b, 20 
18, 19a, 20 
  a 2.08-2.19,b m 
b 0.86, m 
20 43.2 2.45, m 16, 19a, 19b, 
21a, 21b 
  2.45, m 
21 38.4 a 2.09, m 
b 0.96, ddd (12.0, 12.0, 8.5) 
20, 21b, 22 
20, 21a, 21b 
  a 2.08-2.19,b m 
b 0.96, m 
22 49.3 1.72, dddd (11.0, 11.0, 11.0, 
5.8) 
15, 21a, 21b, 23   1.72, m 
23 45.5 1.33, m 12, 22, 24b 12  1.29-1.36,e m 
24 29.6 a 3.50, m 
b 2.13, m 
25, 24b 
23, 24a, 25, 26 
  a 3.48,a m 
b 2.08-2.19,b m 
25  6.05, ddd (11.6, 11.6, 2.4) 24b, 24a, 26 23, 27 21a, 22 6.05, br t (10.0) 
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Literature values for a3.48 (2H, overlap 2a, 24a), b2.08 – 2.19 (4H, overlap 12. 19a, 21a, 24b), c1.86 – 1.92 (2H, overlap 
13a, 16), d1.63 (2H, overlap 3a, 30a), e1.29 -1.36 (5H, overlap 3b, 13b, 17, 18, 23), *signals obtained from HSQC NMR 
+signal is very broad (peak is not observed due to peak broadening). *Experimental and literature experiments 
compared were both recorded in the same solvent. 
 
To investigate the presence of other related PTM analogues in Streptomyces sp. (CMB-CS038) 
crude extract, we obtained two PTMs from the Capon compound library previously characterised in 
our research group (5.15 and 5.16). To investigate whether cone snail-derived Streptomyces sp. 
(CMB-CS038) produces 5.15 and 5.16 we applied an analytical method involving HPLC-DAD-MS 
analysis of the solvent extract of Streptomyces sp. (CMB-CS038), reference compounds (5.15, 
5.16) and single m/z ion extractions. 
 5.15
NH
NH
O
O O
OH
O
H
H
H
H
NH
NH
O
O O
OH
O
H
H
H
H
 5.16  
The HPLC-DAD-MS single ion extraction of m/z 493 [M-H]- and m/z 491 [M-H]- from 
Streptomyces sp. (CMB-CS038) identified 5.15 and 5.16 eluting at comparable retention times as 
the reference compounds obtained from the Capon compound library (Figure 5.15 and Figure 5.16). 
26 124.7 5.80, dd (11.6, 2.6) 24b, 25 24, 27 24b 5.80, br d (12.0) 
27 168.5*      
28 194.9*      
29 18.9 1.11, d (6.3) 17 17, 18, 
16 
 1.11, d (6.4) 
30 27.2 a 1.63, m 
b 1.09, m 
29, 31 
30b 
30  a 1.63,d m 
b 1.10, m 
31 12.8 0.90, t (7.4)    0.90, t (7.4) 
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Figure 5.15 Single ion extraction of m/z 493 [M-H]- from (a) Streptomyces sp. (CMB-CS038) extract and (b) Capon 
compound library reference compound 5.15 
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Figure 5.16 Single ion extraction of m/z 491 [M-H]- (a) Streptomyces sp. (CMB-CS038) extract and (b) Capon 
compound library reference compound 5.16 
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This analytical method (HPLC-DAD-MS) permitted the identification of two additional PTMs 
produced by Streptomyces sp. (CMB-CS038) expressed in very low levels. Figure 5.17 shows the 
HPLC-DAD-MS chromatogram of the solvent extract of Streptomyces sp. (CMB-CS038) aligned 
with the HPLC-DAD-MS chromatogram produced by the pure PTMs 5.14, 5.15 and 5.16 showing 
their elution times and quantities present in the crude extract compared to compound B (5.14). 
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Figure 5.17 HPLC-DAD-MS overlapped chromatograms of (a) Streptomyces sp. (CMB-CS038) extract, (b) 
dihydromaltophilin (5.14) and (c) reference compound (5.15) and reference compound (5.16) 
 
The Streptomyces sp. (CMB-CS038) produced one prominent metabolite (compound B) and 
structure was identified as HSAF (5.14) by detailed 1D and 2D NMR data analysis. We 
hypothesised that the production of other small molecules by Streptomyces sp. (CMB-CS038) may 
be silent or expressed in low levels under our standard culture conditions. However despite the low 
production levels of 5.15 and 5.16 we were able to identify them in Streptomyces sp. (CMB-CS038) 
extracts using the aforementioned analytical method. Bearing this in mind, we explored the 
possibility of identifying other molecules using such analytical methods. We know from the 
diagnostic NRPS PCR (described in section 5.2.2) that Streptomyces sp. (CMB-CS038) may be 
biosynthetically related to Streptomyces albus J1074 and we used this as a starting point to 
investigate the production of other chemistry by searching other reported chemistry from this strain. 
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5.2.3.3 Streptomyces sp. (CMB-CS038) and Streptomyces albus J1074 
 
The diagnostic NRPS PCR of cone snail-derived Streptomyces sp. identified that is NRPS genes 
showed similarity (>90%) to Streptomyces albus J1074, a strain commonly used as an expression 
host.216,217 This similarity prompted us to investigate previous natural products reported from 
Streptomyces albus J1074 and found that other biosynthetic gene clusters for the production of 
antimycins, bacteriocins, lantibiotics, candidicyns, antimycins and paulomycins were identified. We 
then investigated the solvent extracts of all five Streptomyces spp. (CMB-CS038, CMB-CS143, 
CMB-CS132, CMB-CS138, CMB-CS145) for such related co-metabolites reported for 
Streptomyces albus J1074 using HPLC-DAD-MS and m/z single ion extraction. This analysis 
identified the m/z ion 533 [M+H] – corresponding to antimycin A (5.17). To confirm the identity of 
5.17, we used the antimycin A (5.17) standard from the Capon compound library and compared 
their elution times. Comparable elution times and identical mass (m/z ion 533 [M+H] –) confirmed 
the presence of 5.17 in all five cone snail-derived selected Streptomyces spp. solvent extracts 
(Figure 5.18). 
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Figure 5.18 HPLC-DAD-MS single ion extraction (EIS) of m/z 533 [M-H]- from Streptomyces sp. crude extract (a) 
CMB-CS038 (b) CMB-CS143 (c) CMB-CS038 132 (d) CMB-CS138 (e) CMB-CS145 (f) Capon compound library 
antimycin A (5.17)  
 
 
Chapter 5 Cone snail derived microbes  
 154 
 
Antimycins (eg. 5.17 − 5.22) are a large group of compounds (~40 analogues) with a nine-
membered dilactone ring connected to a 3-formamidosalicylic acid moiety.220 Antimycins have 
been reported from Streptomyces sp. associated with ants, which they are believed to offer 
protection from fungi.221 Antimycins are also selective fish toxins widely used as a piscicide in 
aquaculture to selectively eliminate unwanted fish species.222 
 
N
H
OH
H
N
O
O
O
OHC
O
O
O
R2
R1O
5.17 R1= CH(CH3)2                    R2= (CH2)5CH3
5.18 R1= CH(CH3)CH2CH3       R2= (CH2)5CH3
5.19 R1= CH(CH3)2CH3          R2= (CH2)3CH3  
 
Our chemical investigation of cone snail-derived prioritised microbes permitted the identification of 
antifungal producing Streptomyces sp. conserved across several cone snail species. Antifungal 
metabolites may be indicative of a synergistic relationship where the Streptomyces provide the cone 
snail with a level of protection against fungal infection. The PTMs biosynthetic genes have been 
reported in different phylogenetic bacteria,207 with our results indicating that PTM gene distribution 
extends to cone snail associated Streptomyces.  
 
5.2.4 Do cone snail-derived microbes produce or modify conotoxins? 
 
To investigate if microbial isolates obtained from the venom dusct encode for conotoxin-like 
sequences several strains showing activity in the FLIPR assays were selected for genome 
sequencing. The assembled genomes of two unicellular bacteria, CMB-CS005 and CMB-CS008 
and two Streptomyces, CMB-CS022, and CMB-CS150 were searched with the conotoxin 
bioinformatics tool “ConoServer”. To prioritise strains for genome sequencing we measured their 
ability to elicit neuroactivity by applying a FLIPR based biological screening (described in chapter 
2). We probed the ~150 cone snail-derived microbial extracts with a FLIPRTM (Fluorescent Imaging 
Plate Reader) based assay capable of detecting voltage gated human calcium channel (CaV) and 
nicotinic acetylcholine receptor (nAChR) modulators.223 Such channels and receptors are involved 
in chronic pain and their signalling is facilitated through an increase of intracellular calcium 
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(Ca2+).224 The FLIPRTM based assay collects a signal in each well of a 96 or 384 well plate and 
records the Ca2+ influx in cells using fluorescent dyes. We used the model human neuroblastoma 
cell line SH-SY5Y to probe our microbial extracts and detect specific modulation of CaV channels 
and the two nicotinic receptors α7 and α3β2.223,225 Two separate 384 well plates were inserted in the 
FLIPR, one with SH-SY5Y cells and another with the ~150 microbial extracts resuspended in a 5% 
DMSO aqueous solution (100 µL) and the CaV, α7 and α3β2 specific activators (KCl, choline and 
nicotine respectively). The FLIPR is equipped with an automatic pipetting system that adds the 
samples (microbial extracts) and activators to the cell wells while measuring the Ca2+ influx at time 
intervals (10 min between each addition). In principle, the cytosolic Ca2+ concentration is measured 
by the FLIPR and upon the modulation of a receptor or channel, a cell permeable dye [Fluo4] is 
loaded into the cell in combination with a non-cell-permeable quencher. As calcium is released into 
the cytoplasm through signalling cascades, it chelates the dye and causes a fluorescent response. 
Extracellular dye is quenched and cannot fluoresce. A reduced cytosolic Ca2+ concentration causes 
the signal to decrease indicating a blocked channel (inhibition response) (Figure 5.19).  
 
Masking dye 
Ca2+ dye sensitive 
Receptor 
Ion channel 
 
Figure 5.19 FLIPRTETRA based assay to measure Ca2+ influx using a fluorescent dye. Figure adapted from Molecular 
Devices web page.  
The FLIPRTM screenings on ~150 cone snail microbial identified 14 hits, with 8 inhibiting the 
control response and 5 activating the fluorescence response upon addition in combination with 
potentiating the control response. The FLIPRTETRA hits were analysed against the responses elicited 
by extracts prepared from the uninoculated media (blank agar) as a control. Figures 5.20 and 5.21 
show the FLIPR recordings for samples displaying an inhibiting or activating/potentiating response, 
respectively. We selected five strains from the identified hits to subject to genome sequencing and 
search for conotoxin-like sequences. 
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The five isolates were cultured in liquid marine media (100 mL) and their genomic DNA was 
isolated with a standard phenol/chloroform methodology. Sequencing was carried out using 
Illumina platform, and the genome was assembled using SolexaQA (see experimental section for 
genome assembly details). Contiguous DNA sequences (contigs) shorter than 200 bp were 
discarded from the final assembly. Gene prediction and annotation was performed using the best 
assembly produced by the software. 
 
A two-step search for conotoxin-like sequences in assembled genomes was conducted. First, the 
dedicated conotoxin sorting software ConoSorter was used to translate DNA sequences from the 
genome into the six corresponding reading frames and searched against a custom database of 
conotoxin sequences inbuilt in the ConoSorter program using Regular Expressions and profile 
Hidden Markov Models. ConoSorter did not identify similar conotoxin sequences in bacterial 
genomes. Next, to search for highly divergent conotoxin-like sequences, the conotoxin analysis 
pipeline was run on the genomes, but again no conotoxin-like sequences were detected in the 
bacterial genomes screened. The aforementioned methods were used to search only for conotoxin-
like sequences in the bacterial genomes. To investigate if the associated bacteria had a role in 
conotoxin maturation by producing enzymes involved in posttranslational modification producing 
enzymes, a common feature in many conotoxins, we created a custom database consisting of all 
proteins and peptides discovered from cone snails available on the UniProt-SwissProtDB. The 
bacterial genomes were BLASTed using the BLASTx program against the custom database of 3800 
sequences with an e-value threshold for significant similarity considered of 0.0001, in order to limit 
false positive discovery in the small database. In addition, bacterial genomes were BLASTed 
against a custom-built BLAST database consisting of all the protein sequences discovered from 
cone snails. Conotoxin sequences were not detected in the sequenced bacterial genomes with 
ConoSorter.  
To investigate whether small molecule was generating a response in FLIPR based assays instead of 
a conotoxins, we selected Streptomyces sp. (CMB-CS150) andsubjected it to a bioassay guided 
fractionation leading to the identification of bioactive fractions.  However the structure remains 
unknown due to the low amount of material recovered for structure elucidation. The HRESI(+)MS, 
returned a pseudomolecular ion m/z 398.2379 and two pseudomolecular ions and m/z 303.2162 and 
398.2391 suggesting the neuroactivity derives from a small molecule rather than a peptide. 
Previously reports on neuroactive metabolites from cone snail associated microbes include the 
microbe Gordonia sp. associated with C. cricumcisus and Streptomyces sp. CP32 from C. 
pulicarius.192,226 Although we cannot confirm the nature of the neuroactive molecule from our 
FLIPR assays, the detection of activity from such low concentration (<10 nM) suggests the 
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molecule is not only specific to α3β2 nAChR the but bears high potency. We are currently studying 
optimization strategies to recover sufficient quantities for structure determination.  
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Figure 5.20 FLIPR recordings of CaV, α7 and α3β2 nAChR responses from SH-SY5Y cells stimulated by KCl, nicotine 
and choline (30 µM), in the absence (media control) and the presence of microbial extract. Microbial extracts abolished 
CaV, α7 nAChR and α3β2 responses to their specific activator 
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Figure 5.21 FLIPR recordings of CaV, α7 and α3β2 nAChR responses from SH-SY5Y cells stimulated by KCl, nicotine 
and choline (30 µM), in the absence (media control) and the presence of microbial extract. Microbial extracts 
potentiated CaV, α7 nAChR and α3β2 responses to its specific activator, KCl, nicotine and choline respectively 
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Figure 5.22 Semi-preparative HPLC-DAD (210 nm) chromatogram of of Streptomyces sp. (CMB-CS150) for fraction [-
2-3-2-14].  (Zorbax-Sb C18 column, 9.4 mm × 250 mm, 5µm, 3.0 mL/min, 90% H2O/MeCN (0.01%TFA) to 100 % 
MeCN (0.01%TFA) over 30 min)]. FLIPRTETRA active fractions highlighted in red  
5.2.5 Do these small molecules exhibit biological properties? 
 
To investigate the biological properties of 5.14, we tested the pure metabolite against C. albicans 
(IC50 3 µM) (Figure 5.23) and the human cancer cell lines, SW-620 (IC50 3 µM) and NCI-H460 
(IC50 5 µM)  (Figure 5.24). 
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Figure 5.23 Graph of antifungal activity of 5.14 against C. albicans (ATCC 90028)  
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Figure 5.24 Graph of cytotoxicity activity of 5.14 against SW-620 (human colon cancer) and NCI-H460 (lung cancer) 
5.3 Conclusions 
 
We isolated Streptomyces strains from cone snails with the ability to produce antimycin A (5.17), 
an antifungal and a fish toxin as well as several PTM antifungals (5.14 − 5.16). While we cannot 
confirm the ecological role of 5.14 − 5.17, we suspect cone snails could benefit from both 
chemistries defending against potential predators and fungal pathogens. To the best of our 
knowledge, this study is the first to identify PTM-like metabolites of cone snail−associated bacteria 
and to detect Streptomyces sp. with similar chemical and biological profiles across cone snail 
species. To gain knowledge on biosynthetic potential and further biosynthetic gene relationships 
between Streptomyces sp. we are currently analysing genomes of Streptomyces sp. (CMB-CS038, 
CMB-CS145, CMB-CS143, CMB-CS132, CMB-CS138). The involvement of bacteria in the 
biosynthesis or post-translational modifications of conotoxins remains unknown, however our 
FLIPR based screenings suggest that Streptomyces sp. (CMB-CS150) produces neuroactive small 
molecules. Further strategies are required to obtain such neuroactive metabolites in sufficient 
quantities to acquire good quality NMR data for structural elucidation. Such strategies include the 
optimisation of culture conditions and purification methodology. 
5.4 Experimental 
 
5.4.1 General  experimental 
 
See experimental section in chapter 3 for detailed description of the equiptment used for HPLC-
DAD-MS 
5.4.2 Cone snail strain collection 
Cone snail-derived Streptomyces were isolated from the stomach and venom duct of C. miles 
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collected in 2011 from the Lady Musgrave Island at the Great Barrier Reef. Freshly collected cone 
snail specimens were transported in local seawater to the laboratory. Specimens were dissected and 
tissue was homogenised using a mortar and pestle, homogenate applied to ISP-4 agar plates 
(BactoDIFCO, Cat No. 277210), sealed with parafilm and incubated for 3 – 4 weeks. A pure culture 
of Streptomyces spp., obtained by single colony serial transfer on agar plates was cryopreserved at –
80 °C in 20% aqueous glycerol. 
5.4.3 Streptomyces sp. DNA isolation and PCRs  
 
Genomic DNA from Streptomyces sp. isolates was extracted from the centrifuged cell pellet using 
the DNeasy Plant Mini Kit (Qiagen) as per the manufacturers protocol. The 16S rRNA, PKS I and 
NRPS genes were amplified by PCR using the following primers purchased from Sigma–Aldrich: 
 
Gene Primer name Sequence (5’–3’) 
16S rRNA 27F AGAGTTTGATCCTGGCTCAG 
 RC1494 TACGGCTACCTTGTTACGACTT 
PKS I K1F TSAAGTCSAACATCGGBCA 
 M6R CGCAGGTTSCSGTACCAGTA 
NRPS A3F GCSTACSYSATSTACACSTCSGG 
 A7R SASGTCVCCSGTSCGGTAS 
 
For all reactions, the PCR mixture (50 µL) contained genomic DNA (1 µL, 20 – 40 ng), four 
deoxynucleoside triphosphates (dNTP, 200 µM each), MgCl2 (1.5 mM), primer (0.3 µM each), 1 U 
of Taq DNA polymerase (Fisher Biotec) and PCR buffer (5 µL, 10X).  
 
The PCR 16S rRNA amplification was performed with an initial denaturation at 95 °C for 3 min, 30 
cycles in series of 94 °C for 30 s (denaturation), 55 °C for 60 s (annealing) and 72 °C for 60 s 
(extension), followed by one cycle at 72 °C for 6 min. For PKS I, amplification with an initial 
denaturation at 95 °C for 5 min, 35 cycles in series of 95 °C for 30 s (denaturation), 55 °C for 2 min 
(annealing) and 72 °C for 4 min (extension), followed by one cycle at 72 °C for 10 min. For NRPS, 
amplification with an initial denaturation at 95 °C for 5 min, 35 cycles in series of 95 °C for 30 s 
(denaturation), 59 °C for 2 min (annealing) and 72 °C for 4 min (extension), followed by one cycle 
at 72 °C for 10 min. PCR product size was assessed in a 1% agarose gel using a 1Kb ladder  (Life 
Technologies, Cat 1078718), purified with PCR purification kit (Qiagen) and sequenced. The 
sequenced DNA was BLASTed against the GenBank (NCBI database).  
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5.4.4 Chemical profiling 
 
See methodology in chapter 3 experimental section 
5.4.5 Phylogenetic tree 
The 16S phylogenetic tree was constructed based on the optimal nucleotide substitution model as 
determined by jMOdelTest,114 using RaxML GUI, incorporating RaxML using the automatic 
boostrapping option, AutoMRE, in the ML + thorough bootstrapping mode.227 The autoMRE option 
performs up to 1000 bootstraps until the likelihood scores converge. ML calculations are then 
performed to determine the best tree. 
5.4.6 Production, isolation and characterization of 5.17 
 A seed culture of Streptomyces sp. (CMB-CS038) was used to inoculate ISP-4 agar (400 plates) 
and incubated at 26.5 °C for 10 days, after which the agar was diced and extracted twice with 
EtOH:MeOH (1.5 L) and concentrated in vacuo at 40 °C, resuspended in MeOH (5 mL), dried 
under N2 at 40 °C to yield the crude extract (820 mg). The crude extract was then triturated between 
hexane (150 mg) and MeOH (650 mg). MeOH fraction was subjected to two sequential 
fractionations with C8 Sep-Pack (30% H2O/MeCN to 100 % MeCN) and semipreparative HPLC 
purification using Zorbax-SB C3 column (250 × 9.4, 5 µm, 3 mL/min, gradient elution 10% 
H2O/MeCN (0.01% TFA) to 100 % MeCN (0.01% TFA)) over 40 min to yield 5.14. 
 HSAF (5.14). Colorless powder; [α]D22 + 9.2 (c 0.05, MeOH); UV-vis (MeOH) λmax (log ε) 271 
(3.91), 306 (3.86), 371 (3.79) nm; NMR (600 MHz, DMSO-d6) see Figure 5.12 and Table 5.4; 
ESI(+)MS m/z 513 [M + H]+, ESI(−)MS m/z 511 [M − H]–; HRESI(−)MS m/z 511.2807 [M − H] – 
(calcd for C29H39N2O6–, 511.2814). 
5.4.7 Biological assays 
 
All FLIPR assay, antibacterial and cytotoxic methodology is described in experimental section of 
chapter 2 and 3. 
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6 Insect contact sex pheromone from wasp-derived Quambalaria sp. 
(CMB-W001)  
6.1 Introduction  
The Mud dauber wasp-derived fungal strain CMB-W001 was taxonomically identified as a member 
of the rare Quambalaceae family of fungi. Phylogenetic analysis of Quambalaria sp. (CMB-W001) 
indicated a high similarity with Quambalaria cyanescens strains U100 and U105, which were 
isolated from beetles.228 The isolation of a rare fungal strain from wasp with taxonomic links to a 
rare fungus recovered from insects prompted us to undertake a chemical investigation of 
Quambalaria sp. (CMB-W001) to search for new chemistry with possible ecological relevance. 
Interestingly, our chemical investigation on Quambalaria sp. (CMB-W001) yielded 
callosobruchusic acid (6.13), which was previously isolated from the azuki bean weevil 
Callosobruchus chinensis L as a contact sex pheromone.229 A contact sex pheromone refers to a 
non-volatile metabolite that on contact elicits a reproductive biological mating response. That we 
isolated 6.13 from a wasp-derived fungus is noteworthy, as it calls in to question the biosynthetic 
origins of weevil derived 6.13 and raises the possibility the Quambalaria sp. may have a more 
intimate symbiotic relationship with insects than previously imagined. This chapter details in the 
chemical and biological studies conducted on wasp-derived Quambalaria sp. (CMB-W001). 
6.2 Results and discussion 
6.2.1 Wasp-derived Quambalaria sp. (CMB-W001) 
 
When cultivated on ISP-2 agar media for 10 days at 26.5° C, the fungal strain CMB-W001 presents 
a white surface with corrugated purple colouring across the bottom of the agar plate. 
a) b)
 
 
Figure 6.1 (a) Picture of the Australian Mud dauber wasp (b) Fungal isolate Quambalaria sp. (CMB-W001) cultivated 
on ISP-2 agar media 
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Fungal isolate CMB-W001 was recovered from the cryo-archive and subcultured for chemical 
analysis and taxonomy investigation. ISP-2 liquid media (100 mL) was inoculated, incubated at 
26.5 °C for 10 days and the fungal mycelia was recovered by centrifugation. Genomic DNA was 
isolated using a blood and tissue DNA kit (QUAGEN). The Internal Transcribed Spacer 1 (ITS1), 
ITS2 and the 5.8S ribosomal DNA (rDNA) region were amplified by PCR using universal primers 
ITS1 and ITS4. The amplified DNA (~800 bp) was used as a query to BLAST against GenBank 
database showing 100% similarity with Quambalaria cyanescens U100 (GenBank accession 
number HF569152.1) and Quambalaria cyanescens U105 (GenBank accession number 
HF569150.1). Quambalaria sp. (CMB-W001) ITS sequence was deposited in GenBank database 
with accession number KT454935. 
 
Quambalariaceae is a rare fungi family, which contains a single genus Quambalaria and five 
species: Q. eucalypti, Q. pitereka, Q. cyanescens, Q. simpsonii and Q. coyrecup. Several 
Quambalaria spp. have been implicated in plant pathogenicity, including Quambalaria coryrecup 
as a causative agent of canker and shoot blight disease in Eucalyptus trees.230 Quambalaria 
cyanescens has been isolated from various sources such as plants,231 from clinical samples228 and 
bark beetles.232 In clinical samples Quambalaria cyanescens was initially regarded as an 
opportunistic pathogen, however studies have not confirmed a direct correlation between infection 
and the fungus.228 Interestingly, Quambalaria cyanescens has been found in association with 
different species of beetles around the World including U.S.A, Turkey, Hungary, Bulgaria and 
Spain.228 Quambalaria cyanescens has also been isolated from trees of Corymbia spp. in Australia 
(Table 6.1).230 
 
Table 6.1 Quambalaria cyanescens strains, host and geographical location of samples 
Quambalaria cyanescens 
Strain code 
Host Geographical location 
 Beetle  
MK742 Chaetoptelius vestitus  Turkey 
MK808 Phleotribus scarabeoides  Syria 
MK1710 Scolytus intricatus  Bulgaria 
MK 917  Thamnurgus characiae  Croatia 
MK617 Phleotribus scarabeoides  Spain 
CF3526 Hypoborus ficus  Czech 
U105 Undetermined  U.S.A 
U100 Undetermined  U.S.A 
U163 Undetermined  U.S.A 
 Plant  
WAC12954 Corymbia calophylla  Australia 
BRIP48386 Corymbia spp. Australia 
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To study the phylogenetic relationship between previously reported Quambalaria spp. and 
Quambalaria sp. (CMB-W001), we constructed a phylogenetic tree using ITS DNA sequences. A 
PhyML Maximum Likelihood phylogenetic tree was constructed using 25 related sequences of 
Quambalaria spp. extracted from GenBank. The phylogenetic tree confirmed that wasp-derived 
Quambalaria sp. (CMB-W001) shares homology within other Quambalaria cyanescens species 
particularly with strains U100 and U105 (100%), which were isolated from beetles. Less similarity 
is shown with strains from plant-derived Quambalaria cyanescens (99%) and other species such as 
Q. pitereka and Q. eucalyptus (94-96%) (Figure 6.2). 
 
Sympodiomycopsis  sp. NYNU  121010 (87%) [KF246552.1]
Sympodiomycopsis  kandeliae BCRC:23165 (86%) [GQ465043.1]
Quambalaria pitereka BRIP48505 (95%) [EF444851.1]
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Figure 6.2 Phylogenetic tree obtained by PhyML Maximum Likelihood analysis of ITS DNA sequences using the 
optimal nucleotide substitution model determined by jModeltest2114 using UGENE115 showing the relationship of CMB-
W001 among Quambalaria spp. strains with their % similarity in parenthesis and accession in braquets 
 
The aforementioned phylogenetic tree also permitted the visualisation of the closer similarity 
between Quambalaria sp. (CMB-W001) with insect-derived strains compared to plant-derived 
strains. That we obtained Quambalaria sp. (CMB-W001) from a wasp was an interesting finding 
and raised questions on a shared wasp-fungi chemical ecology. Although the fungi Quambalaria 
cyanescens has been reported from beetles from different geographical regions in the world, there 
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are no previous studies aimed to explore such a shared ecology. Indeed knowledge of the secondary 
metabolite capability of Quambalaria sp. is very limited.  
6.2.2 Chemistry of Quambalaria spp.  
 
Reports on natural products from Quambalaria spp. are limited to a 2008 study which described the 
known antibacterial terpene (+)-globulol (6.1),233 and a 2015 study which described the new naphto 
quinone quambalarines A (6.2) and B (6.3) together with the known naphtoquinone mompain 
(6.4).234 None of these studies explore the possible ecological roles played by these metabolites. To 
compare with previously reported chemistry and get an insight the chemical profile of wasp-derived 
Quambalaria sp. (CMB-W001) we conducted a preliminary HPLC-DAD-MS analysis on a small-
scale agar culture.  
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6.2.3 Chemical profile of Quambalaria sp. (CMB-W001) 
 
A single 7-day ISP-2 agar plate cultivation of Quambalaria sp. (CMB-W001) was extracted with 
MeOH:EtOAc (3:1, 30 mL) and the extract was dried in vacuo and resuspended in MeOH (1 
mg/mL) for  HPLC-DAD-MS analysis, which revealed 7 major signals with ES(-)MS m/z ions 229, 
152, 199, 415, 429, 451 and 280 ([M-H]-) respectively (Figure 6.3). 
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Figure 6.3 HPLC-DAD-MS (210 nm) chromatogram of Quambalaria sp. (CMB-W001) crude extract with UV-vis 
spectra colour coded for corresponding signal.  
 
To determine if the aforementioned chemistry from Quambalaria cyanescens (6.1-6.4) was present 
in the Quambalaria sp. (CMB-W001) solvent extract, we performed a single ion extraction of their 
m/z ions from the HPLC-DAD-MS data. Pseudomolecular m/z ions of 6.1-6.4 were not found in 
Quambalaria sp. (CMB-W001) extract. To investigate the chemistry produced by Quambalaria sp. 
(CMB-W001) we conducted a literature investigation on chemistry of beetles and scale-up 
cultivation.  
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6.2.4 Beetle pheromones  
 
Pheromones are typically molecules with low molecular weight (80-300 Da) used for biological 
communication that play an important role in enhancing survival.235 In insects, pheromones are 
often used to evoke aggregation, trail following, dispersion as well as sexual and alarm behaviour. 
The first insect pheromone identified was (E, Z)-10,12-hexadecadienol (bombykol) (6.5) isolated 
from the silkworm moth Bombyx mori.236,237 A more widely studied pheromone is 9-oxodec-trans-
2-enoic acid (6.6) from the honeybee Apis mellifera L. known as the “the queen substance” and is 
involved in colony cohesion, queen cell construction and as a mating stimulant.238-240 A number of 
insect pheromones share structural features with 6.5 and 6.6 including straight chain hydrocarbons, 
and a functional group (alcohol, ketone, carboxylic acid, aldehyde or acetate ester) and double 
bonds.241  
O
OH
O
OH
6.5 6.6  
Other insect pheromones include cyclised hydrocarbons such as frontalin (6.7), myrtenol (6.8), 
verbenonel (6.9), a-pinene (6.10) and bevicom (6.11). Frontalin (6.7) is an aggregation pheromone 
biosynthesised through cyclisation in the beetle mid-gut.242 Myrtenol (6.8), is also produced in 
female beetles.243 Verbenone (6.9) is a pheromone that affects male-female ratio in beetles,244 while 
α-pinene (6.10) is a pheromone that shows synergistic effects with frontalin in aggregation.245 
Endo-bevicom (6.11) is produced by male beetles as a repellent to other beetles.245 All of 6.7 to 
6.11 are modified monoterpenes. 
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Pheromones can be biosynthesised by the insect,246 or can be obtained from dietary plants.247 The 
site of pheromone biosynthesis within insects can vary and can include specialised glands.248-250 
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Interestingly, some studies have suggested that certain pheromones are synthesised by insect-
derived microbes.251 During our chemical investigation of Quambalaria sp. (CMB-W001), we 
identified a pheromonal structure (6.13) previously reported in beetles. To the best of our 
knowledge, the biosynthesis of 6.13 has not been previously attributed to fungi.  
 
Insects are often engaged in symbiotic associations with fungi.252 Since many insect studies are 
focused on species that are serious pests,251 beetles have been widely studied and shown to 
participate in microbial partnerships to enhance survival.253 Nevertheless, little is known on 
pheromone biosynthesis with only a few examples of pheromone biosynthesis attributed to insect 
associated microbes.251 For example, 6-methyl-5-hepten-2-one (6.12) is produced by a 
basidiomycete fungi associated with the southern pine beetle Dentroctonus frontalis, first described 
in 1977 by Brand et al.254 It was interesting to note that recent 2013 studies on frontalin 
biosynthesis by the beetle Dentroctonus ponderosae acknowledge 6.12 as a precursor, but do not 
mention the possibility of a associated fungus as the biosynthetic source (Figure 6.4).255  
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Figure 6.4 Proposed mechanism for the conversion of 6-methyl-5-hepten-2-one (6.12) to the pheromone frontalin (6.7) 
 
In our chemical profiling of the extracts obtained from cultivation of Quambalaria sp. (CMB-
W001), our attention was drawn to the water soluble partition, which contained a dominant 
metabolite (6.13) eluting at 7.2 min with an m/z 199 [M-H]- and a non descript UV-vis (DAD) 
profile. While this metabolite lacked any of the characteristics more commonly associated with 
complex natural products rich in novel chemical scaffolds and functionality, we were nevertheless 
intrigued that it was water soluble. We were also mindful that pheromones are low molecular 
weight molecules, and were hopeful that 6.13 may prove to be just such an ecologically significant 
molecule. The structure elucidation of 6.13 is described below. 
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6.2.5 Callosobruchusic acid (6.13)  
 
The HRESI(+)MS of 6.13 revealed a pseudomolecular ion (m/z 223.1556 [M+Na]+) indicative of a 
molecular formula (C10H16O4, Δmmu -1.83) requiring 3 double bond equivalents (DBEs). The 1H 
NMR (600 MHz, DMSO-d6) data for 6.13 displayed resonances for an olefinic methine (δH 5.58 
ppm), two deshielded methyls (δH 2.05 ppm and 1.05 ppm) and a methine (δH 2.3 ppm), and 
multiplets (δH 1.3 to 2.3 ppm) assigned to four methylenes on the basis of HSQC NMR spectra 
(Figure 6.7). The structure of 6.13 was elucidated by detailed analysis of the 1D and 2D NMR 
spectra. 
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Figure 6.5 1H NMR (600 MHz, DMSO-d6) spectrum of 6.13. * H2O, # DMSO 
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Figure 6.6 DEPT 13C NMR (150 MHz, DMSO-d6) spectrum for 6.13 
 
Table 6.2 NMR (600 MHz, DMSO-d6) data of 6.13 
Position δC (ppm) δH , mult (J in Hz) 1H-1H COSY 1H-13C HMBC 
1 167.6 - - - 
2 116.3 5.58, s - 1, 4, 9 
3 164.8 - - - 
4 39.6 2.10, t (7.5) 5 5 
5 24.4 1.42, m  4, 6 7 
6 32.5 a 1.29, m 
b 1.51, m 
5 7 
7 40.0 2.32, m 10 8, 10 
8 177.6 - - - 
9 18.0 2.05, s - 3, 4 
10 17.2 1.05, d (7.5) 7 - 
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Figure 6.7 HSQC NMR (600 MHz, DMSO-d6) spectrum of 6.13 
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Figure 6.8 2D NMR (600 MHz, DMSO-d6) key correlations of 6.13 
 
The planar structure of 6.13 was identical to callosobruchusic acid, first reported in 1981 by Tanaka 
et al., from the azuki bean weevil Callosobruchus chinensis L as a contact pheromone.229 The 
presence of a chiral centre at position C-7 and crucial involvement of chirality in the activity of 
pheromones prompted us to investigate previous stereochemistry-activity relationships found for 
6.13 and determine the configuration of our sample isolated from Quambalaria sp. (CMB-W001). 
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6.2.6  Stereochemistry of 6.13: wasp-derived Quambalaria sp. (CMB-W001) vs. azuki bean 
weevil Callosobruchus chinensis L 
 
 
Chirality is an important structural feature of pheromones and is often a crucial element for the 
effectiveness of the signal.256 It can be a difficult task to establish the absolute configuration of 
insect pheromones due to the very small quantity of material available. To overcome this limitation, 
chemical ecologists for many years relied on the synthesis of stereoisomers to probe the role of 
enantiomers in insect behaviour.257 Examples of pheromonal stereochemistry-activity relationships 
resolved by synthesis include the alarm pheromone of the ant where (S)-Atta texana 4-methyl-3-
heptanone (6.14a) is 400 times more active than the R enantiomer (6.14b),258 the pheromone of the 
female gypsy moth Lymantria despair, where the (7S, 8R) enantiomer (6.15a) displays stronger 
activity than the sex (7S, 8R) enantiomer (6.15b),259 and the sex pheromone of the female Japanese 
beetle Popillia japonica, where the (R) enantiomer (6.16a) is more active than the (S) enantiomer 
(6.16b) (Figure 6.9).260 Many pheromonal stereochemistry-activity relationships have been recently 
reviewed.256 
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Figure 6.9 Examples of pheromone stereochemistry-activity relationship studies. Enantiomers shaded in grey exhibit 
stronger ecological responses than the other enantiomer  
 
Thus, to establish the configuration of 6.13 isolated from Quambalaria sp. (CMB-W001) we 
reviewed previous literature reports on the absolute configuration of azuki been weevil sourced 
6.13. The azuki bean weevil pheromone 6.13 was found to be enantiomerically impure with a R/S 
ratio of 3.4:1, as confirmed by the Ohrui-Akasaka method261 which uses femtomolar-sensitive 
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fluorescence detectors coupled to HPLC together with synthetic standards of both (7R) (6.13a) and 
(7S) (6.13a) enantiomer.262,263 To determine the stereochemistry of our sample of 6.13 isolated from 
the wasp-derived Quambalaria sp. (CMB-W001), we compared the optical rotation measurement of 
synthetic (7R)-6.13 ([α]D21= −11.75 (1.105, CHCl3)) and (7S)-6.13 (α]D21= +10.50 (0.10, CHCl3)) 
reported by Mori et.al,264 with 6.13 ([α]D21 +7.24 (c 0.05, CHCl3)) from Quambalaria sp. (CMB-
W001) (Figure 6.10). Efforts to resolve 6.13 by a range of chiral HPLC columns and elution 
methods proved inconclusive.  
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Figure 6.10 Diagram showing the two enantiomers of 6.13 (R) or (S) and their optical rotations reported by Mori et 
al.264 and the optical rotation of 6.13 from Quambalaria sp. (CMB-W001) 
6.3 Conclusions 
 
We identified and elucidated the structure 6.13, to the best of our knowledge for the first time from 
a fungal source Quambalaria sp. While we cannot comment on the possible ecological role played 
by 6.13 in Mud-dauber wasps, it is intriguing to speculate that an insect contact pheromone may in 
fact be fungal in origin. We are currently probing the effect of 6.13 from Quambalaria sp. (CMB-
W001) in insect behavioural assays with collaborative partners. Future work includes the extraction 
of wasp tissue to identify 6.13 as well the study of chemical profiles of beetle-derived Quambalaria 
to search for 6.13 and test its effect in beetle mating behavioural response assays. The organic 
soluble Quambalaria sp. (CMB-W001) metabolites are currently under investigation by another 
PhD student from our group. 
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Quambalaria sp. (CMB-W001) is a rare genera of fungi typically found in association with beetles. 
Our phylogenetic analysis suggests that the most closely related Quambalaria sp. to Quambalaria 
sp. (CMB-W001) are sourced from beetles and found to be an unexpected link. We know from 
pheromonal insect studies that 6.13 lacks species specificity and we know that chemical 
convergence between species is not uncommon. Therefore it is plausible that Mud dauber wasps use 
a fungal-derived 6.13 as a pheromone. If this is indeed the case it is a rare example of co-evolution, 
drawing a symbiotic trans-kingdom pheromonal relationship between a fungi and a wasp.  Further 
studies are required to determine these chemical interactions. 
6.4 Experimental  
6.4.1 General experimental 
 
See details in chapter 3 experimental section 
6.4.2 Fungal strain collection 
The fungus Quambalaria sp. (CMB-W001) was isolated from the outer tissue of a Mud-dauber 
wasp collected in 2012 from Brisbane, Queensland. The freshly collected wasp specimen was 
transported to the laboratory in sealed container, after which it was rinsed in sterile water. Tissue 
was homogenised using a mortar and pestle and applied to ISP2 agar plates (comprising 2% 
glucose, 1% peptone, 0.5% yeast extract) and the plates sealed with parafilm and incubated for 3–4 
weeks. A pure culture of CMB-W001, obtained by single-colony serial transfer on agar plates, was 
cryopreserved at –80 °C in 20% aqueous glycerol. 
 
6.4.3 Fungal strain taxonomy 
 
See details for genomic DNA isolation and PCR amplification of ITS rRNA region in experimental 
section of chapter 3. The BLAST search showed the amplified ITS sequence from CMB-W001 was 
100% homologous with Quambalaria cyanescences U100 and U105 (GenBank accession number 
HG421952.1 and HF569150.1 respectively).  
 
6.4.4 Phylogenetic tree 
 
ProtTest server was used to determine the optimal substitution model for the sequences using the 
critical Akaike Information Criterion (cAIC) generated for each model. The JC69 model was used 
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to infer phylogeny ITS sequences. Sequence alignments were produced with the MUSCLE 
program. Trees were constructed using the RaxML 7.014 program using the aforementioned 
models.  
 
6.4.5 Production, isolation and characterization of 6.13  
 
A seed culture of Quambalaria sp. (CMB-W001) was prepared by inoculating a falcon tube (50 
mL) containing YES medium (10 mL) and incubated at 200 rpm at 26.5 °C overnight. Six 2L 
Erlenmeyer flasks containing sterile YES medium (500 mL) were inoculated with the overnight 
culture (1 mL) and incubated at 26.5 °C for 15 d, after which media was centrifuged and aqueous 
and fungal mycelium were separated. Fungal mycelium was extracted with acetone (3 × 3.8 L) and 
concentrated in vacuo at 40 °C to obtain the crude extract (63.4 g). The crude extract was then 
sequentially purified in a C18 column, 100 g (100% H2O, 90% H2O/ 10% MeOH, 50% H2O/ 50% 
MeOH, 100% MeOH) to yield (S)-callosobruchusic acid (6.13) (220 mg). 
 (S)-callosobruchusic acid (6.13) yellowish solid; [α]D21 +7.0 (c 0.10, MeOH); UV-vis (MeOH) 
λmax (log ε) 371 (3.57), 306 (3.48), 271 (3.43) nm; NMR (600 MHz, DMSO-d6) see Figure 6.5 and 
Table 6.2; ESI(+)MS m/z 201 [M + H]+, ESI(−)MS m/z 199 [M − H]–; HRESI(+)MS m/z 223.0940 
[M + Na]+ (calcd for C10H16O4Na+, 223.0941). 
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7 Genome mining guided discovery of new class II lantipeptide from 
cone snail-derived Bacillus sp. (CMB-CS100)  
 
7.1 Introduction 
 
The previous thesis chapters were dedicated to the identification of new chemistry from venomous 
animal-derived microbes primarily using chemistry methods. We described the identification of a 
new nitrated diketopiperazine, waspergillamide A (3.24), new siderophores (4.9 − 4.14), and new 
azaphilone analogues (4.34 and 4.36). We know from the scientific literature on microbial genome 
sequencing that some biosynthetic genes are not expressed under traditional culture methods, or 
their production yields are too low to be detected by traditional chemical and spectroscopic 
methods. A way to address this is to apply genomic analysis to determine and access the full 
biosynthetic capabilities of an organism. The observation that Bacillus sp. (CMB-CS100) displayed 
antibacterial activity in our biological screening in addition to have obtained a well assembled 
genome from this strain, we selected this microbe for proof of concept studies and perfomed an in 
silico analysis using genome mining bioinformatics tools and databases such as antiSMASH,265 
Bactibase,266 and BAGEL.44 This analysis resulted in the identification of a biosynthetic gene 
cluster, encoding a class II lantipeptide that potentially belongs to a new subclass of two-component 
lantibiotics. This chapter describes the isolation of Bacillus sp. (CMB-CS100), genome sequencing, 
identification of the lantipeptide gene cluster through antiSMASH, precursor gene (pre-peptide) 
amino acid sequence analysis, antibacterial assays and proteomics. 
7.2 Genome Mining 
 
The full genome sequence of the soil Streptomyces coelicor A337 revealed an unexpected level of 
secondary metabolic capacity, ushering in a new era of sequencing-based natural products 
discovery called genome mining.267,268 The development of dedicated bioinformatics tools and 
databases to annotate genes has helped identify numerous biosynthetic genes and their functions.269 
By identifying catalytic centres in acetyl transferase (AT) domains of polyketide synthases (PKS) 
and adenylation domains of non-ribosomal polyketide synthases (NRPS) bioinformatics platforms 
can detect the presence of putative PKS and NRPS genes within sequenced microbial genomes.265  
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Similarly, the characterisations of modifying enzymes such as dehydratases (DH), enoylreductases 
(ER), ketoreductases (KR), epimerases, methyl-transferases, or oxidases provides additional 
information about the structure of the natural products.270,271 Many of the biosynthetic gene clusters 
found through genome sequencing are not expressed under commonly used culture conditions, and 
are referred to as “silent” or “cryptic”. Genome mining refers to the identification of such “silent 
genes” using bioinformatics and developing strategies to activate such genes with either culture 
condition variation272 and/or heterologous expression.268 In our study, we sequenced the genome of 
a cone snail-derived Bacillus sp. (CMB-CS100) strain, and analysed a lantipeptide gene cluster. 
Lantipeptides are natural products synthesised through traditional ribosomal pathways included in a 
large group of natural products referred as Ribosomally synthesised and post-translationally 
modified peptides (RiPPs).  
7.3 Ribosomally synthesised and post-transcriptionally modified peptides (RiPPs) 
 
RiPPs are a growing class of structurally diverse natural products found across all branches of life, 
that have been shown to exhibit selective biological properties.25,273 An important feature of RiPPs 
is their high level of post-translational modifications which undoubtedly contribute to structural 
diversity and biological properties.25 Bacteriocins represent a subclass of RiPPs and are believed to 
be produced to inhibit the growth of microbial competitors.274,275 
7.3.1 Bacteriocins 
 
Bacteriocins exhibit antibacterial activity against many microbial strains including closely related 
strains, while the parental strain is protected through an immunity mechanism.276 Bacteriocin 
antibacterial activity is exerted through various mechanisms. Bacteriocins can target the cell 
membrane by inhibiting lipid II and disrupting peptidoglycan synthesis,277,278 by forming pores that 
disrupt the integrity of the cell wall,279 or by targeting DNA or RNA leading to disruption of protein 
biosynthesis (Figure 7.1).280 
 
Chapter 7 Genome mining guided discovery of a novel lantipeptide  
 180 
 
Figure 7.1 Common mechanism of action of representative bacteriocins. From Cotter et al.276 
 
Currently, there are ~200 structurally characterised bacteriocins deposited in Bactibase, a dedicated 
bacteriocin database.266 Bacteriocins are attractive drug leads since they are highly specific to 
particular strains of bacteria avoiding the collateral impact so evident in wide-spectrum 
antibiotics.281 Bacteriocins are usually synthesised through a simple biosynthetic scheme where a 
precursor peptide with a leader sequence is encoded in a gene, after translation the leader sequence 
is removed and the remaining peptide is post-translationally modified by a series of enzymes.282 
Although the number of characterised bacteriocins is not extensive, a few bioinformatics platforms 
do provide the means to identify novel bacteriocin genes in sequenced genomes.283,284 One 
significant class of pore forming bacteriocins are the lantipeptides which contain characteristic 
thioether cross-links crucial for their stability and activity.282  
7.3.2 Lantipeptides  
 
Lantipeptides are highly post-translationally modified and have a wide distribution among 
species.285 The name lantipeptides derives from their thioether-linked amino acids lanthionine (Lan) 
and methyllanthionine (LanMe).29,286 These amino acids are formed by the dehydration of serine 
and threonine residues to yield dehydroalanine (Dha) and dehydrobutyrine (Dhb) respectively, 
followed by intramolecular Michael addition of cysteine residues yielding the thioether crosslink 
(Figure 7.2a).29 Lantipeptides are classified in four groups based on the type of post-translational 
enzymes that introduce the thioether cross-links.273 In class I, the dehydration of amino acids is 
catalysed by LanB and cyclisation by LanC. For lantipeptide class II, dehydratation and cyclisation 
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is carried out by a single bi-functional synthase LanM. For class III, modifications are carried out 
by a tri-functional synthase LanKC, which consists of a N-terminal lyase domain, a central kinase 
domain and a C-terminal cyclase domain.287,288 For class IV lantipeptides, dehydration and 
cyclisation is carried out by synthase LanL, which contains a bi-functional analogous synthase with 
an N-terminal lyase and kinase domains (Figure 7.2b).289,290 
 
O
HN
R
OH
OHN
HS
Xn
R=H, Ser     R=Me,Thr
O
HN
OHN
HS
Xn
R
R=H, Dha     R=Me,Dhb
Xn
R=H, Lan     R=Me,MeLan
NH
S O
O R
HN
 LanB  LanC
 
Class I
Class II
Dehydratase Cyclase
Dehydratase
Class  IV
Class  III
LanB
LanM
LanC
LanKC
LanL
LanC-like cyclase
Lyase Kinase
Lyase Kinase
Putative cyclase
LanC-like cyclase
 
Figure 7.2 Dehydration and cyclisation reactions in lantipeptide biosynthesis (top) Lantipeptide classes an their 
modification enzymes (bottom) 
 
The prototype example of Class I lantipeptides, nisin (7.1), was isolated from Lactococcus lactis 
and used as a food preservative since the 1940s.291-293 The nisin pre-peptide (leader and 
lantipeptide) is modified by two separate synthases, NisB (Lan B) and NisC (Lan C), yielding the 
thioether cross-linkage, then the NisP protease removes the leader peptide from the mature product 
(Figure 7.3).282 
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Figure 7.3 General scheme for biosynthesis of nisin. NisB (LanB) dehydrates serine and threonine residues to Dha and 
Dhb (green and purple) respectively, NisC (Lan C) enzyme carries out Michael addition with cysteine residues to form 
the thioether crosslinks. NisP protease removes the leader peptide from the mature product. Figure from Knerr et al.282 
 
The archetypical class II lantipeptides mersacidin (7.2) was isolated in 1992 from Bacillus by 
Chatterjee et al.294 Mersacidin (7.2) exhibits activity against S. aureus including methicillin-
resistant using a mechanism that targets the cell wall precursor lipid II and inhibits the biosynthesis 
of peptidoglycan leading to the formation of pores and loss of wall integrity.295 A number of other 
class II lantipeptides also bind to lipid II, all bearing a conserved lipid II-binding motif.296  
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Genome mining and in silico analysis have expanded the number of two-component class II 
lantipeptides, which comprise two chains with a synergistic mode of action297 including 
haloduracins (7.3 -7.4) from Bacillus halodurans C-125 and lichenicidins α and β (7.5 -7.6) from 
Bacillus licheniformis (Figure 7.4 and Figure 7.5).298-300 Typically the two-component lantipeptide 
gene clusters contain two encoded peptides (LanA1 and LanA2) and two modification (Lan M) 
enzymes (LanM1 and LanM2). The two-peptide components act synergistically by binding to lipid 
II and form pores in the target bacterial membrane, similar to mersacidin (7.2). This similar 
mechanism of action is attributed to the mersacidin lipid-II binding motif found in the two-
component lantipeptide α chain.301,302 
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Figure 7.4 Structure of class II two-component lantibiotic haludoracin α (7.3) and β (7.4) 
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Figure 7.5 Structure of class II two-component lantibiotic lichenicidin α (7.5) and β (7.6) 
 
The abundance of lantipeptides was greatly underestimated until recent genome sequencing 
revealing several new lantipeptide classes (Table 7.1). Genome sequencing of bacterial genomes 
also revealed the wide distribution of lantipeptide genes across hundreds of genomes from different 
phylums including Bacteroidetes, Chlamydiae, Proteobacteria and Cyanobacteria.282,303-306 To date 
there are over 90 characterised lantipeptides with a predicted or confirmed structure, mass and 
physicochemical and biological properties and are deposited in the dedicated bacteriocin database 
called Bactibase.266 
 Table 7.1 Examples of lantipeptides, classification and their discovery method 
Antibiotic Class Dicovery Method 
nisin A (7.1) I Antibacterial inhibition observed292 
subtilin (7.7) I Antibacterial inhibition observed307 
microbisporicin (NAI-107) (7.8) I High-throuhgput screening 308  
mutacin 1140 (7.9) I Deffered antagonism309 
haloduracins α and β (7.3-7.4) II  In silic analysis300 
lichedicidins α and β (7.5-7.6) II  In silico analysis298 
sap B (7.10) III Structural elucidation, In silico analysis310 
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7.4 Lantipeptide applications 
 
The lantibiotic nisin (7.1) has been used since the 1940s as an effective food preservative without 
the appearance of resistant strains.311 The antibacterial activity and specificity displayed by 
lantipeptides against a number of Gram-positive and Gram-negative pathogens has made them 
attractive drug leads. A number of lantipeptides have shown activity against medically significant 
Gram-negative Neisseria and Helicobacter strains as well as drug resistant Gram-positive 
Staphylococcus, Streptococcus, Enterococcus and Clostridium strains.312 A few lantibiotics like 
microbisporicin NAI-107 (7.8), mutacin 1140 (7.9), and lactacins 3147 α and β (7.11 − 7.12) have 
undergone pre-clinical trials as antibiotics.313-315 The actagardine derivative NVB302 (7.13) and 
duramycin (7.14) completed phase I and II clinical trials for the treatment of Clostridium difficile 
and cystic fibrosis respectively.316,317 Besides clinical use, lantipeptides are currently investigated 
for agriculture usage and as molecular probes for imaging.28,318 
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7.5 Bacillus spp. as sources of lantipeptides 
 
Many Bacillus have yielded antimicrobial agents in recent years including novel lantipeptides, a 
few examples are shown in Table 7.2. 
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Table 7.2 Examples of Bacillus-derived lantipeptides  
Strain lantipeptide 
B. subtilis ATCC 6633 subtilin (7.7)319 
Bacillus subtilis strain A1/3 ericin S (7.15)320 
Bacillus sp. strain HIL Y-85 mersacidin (7.2)321 
Bacillus halodurans C-125 haloduracin α and β (7.3 – 7.4)299 
Bacillus licheniformis DSM13 lichenicidin α and β (7.5 – 7.6)322 
Bacillus amyloliquefaciens GA1 amylolysin (structure undetermined)323 
Bacillus subtilis MMA7 subtilomycin  (structure undetermined)324 
 
The genus Bacillus is ubiquitous and tolerates adverse and extreme conditions, such as high 
temperatures, pH and salinity, allowing its survival and adaptation to a diverse range of terrestrial 
and marine environments.325 Bioactive chemistry from several marine-derived Bacillus sp. strains in 
recent years has increased interest in them as producers of structurally versatile bioactive 
metabolites.326-329 Among the range of bioactive molecules produced by marine Bacillus sp., RiPPs 
are an underexplored class of molecules with only a few isolated from marine bacteria.324 In our 
studies we ventured into an in silico investigation of a cone snail-derived Bacillus sp. (CMB-
CS100) genome and focused our efforts on a lantipeptide gene cluster. Results and discussion 
7.5.1 Isolation of Bacillus sp. (CMB−CS100) 
 
The strain Bacillus sp. (CMB-CS100) was recovered from the cultivation of homogenised stomach 
tissue from a specimen of Conus miles collected from the Great Barrier Reef in September 2011 
(specimen dissection and microbial cultivation methodology is detailed in chapter 2). When 
cultivated in marine agar, Bacillus sp. (CMB-CS100) displayed a pale peach colouring after 2-3 
days at 26.5 °C (Figure 7.6).  
 
 
Figure 7.6 Bacillus sp. (CMB−CS100) cultivated on marine agar for 2-3 days at 26.5 °C 
 
The genomic DNA from Bacillus sp. (CMB-CS100) was obtained with a modified 
phenol/chloroform method,330 and was sequenced using the Ilumina platform (see experimental for 
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genome assembly details). The taxonomy was obtained from the identification of the 16S rRNA 
DNA sequence in the Bacillus sp. (CMB-CS100) assembled genome using the 27F primer sequence 
as a searching tool to locate the region conding for the 16S rRNA. To study the phylogenetic 
relationship between reference strains of Bacillus spp. and CMB-CS100, we constructed a 
phylogenetic tree using 16S rRNA DNA sequences from the Refseq BLAST in which CMB-CS100 
showed a closer similarity to several strains of Bacillus licheniformis (Figure 7.7). 
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Figure 7.7 Phylogenetic tree obtained by PhyML Maximum Likelihood analysis of 16S rRNA sequences using the 
optimal nucleotide substitution model determined by jModeltest2114 using UGENE115 showing the relationship of CMB-
CS100 among selected reference strains (RefSeq GenBank) with their accession numbers indicated in braquets 
 
7.5.2 Genome mining guided identification of lantibiotics in Bacillus sp. (CMB−CS100)  
 
We used three bioinformatics platforms to explore biosynthetic genes of Bacillus sp. 
(CMB−CS100) namely antiSMASH,265 Bactibase266  and BAGEL3.44 The antiSMASH genome 
mining platform is designed to discover biosynthetic gene clusters in whole genome sequences of 
bacteria and fungi.265 AntiSMASH identifies biosynthetic clusters such as Non-ribosomal peptide 
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synthases (NPRS), polyketide synthase (PKS), as well RiPPs using Hidden Markov Models 
(HMMs) of protein motifs and predicts their products.283 Bactibase is a Bacteriocin database that 
incorporates several tools to perform homology searches, multiple sequence alignments, Hmmer-
based searches and identifies biosynthetic pathways via sequence similarity.266 BAGEL3 is a 
bacteriocin-mining tool that combines direct and indirect mining to detect novel bacteriocins in 
whole genomes.44  
 
 AntiSMASH and BAGEL identified a lantipeptide cluster in the genome of Bacillus sp. (CMB-
CS100). While antiSMASH predicts all possible biosynthetic gene clusters (PKS, NRPS and 
RiPPs), BAGEL3 is dedicated to bacteriocin gene identification. We focused on the lantipeptide 
cluster identified by antiSMASH and carried out a detailed amino acid sequence analysis of the 
precursor pre-peptide amino acid sequences. We retrieved four open reading frames corresponding 
to pre-peptide amino acid sequences from the lantipeptide cluster predicted by antiSMASH, we 
then used these sequences to search for sequence homologs in Bactibase. Amino acid sequences 
showing similarity to our query Bacillus sp. (CMB-CS100) pre-peptide amino acid sequences were 
retrieved from Bactibase and aligned with the sequence alignment tool MUSCLE.331 To analyse the 
Bacillus sp. (CMB-CS100) pre-peptides, we followed an analysis pipeline including the 
aforementioned bioinformatics tools (antiSMASH, Bactibase and BAGEL3) (Figure 7.8). Our 
analysis provides evidence of a novel class II lantipeptide potentially belonging to a new subclass of 
two-component lantipeptide. We expressed the lantipeptide under standard culture conditions, 
obtained purified fractions and subjected the fractions to antibacterial assays. 
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Figure 7.8 Schematic representation of the pipeline applied to Bacillus sp. (CMB-CS100) for the identification, 
sequence analysis and recovery of the lantipeptide AntiSMASH: genome of Bacillus sp. (CMB-CS100)  
 
AntiSMASH identified 13 biosynthetic gene clusters in the genome of Bacillus sp. (CMB-CS100), 
three NRPS-PKS hybrid, three NRPS, one bacteriocin, one terpene, one siderophore, one PKS type 
III, one lantipeptide cluster and one putative cluster marked as “other” (Figure 7.9).  
Chapter 7 Genome mining guided discovery of a novel lantipeptide  
 192 
 
Figure 7.9 Screen snapshot of antiSMASH predicted gene clusters  
 
We focused this work on the lantipeptide biosynthetic cluster from Bacillus sp. (CMB-CS100) with 
view to discover a novel antibiotic. The Bacillus sp. (CMB-CS100) lantipeptide gene cluster 
revealed 15 open reading frames (ORF), namely the cns locus (cone snail), including four pre-
peptide precursor genes (cnsA1-cnsA4) and two LanM enzymes (cnsM1 and cnsM2). Lowercase 
italics refer to the structural genes (eg. cnsA1 and cnsM1), and the translated peptide is referred to 
with a non-italic font (CnsA1-CnsA4 and CnsM1). 
 
The presence of two LanM modification enzymes in a lantipeptide gene cluster is a common feature 
of the two-component class of lantipeptides found in the gene cluster of haloduracins (7.3 – 7.4) 
from Bacillus sp. and lichenicidins from Bacillus licheniformis DSM13 (7.5 – 7.6).297,298 However, 
in contrast to haloduracins (7.3 – 7.4) and lichenicidins (7.5 – 7.6), the lantipeptide gene cluster in 
Bacillus sp. (CMB-CS100) showed four lantipeptide putative structural genes instead of two 
structural genes. Further analysis on amino acid sequences showed that the two LanM proteins 
CnsM1 and CnsM2 are 26% similar to each other and individually homologous to LchM1 of B. 
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licheniformis (37%, ADM36019.1) and LchM2 of B. licheniformis (CnsM2 is 29%, ADM36019.1), 
respectively. 
 
The CnsT shares 37% homology to the lantibiotic mersacidin transporter system of Bacillus 
(WP_007614860.1). The genetic organization of the lantipeptide cluster 13 from Bacillus sp. 
(CMB-CS100) as well as the two-component lantipeptide linchenicidin is shown in Figure 7.10.  
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Figure 7.10 Line diagram of genetic organization of (a) putative cone snail-derived Bacillus sp. (CMB-CS100) 
lantipeptide and (b) the two-component lantibiotic, lichenicidin from Bacillus lichiniformis DSM13  
 
To explore why four structural genes (cnsA1 – cnsA4) are present in Bacillus sp. (CMB-CS100) 
lantipeptide cluster rather than two pre-peptide components (licA1 and licA2) as seen in the 
lichenicidins (7.5 – 7.6) gene cluster, we aligned the four translated pre-peptide sequences namely 
CnsA2-A4 to study any interesting sequence features.  
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Leader sequence Pre-peptide sequenceCleavage site  
Figure 7.11 CnsA1-A4 amino acid sequence MUSCLE alignment  
 
In Bacillus sp. (CMB-CS100), the three adjecent pre-peptides (CnsA2-A4) are nearly identical, 
encoding two variants. One variant (CnsA3) differs with a val (V) instead of an ile (I) at position 30 
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of the core peptide (Figure 7.11). The putative CnsA1 and CnsA2-A4 pre-peptides have a double 
glycine cleavage motif, identifying the pre-peptide leader sequence.  
 
Pre-peptide leader sequences, featuring 26 amino acids for CnsA1, 22 amino acids for CnsA2, 22 
amino acids for CnsA3 and 27 amino acids for CnsA4, with divergent N-termini. While the role of 
lantipeptide leader sequences remains unclear, some studies suggest that they can greatly increase 
the efficiency of post-translational modification.332 The presence of diverging leader sequences in 
CnsA2-A4 may indicate that three different analogues are produced and/or localisation of the 
translated protein within the cell varies. The CnsA1-A4 pre-peptide amino acid sequences were 
BLASTed against the Bactibase databases and returned a top sequence homology to alpha and beta 
pre-peptide chains of two-component lantibiotics. 
 
7.5.2.1 Bactibase 
 
Bactibase is a dedicated bacteriocin database that documents ~ 200 bacteriocins. Bactibase BLAST 
showed that CsnA1 shares homology with the unmodified pre-peptide alpha chain of two-
component lantibiotics, such as halorudacin α (7.3) (32%), lacticin 3147 α (7.11) (29%), enterocin 
W α (7.16) (29%), lichenicidin α (7.5)  (25%), plantaricin W α (7.18) (25%). Similarly, amino acid 
sequences for CnsA2-A4 share homology to the unmodified pre-peptide beta chain of two-
component lantibiotics such as haloduracin β (7.4) (30%), plantaricin W β (7.19) (25%), 
lichenicidin β (7.6)  (25%), lacticin 3147 β  (7.12) (30%) and enterocin W β (7.17) (22%).  
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To get a further insight on pre-peptide amino acid sequence similarities, we extracted the amino 
acid sequences of the closest homologs of two-component lantibiotics from Bactibase and 
performed an alignment of CnsA1 pre-peptide with two-component alpha chain, and CnsA2-A4 
with beta chains. The amino acid sequence alignments revealed a conserved Cys (C) framework 
among aligned sequences suggesting that Bacillus sp. (CMB-CS100) lantipeptide and the structure 
of two component lantibiotics bear a similar ring topology. We based our analysis by comparing 
with haloduracin (7.3 – 7.4) and suggest it is likely that Bacillus sp. (CMB-CS100) bears rings 
between pre-peptide residues 7 and 15 (ring A), 16 and 21 (ring B), 18 and 31 (ring C) for CnsA1 
(Figure 7.12). Haloduracin (7.3 – 7.4) bear an N-terminal disulfide bridge between two Cys 
residues lacking in CnsA1, however CnsA1 presents two Cys residues located at the C-terminal, 
which may imply that the disulphide bridge forms at the C-terminal rather than the N-terminal for 
haloduracin (7.3 – 7.4). Disulfide bridges are not uncommon in lantipeptides, with haloduracin α 
(7.13) presenting an N-terminal disulfide bridge and other class II lantibiotics such as bovicin HJ50 
(7.20), perecin (7.21), cerecin (7.22) and thurucin (7.23) presented a disulfide bridge at the 
lantipeptide C-terminal.299,333 Although early structure-activity relationship studies suggested that 
disulfide bridges have minor importance in the antimicrobial activities,334 recent studies on 7.20 − 
7.23 proved the disulfide bridges were crucial to lantipeptide antibacterial activity.333 
 
While the structural genes for the Bacillus sp. (CMB-CS100) lantipeptide cluster are indicated with 
lower case italics (cnsA1-cnsA4) and the translated pre-peptide indicated with regular fonts (CnsA1-
CnsA4), when referring to the final folded lantipeptide product, the lantipeptide name will be 
followed with the letters alpha and beta in greek letters (α and β), wich will indicate the final 
conformation of each chain of the two component lantipeptide. 
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Figure 7.12 MUSCLE amino acid sequence alignment of CnsA1 with two-component lantipeptide amino acid 
sequences. Ring formation (A-C, blue arrows) present in many two-component lantibiotics (haloduracin alpha, 
enterocin W alpha, plantaricin W alpha). Disulfide bridge between Cys in haloduracin alpha, enterocin W alpha, 
plantaricin W alpha is indicated with a black connecting line. Unique N-terminal Cys and Thr residues in CnsA1 are 
indicated in red arrows.  
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Structure-activity relationship studies on haloduracin α have shown that rings A and C are essential 
for antibacterial activity while ring B is not, on the other hand for haloduracin β, rings C and D are 
essential for antibacterial activity while A is not (Figure 7.13).334 Using haloduracin α structure as a 
template, it is likely that CnsA1 α bears rings A, B and C but diverges in the location of the 
disulfide bridge, from the N-terminal to the C-terminal. While no antibacterial activity has been 
attributed to disulfide ring in haloduracin α, studies suggest that the disulfide bridge protects the 
lantipeptide from proteolytic activity.334  
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Figure 7.13 haloduracin α (7.3) and haloduracin b (7.4) ring topology 
 
 
To further explore the amino acid sequence similarity shared between CnsA1 and alpha chain of 
two-component lantipeptides, we constructed a phylogenetic tree using amino acid sequences 
obtained from Bactibase. The phylogenetic tree confirmed that CnsA1 is substantially different 
from its closest homologs, haloduracin α (32%), lacticin 3147 α (29%) and lichenicidin α (25%) 
diverging into a separate branch in the phylogenetic tree  (Figure 7.14).  
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Figure 7.14 Phylogenetic tree constructed with amino acid sequences of CnsA1 and amino acid sequences of alpha 
chain of two-component lantibiotics and closest lantipeptide amino acid sequences from Bactibase 
Using the same amino acid sequence principle applied to analysis of CnsA1, CnsA2-A4 amino acid 
sequences were retrieved from antiSMASH and aligned with amino acid sequences for two-
component beta chains from Bactibase. Similarly, the alignment revealed a conserved Cys 
framework among amino acid sequences. Using the haloduracin β structure as a template, it is 
likely that lantionine rings form between Cys residues 18 and 22 (ring B), 24 and 27 (ring C), 29 
and 34 (ring D) for CnsA2-A4 (Figure 7.15).  
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Structure-activity relationship reports on haloduracin β show its rings C and D are essential for 
antibacterial activity, while no activity is associated with ring A.334 For Bacillus sp. (CMB-CS100) 
lantipeptide, it is likely that CnsA2-A4 β has a similar ring topology to haloduracin β except for 
ring A, since CnsA2-A4 lack the N-terminal Cys residue. This may imply that the folded peptide 
for CnsA2-4 β could retain its antimicrobial activity although lacking ring A. It is also likely that 
the N-terminal of CnsA2-4 β may be susceptible to degradation due to the absence of this rings and 
as a result in a smaller lantipeptide chain than expected from the length of the pre-peptide sequence 
(CnsA1-A4).   
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Figure 7.15 MUSCLE amino acid sequence alignment of CnsA1-A4. Blue arrows indicate the conserved amino acid 
cys framework to yield the common rings (B, C and D) found in II two-component lantipeptides. Black arrow indicates 
the A ring in two-component lantipeptide but lacking in CnsA1-A4 
 
To determine sequence similarities between CnsA2-CnsA4 sequenes to beta chain of two-
component lantibiotics, we created a phylogenetic tree with sequences obtained from Bactibase. 
CnsA2-diverge into a separate branch in the phylogenetic tree confirming it is a distinct lantipeptide 
compared to previously characterised lantipeptides (Figure 7.16). 
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Figure 7.16 Phylogenetic tree constructed with amino acid sequences of CnsA2-CnsA4 and amino acid sequences of 
beta chain of two-component lantibiotics and closest lantipeptide amino acid sequences from Bactibase  
Amino acid sequence analysis using the aforementioned bioinformatics tools allowed us gain 
insights on the lantipeptide encoded in the genome of Bacillus sp. (CMB-CS100). To compare the 
outcome of our previously described analysis to other mining tools, we subjected Bacillus sp. 
(CMB-CS100) genome to a bacteriocin-mining platform called BAGEL3. 
7.5.3 BAGEL3 
  
The genome of Bacillus sp. (CMB-CS100) was uploaded onto BAGEL3. Th output was similar to 
antiSMASH and while BAGEL3 predicted structural genes for cnsA1-cnsA4, the information 
provided was limited to pre-peptide prediction. The other components of the gene cluster, such as 
enzyme modification of the amino acid sequence remains unclear. Nevertheless, BAGEL3 
confirmed our finding by showing the identification of a class II lantipeptide cluster in Bacillus sp. 
(CMB-CS100) genome (Figure 7.6).  
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Figure 7.17 Screen shot of BAGEL3 output results for Bacillus sp. (CMB-CS100) Indication of the presence of a class 
II lantipeptide Pre-peptide predicted sequences and line diagram of lantipeptide cluster  
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7.5.4 Structure of the two-component class II lantipeptide from Bacillus sp. (CMB-CS100) 
 
In the previous sections we have used amino acid sequence analysis to establish structural 
components in CnsA1-A4, which allowed us to propose a structure for Bacillus sp. (CMB-CS100) 
lantipeptides (Figure 7.18). A plausible structure of our CnsA1 bears the mersacidin-lipid-II-
binding motif characteristic of pore-forming lantibiotics, such as mersacidin (7.2) and haloduracin 
α  (7.3) (Figure 7.19). The presence of three tandem structural genes (cnsA2-cnsA4) in the Bacillus 
sp. (CMB-CS100) lantipeptide biosynthetic gene cluster is uncommon in other two-component 
lantibiotics gene clusters. As mentioned earlier, their diverging leader sequences may imply a 
variation on their post translational modifications resulting in the production of three divergent beta 
chains, but this still remains to be confirmed. Further analysis will also be required to confirm the 
proposed structure and establish the number unmodified Thr residues. 
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Figure 7.18 Proposed structure for CnsA1 α and CnsA2-A4 β. Possible Thr dehydration (Dhb) sites (purple). Plausible 
unmodified Thr (green). Residue variation (orange), Ile in CnsA2 β and CnsA3 β and Val in CnsA4 β 
Chapter 7 Genome mining guided discovery of a novel lantipeptide  
 205 
Met 
Tyr 
Pro$
Glu$
Asn 
Leu 
 S 
Gly 
Tyr Ala$
Ala$
Leu 
Ala$Asn 
Ile 
Gly 
Ala$
Trp 
Cys 
Ala$ Abu 
Lys$
Abu 
Val 
Ala$
Ser 
 S 
 S haloduracin α"
Cys 
Arg 
Asn  S - S 
A B 
C 
mersacidin3lipid3II3binding$
$mo8f$$
Ala$
Dha$
Val$
Abu$
Leu$
Ala$
Glu Ala 
 Ile 
Leu 
Phe 
Gly 
 S 
Abu 
Abu 
 S 
mersacidin 
Val$
Gly 
Gly 
Gly 
Abu$
 S 
 HN 
 S 
mersacidin3lipid3II3binding$
$mo8f$$
7.2 
7.3 
 
Figure 7.19 Mersacidin (7.2) and haloduracin α (7.3), dashed red circles outline the mersacidin-lipid-II-binding motif 
 
 Ongoing work will determine the definite structure of CnsA1 α  and CnsA2-A4 β, but we can 
confirm from our amino acid sequence analysis that Bacillus sp. (CMB-CS100) encodes a novel 
subclass of class II two-component lantipeptide, potentially a novel subclass which may bear the 
unique feature of three β chain analogues. Progress on the lantipeptide extraction and identification 
of antibacterial activity has been made and is described in the following section. 
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7.5.5 Cultivation, extraction and purification of lantipeptide from the Bacillus sp. (CMB-CS100)  
 
The native strain Bacillus sp. (CMB-CS100) was cultured and the lantipeptide was extracted from 
the bacterial pellet as previously described for haloduracin (7.3 -7.4) and lichenicidin (7.5 -
7.6).298,299 The methodology involves the extraction with isopropanol at low pH to obtain a crude 
concentrate, which was then subjected to sequential purification steps (Figure 7.20). The crude 
extracts and purified fractions were monitored with antibacterial assays against our standard panel 
of Gram-negative and Gram-positive bacteria. Antibacterial activity was detected against Bacillus 
subtilis (ATCC 6633) in the isopropanol crudes and in one purified fraction ([-3-3]).  
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Figure 7.20 Scheme of purification steps for lantipeptide purification from Bacillus sp. CMB-CS100 (a) Centrifugation 
(7000 g × 20 min at 4 °C) (b) Isopropanol (70%, pH = 2) extraction for 4 hours (150 RPM at 4 °C) (c) C18 Sep-Pack 
with EtOH (30%) and Isopropanol (70%, pH= 2) elution (d) and (e) Size exclusion chromatography (LH-20 Sephadex, 
isocratic 70% H2O/30% MeCN) 
 
To validate production of the lantipeptides by Bacillus sp. (CMB-CS100), the purified samples ([-3-
1] to [-3-10]) (Figure 7.20) were subjected to LC-MS and LC-MS/MS. The results were first 
analysed though the Proteinpilot software, which matches the MS/MS ion fragmentation patterns 
detected in the sample with the theoretical spectra predicted based on the amino acid sequence 
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input, in this case CnsA1-CnsA4. Proteinpilot detected an amino acid sequence fragment for 
CnsA2-CnsA4 in sample [-3-3] at maximal confidence  (>99%) (Table 7.3 and Figure 7.21).  
 
This result was consistent with the antibacterial activity detected in sample [-3-3]. These findings 
confirmed the constitutive production of CnsA2-CnsA4 by the native Bacillus sp. (CMB-CS100) 
strain and suggested the novel lantipeptide displays antibacterial activity. With respect to CnsA1, 
Proteinpilot software was unable to recognise a fragment in the active sample ([-3-3]). We believe 
this may be due to the highly modified nature of CnsA1 and the lack of optimization of Proteinpilot 
software to identify highly post-translationally modified lantipeptides.  
 
 Table 7.3 MS/MS sequences identified (highlighted in green) by Proteinpilot (> 99% confidence value) from fractions 
[-3-3] 
Fractio
n 
Pre-peptide Sequence Confidence 
(%) 
Precursor 
mass 
[-3-3] CnsA2-
A4 
VKKQFQALEEVSEMELKELAGG-
AENTPMTVTPTTITVPISLAGCPTTKCASIVSPCNG 
99 1169.62 
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Figure 7.21 Plausible structure of Bacillus sp. (CMB-CS100) lantipeptide CnsA2-A4 β. Dashed red line indicates the 
peptide sequence identified by Proteinpilot in fraction [-3-3] 
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7.6 Conclusion 
 
We investigated the genome of cone snail-derived Bacillus sp. (CMB-CS100) and accessed a map 
of its biosynthetic potential via bioinformatics platforms such as antiSMASH, BAGEL3. We 
applied a detailed amino acid sequence analysis and identified a class II lantipeptide potentially 
belonging to a new subclass of two-component lantibiotics. The production of the identified 
lantipeptide by the native Bacillus sp. (CMB-CS100) was confirmed through proteomic analysis. 
Ongoing work will focus on the recovery of the novel lantipeptide to confirm the predicted 
structure.  
 
Our discovery expands knowledge on lantipeptide biosynthetic clusters particularly for two-
component class II lantibiotics and encourages the use of genome-guided discovery in combination 
with chemistry-based methods to accelerate discovery of novel antibiotics with potential clinical 
applications. Here we applied a concise pipeline that allowed us to access, detect and identify a 
novel amino acid sequence coding for a potentially new lantipeptide. The strategies used for this 
study allowed us to construct a plausible structure and determine its antibacterial properties.  
7.7 Experimental 
7.7.1 General experimental 
 
See general experimental section for Chapter 2, 3, 4.  
 
7.7.2 Bacillus sp. strain collection  
 
The strain Bacillus sp. (CMB-CS100) was isolated from the stomach of the cone snail C. miles 
collected in 2011 from Lady Musgrave Island at the Great Barrier Reef, Queensland. Freshly 
collected cone snail specimen was transported to the laboratory, after which it was rinsed in sterile 
seawater. Tissue was dissected and homogenised using a mortar and pestle and applied to marine 
agar plates, sealed with parafilm and incubated for 3 – 4 weeks. A pure culture of CMB-CS100, 
was obtained by single-colony serial transfer on agar plates and was cryopreserved at –80 °C in 
20% aqueous glycerol. 
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7.7.3 Genomic DNA extraction 
 
High molecular weight genomic DNA (gDNA) was extracted using a modified of the protocol 
developed by Tripathi et al., for Streptomyces aureofaciens.330 Culture (100 mL) was centrifuged at 
4,000 × g for 10 min at 4 °C and cells washed twice with STE buffer (0.3 sucrose, 25 mM Tris/HCl 
and 25 mM Na2EDTA, ph 8.0); 1.0 g (wet weight) mycelium was resuspended in 8.55 mL STE 
buffer and 950 µL lysozyme (20 mg/ml STE buffer) (Amersham Life Science, UK) was then added. 
After protoplast formation at 20-30 min at 30°C, 500 µL 10% SDS (w/v) and 35 µL Proteinase K 
(50 mg/ml) were added and the mixture was held at 37 °C for 1 hour. After which 1.8 ml 5 M NaCl 
was added with gentle mixing to avoid shearing the DNA, 1.5 mL 10% (w/v) of CTAB in 0.7 M 
NaCl (CTAB/NaCl solution) was added and incubated for 20 min at 65 °C. The lysate was 
transferred to a new fresh sterile tube and extracted twice with an equal volume of 
phenol/chloroform/isoamyl alcohol (25:24:1 v/v) and centrifuged at 12,000 g for 10 min. The 
aqueous phase was also extracted once with chloroform/isoamyl alcohol (24:1, v/v) and transferred 
to a fresh tube. DNA was precipitated with 0.6 volume of propan-2-ol washed twice with 70% (v/v) 
ethanol, vacuum dried and dissolved in 100 µl of TE buffer (10 mM Tris/HCl and 1 mM EDTA, pH 
8.0). RNase A (50 µg/ mL) (Amersham Life Science, UK) was added with incubation at 37 °C for 2 
h. The sample was again extracted with phenol as described above and resuspended in 100 µL of 
TE buffer.  
 
7.7.4 Genomic DNA extraction and genome sequencing and assembly 
 
Marine broth (50 mL) was inoculated with a colony of Bacillus sp. (CMB-CS100) and incubated at 
26.5 °C for 24 hours. High molecular weight genomic DNA was extracted from the culture pellet 
using a modified phenol/chloroform method.330 The final DNA pellet was resuspended in DNase 
free water (100 µL) to obtain a final concentration of 250 ng/µL. The gDNA was sequenced on 
Illumina Hi-Seq paired end sequencing platform. SolexaQA package 335 was used to trim reads to 
the longest contiguous read segment above a 0.05 P-value. Quality-trimmed reads shorter than 50 
bp were discarded. De novo genome assembly was performed with SOAPdenovo 336 using k-mer 
values between 21 and 91. These k-mer values represent the minimum read overlap required during 
the assembly of contigs. Contiguous DNA sequences (contigs) shorter than 200 bp were discarded 
from the final assembly. For comparison, reads were also assembled using both Velvet 337 and 
ABYSS 338 genome assemblers. Gene prediction and annotation was performed on the best 
assembly produced by the software. 
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7.7.5 Pre-peptide sequence alignments and Phylogenetic trees 
 
Sequence alignments were produced with the MUSCLE program. ProtTest server was used to 
determine the optimal substitution model for the sequences using the critical Akaike Information 
Criterion (cAIC) generated for each model. The Blosum 62 + I model was used to infer phylogeny 
in Alpha sequences while the VT model was used for the Beta sequences. Trees were constructed 
using the Mr.Bayes program using the aforementioned models. For the Markov Chain Monte Carlo 
(MCMC) inference, 1000000 generations were used with a subsampling frequency of 1000. Trees 
were visualised using Ugene’s tree view. 
 
7.7.6 Cultivation of Bacillus sp. (CMB-CS100) and lantipeptide purification  
A seed culture of Bacillus sp. (CMB-CS100) was prepared by inoculating a falcon tube (50 mL) 
containing marine broth (10 mL) and incubated in a shaker at 26.5 °C for 24 h. Six 2 L Erlenmeyer 
flasks containing sterile LB broth (500 mL) inoculated with the overnight culture (0.5 mL) were 
incubated at 26.5 °C for 16-18 h, after which the culture was centrifuged and pellet was extracted 
with isopropanol pH = 2 (300 mL) for 5 h at 4 °C, concentrated in vacuo at 40 °C to obtain crude 
extract concentrate (5 mL). Crude extract was applied to an equilibrated C18 Sep-Pack column, 
washed with 30% EtOH (30 mL) and eluted with isopropanol (100 mL). Isopropanol fraction was 
concentrated to 3-5 mL an applied to LH-20 separation column and 10 fractions were collected.  
We applied a modified isopropanol method to extract the two-component lantibiotic from Bacillus 
sp. (CMB-CS100). Four flasks (2L) containing LB media (500 mL) was inoculated with an 
overnight culture (10 mL) and incubated at 37 °C for 18 h, bacterial pellet by centrifugation (7000 g 
for 20 min at 4 °C), resuspended with 70% isopropanol (pH = 2) and placed on shaker for 4 h at 4 
°C. Isopropanol was recovered by centrifugation and dried in vacuo to approximately 5 mL) and 
loaded into a Sep-Pak C18 column equilibrated with MeOH and water. The C18 Sep-Pak column was 
washed (30% EtOH) once and lantipeptide concentrate eluted with 70% isopropanol (pH= 2). The 
isopropanol recovered from C18 Sep-Pak elution was concentrated in vacuo to 2 mL and loaded 
onto a size exclusion chromatography column (Sephadex LH-20 column, isocratic 70% 
H2O/30%MeCN) to yield 10 fractions. 
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7.7.7 LC-MS and LC-ESI-MS 
 
LC-MS and LC-ESI-MS were performed on the 5600 triple TOF (AB SCIEX, Framingham, MA, 
USA). The AB Sciex 5600 triple TOF is an electrospray quadruple time of flight (QqTOF) MS 
equipped with a Duo-Spray ionization source and coupled to an upstream Shimadzu series HPLC 
system. Samples were separated on a gradient of 1 −80% B (90% MeCN/0.1% formic acid) over 50 
min prior to injection. Ions were sprayed at a voltage of 5300 V, and full scan MS was performed 
for 250 ms with product ion data recorded in the Information Dependent Acquisition (IDA) mode. 
Data was acquired for ions in a mass range of 300-2000 (m/z) in the MS mode and 80-2000 (m/z) 
for the MS/MS. The proteinPilotTM 4.0 software (AB SCIEX, Framingham, MA, USA) was used 
for sequence identification by performing a BLAST of pre-peptide (CnsA1-CnsA4) sequences in 
the LC-ESI-MS/MS data of each purified fraction using the paragon algorithm. 
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8 General conclusions and outlook 
 
This study was set out to explore microbes associated with venomous animals as a source of novel 
chemistry. We began this investigation under the assumption that venomous animal associated 
microbes may impart important chemistry that would be ecologically beneficial to the host. 
Microbes sourced from a number of Australian venomous animals included fungi as well as 
sporulating actinobacteria and non-sporulating bacteria. These isolates were subjected to chemical 
profiling, with many demonstrating ability to produce secondary metabolites under standard 
cultivation media.  Biological profiling (chapter 2) was used in conjugation with chemical profiling 
to further prioritise isolation.  
 
Waspergillamide A (3.24) is a first class example of a diketopiperazine tetrapeptide with the added 
novelty of bearing a nitro functionality. The investigation into the biosynthesis and in particular the 
role of PABA as the starter unit is ongoing. Perhaps one of the most surprising finding in our study 
involves the isolation of the rare fungi Quambalaria sp. (CMB-W001) from wasp, leading to the 
identification of a pheromone previously isolated from insects (beetle). Recent personal 
communication with a collaborative partner testing the contact sex pheromone in insect behavior 
assays indicated that callosobruchusic acid (6.13) elicits a response with Queen bees. These studies 
support our inter-kingdom pheromone crossover hypothesis. This investigation was greatly 
supported with the phylogenetic analysis conducted allowing the identification of the unexpected 
link between Quambalaria sp. and their association with beetles.  
 
Cone snail associated Streptomyces sp. solvent extracts were prioritised by bioassays described in 
chapter 2 showing the ability to produce antifungal agents. This antifungal activity detection led this 
investigation to the identification of several antifungal molecules such as antimycin (5.17) and 
PTMs (5.14 − 5.16). The observation of an antifungal activity elicited by various Streptomyces 
obtained form different cone snail species hinted towards a true symbiotic relationship and perhaps 
is a result of a co-evolution between cone snails and antifungal producing microbes. The chemical 
investigation and structure elucidation of chemistry from cone snail-derived Streptomyces was 
greatly hampered by the extremely low quantities of pure metabolites obtained for NMR analysis (< 
1 mg). However, the identification of antifungals was greatly facilitated with the use of sensitive 
analytical methods and the access of standards. Efforts to obtain the structure of metabolites with 
neuroactive properties was inconclusive due to the amount of material for NMR structure 
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elucidation. This represents a great limitation in obtaining novel compounds or compounds 
responsible for the bioactivity detected during biological screenings. 
 
Genome mining represents a promising tool to access the chemical biosynthetic potential of 
selected strains, which show a low production of metabolites. As part of our studies we included the 
in silico investigation of cone snail-derived Bacillus sp. (CMB-CS100). The in silico analysis 
allowed the identification of a novel biosynthetic gene cluster, which was validated with MS/MS 
assays. Our studies highlight the evident need to unite chemistry and genomic efforts to effectively 
obtain metabolites that ultimately will fulfill the expectations placed on microbes as the untapped 
source of novel bioactive metabolites. 
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